CN1543569A - 识别凝血酶阴性的葡萄球菌和金黄色葡萄球菌的表面蛋白的交叉反应性单克隆抗体和多克隆抗体 - Google Patents
识别凝血酶阴性的葡萄球菌和金黄色葡萄球菌的表面蛋白的交叉反应性单克隆抗体和多克隆抗体 Download PDFInfo
- Publication number
- CN1543569A CN1543569A CNA028160010A CN02816001A CN1543569A CN 1543569 A CN1543569 A CN 1543569A CN A028160010 A CNA028160010 A CN A028160010A CN 02816001 A CN02816001 A CN 02816001A CN 1543569 A CN1543569 A CN 1543569A
- Authority
- CN
- China
- Prior art keywords
- ser
- thr
- lys
- ala
- asn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
提供了与凝血酶阳性的葡萄球菌细菌,例如溶血葡萄球菌发生交叉反应的多克隆和单克隆抗体,所述的抗体能够识别凝固酶阳性的和凝固酶阴性的葡萄球菌细菌的表面蛋白质。从基于金黄色葡萄球菌和凝固酶阴性的葡萄球菌之间共有的特性分离的表面蛋白质可以制备抗体,这些重组表面蛋白质可用于制备本发明的抗体。还提供了利用这些蛋白质和抗体用于治疗或抵抗各种各样的葡萄球菌的感染的疫苗和方法。
Description
相关申请
本申请要求享受2001年6月15日递交的美国临时申请系列号60/298,098的利益。
发明领域
总的来说,本发明涉及来自金黄色葡萄球菌的表面蛋白质及其活性的区域例如它们的A功能域,它具有凝固酶阴性的葡萄球菌例如表皮葡萄球菌和溶血葡萄球菌上的同源蛋白质,以及识别上述的蛋白质的抗体,具体地说,涉及分离的单克隆和多克隆抗体,它们识别来自金黄色葡萄球菌和凝固酶阴性的葡萄球菌的特定的蛋白质,以及抗金黄色葡萄球菌和凝固酶阴性的葡萄球菌的交叉反应,因此可用于疫苗,以及用于预防或治疗各种各样的由葡萄球菌的细菌引起的感染的方法。
发明背景
对于大多数引起动物和人类的传染病的微生物,在宿主中成功地形成集落是一个必需的过程。微生物的粘附是最后导致疾病的一系列事件的第一个重要步骤。借助细菌表面的特定的adhesins,通过粘附到宿主组织或血清限定的移植入的生物材料,例如导管,人工的关节,血管的移植片,病原微生物在宿主中形成集落。MSCRAMMs(识别粘附的基质分子的微生物表面成分)是细胞表面adhesins的一个家族,它们识别和特定地结合到宿主的细胞外的基质的不同的组分。一旦细菌成功地粘附并且在宿主组织中形成集落,他们的生理机能被急剧改变并且分泌受损害的成分例如毒素和水解蛋白质的酶。此外,粘连的细菌常常产生生物膜并且很快地变得对大多数的抗生素的杀戮效果更具抗性。
金黄色葡萄球菌产生从皮肤上的损害例如伤口感染,脓疱病,疖到包括肺炎,脓毒性的关节炎,脓毒病,心内膜炎的威胁生命的状况以及生物材料相关的传染病的范围的感染谱。已知金黄色葡萄球菌表达不同的MSCRAMMs的全部技能,它们独立地或者协调地促进微生物的粘附到特定的宿主组织组分。另外,葡萄球菌细菌的另一个类型被识别为凝固酶阴性的细菌,包括例如已知同样地表示MSCRAMMs的表皮葡萄球菌和溶血葡萄球菌,也对各种各样的细菌的感染和有关的疾病负有责任。关于这一点,通常MSCRAMMs由抗体,多克隆和单克隆抗体,对免疫学的攻击提供出色的靶。
然而,由于抗体本性非常特异的,就不同类型的葡萄球菌而言,例如一方面金黄色葡萄球菌(凝固酶阳性)和另一方面表皮葡萄球菌和溶血葡萄球菌(凝固酶-阴性的),研制显示不同的类型的细菌之间年的交叉反应性的抗体,仍然是值得注意的问题。这样的交叉的反应的抗体是特别令人想望的,因为他们具有使人类和动物患者致免疫的潜在性和提供抵抗由两种类型的葡萄球菌的细菌,即凝固酶阳性的细菌例如金黄色葡萄球菌和凝固酶阴性的细菌,例如表皮葡萄球菌和溶血葡萄球菌引起的感染潜在性。因此这样的抗体在预防或治疗各种各样的由葡萄球菌的细菌引起的感染中非常地有效。
发明概述
因此,本发明的目的之一提供识别来自凝固酶阳性的细菌例如金黄色葡萄球菌的MSCRAMMs以及来自凝固酶阴性的细菌,例如表皮葡萄球菌和溶血葡萄球菌的MSCRAMMs的单克隆抗体。
本发明的还有一个目的是识别和分离来自葡萄球菌的细菌的MSCRAMMs,以及他们的活性的区域例如A区域,该区域可用于产生与凝固酶阳性的和凝固酶阴性的葡萄球菌发生交叉反应的单克隆和多克隆抗体。
本发明的另一个目的提供可以识别来自凝固酶阴性的葡萄球菌的表面蛋白质例如DgsK蛋白质的A区域,同时识别来自金黄色葡萄球菌的表面蛋白质例如SasA蛋白质的分离的抗体。
本发明的又一方面是利用本发明的分离的蛋白质,A区域和抗体生产用于治疗或预防葡萄球菌的感染的疫苗,以及提供了其中将本发明的疫苗和抗体可用于预防或治疗葡萄球菌的感染的方法。
这些和其他的目的通过本发明实现,所述的发明包括识别和分离一种类型的葡萄球菌的细菌例如凝固酶阴性的或凝固酶阳性的葡萄球菌的表面蛋白质,它导致产生识别两种类型的葡萄球菌的表面蛋白质的交叉的反应性的抗体,并且因此将抗体用于治疗或预防各种各样葡萄球菌的感染的疫苗和方法。本发明还涉及从这些表面蛋白质产生多克隆和单克隆抗体,以及它们用于预防或治疗葡萄球菌的感染。
对本领域内技术人员而言,根据阅读本说明书和/或在此处记载的参考文献,这些具体的实施方案和在公开的发明的精神和范围之内的其他的供替代的选择和改变是显而易见的,所有引用的文献都被并入本文。
附图简述
附图1是本发明的in silico预测的蛋白质的一级的结构图。
附图2显示本发明的开放读框表达的N-末端His标记的纯化的重组的蛋白质的考马斯亮蓝染色凝胶。
附图3A-3C显示分别用抗-KesK抗体(附图3A),抗-KnkA抗体(附图3B)和抗DsqA抗体(附图3C)探测时金黄色葡萄球菌的细胞壁提取物的Western印迹。
附图4A-4B显示表达金黄色葡萄球菌的MSCRAMM称为KnkA(附图4A)和KesK(附图4B)的乳酸乳球菌的点印迹和Western免疫印迹。
附图5A-5D代表用康复的人血清体内检测表达本发明重组LPXTG蛋白质,包括RrKn和RrKN2(附图5A),Kesk1和Kesk2A(附图5B),KnkA(附图5C)和DsqA2(附图5D)的探测情况。
附图6显示证实抗金黄色葡萄球菌SasA的兔多克隆抗体与从表皮葡萄球菌HB细胞表面释放的蛋白质以及来自从表皮葡萄球菌克隆的DsgK的重组A-区域发生交叉反应的Western印迹分析结果。
优选的实施方案的详细描述
根据本发明,提供了来自凝固酶阳性的葡萄球菌的细菌例如金黄色葡萄球菌以及凝固酶阴性的葡萄球菌的细菌例如表皮葡萄球菌和溶血葡萄球菌,的特定的表面蛋白质,包括其活性片段例如这些蛋白质或可以产生识别完整的蛋白质的抗体的其他的表位区域的A区域。根据本发明,基于MSCRAMMs(识别粘附基质分子的微生物表面成分)的一些共有的特征实施候选肽序列和蛋白质的鉴定和分离,在大多数情况下,这些特征共价地固定到细胞壁肽葡聚糖。这些表面蛋白质具有下列的共有的特征可用于确定和分离本发明的序列,即:(i)Sec-依赖性分泌必需的N-末端信号肽(长度大约40个残基),(ii)一个富含脯氨酸和甘氨酸残基或由丝氨酸和门冬氨酸盐二肽重复组成点的跨壁功能域;(iii)蛋白质共价固定到肽葡聚糖中的五个甘氨酸交联桥必需的LPXTG基序,(iv)一个疏水的跨膜功能区,跟随其后的(v)几个带正电荷的残基。
根据本发明,按照以上所述的特性,通过开发金黄色葡萄球菌的完整的基因组,识别了至少八个新的开放读框编码的蛋白质,具有分泌和固定象征MSCRAMMs的基序(即的携带N-末端信号肽和跟随疏水的功能区之后的C-末端LPXTG基序和一个带正电的尾部)。表1阐明所识别的蛋白质的一览表,包括在金黄色葡萄球菌基因组中的分布,蛋白质的大小和C-末端细胞壁排序序列。
表1
名称 | 分布 | 大小 | C-末端 |
EkeS | ENCSJM | 2189aa | LPNTGSEEMDLPLKELALITGAALLARRRSKKEKES |
DsqA | ENCSJM | -1363-2283aa | LPDTGDSIKQNGLLGGVMTLLVGLGLMKRKKKKDENDQDDSQA |
KesK | ENCSJM | -909aa | LPKTGETTSSQSWWGLYALLGMLALFIPKFRKESK |
KrkN2 | ENCSJM | -278aa | LPKTGLTSVDNFISTVAFATLALLGSLSLLLFKRKESK |
KrkN | ENCSJM | -661aa | LPQTGEESNKDMTLPLMALIALSSIVAFVLPRKRKN |
RkaS | ENCSJM | -801aa | LPKTGTNQSSSPEAMFVLLAGIGLIATVRRRKAS |
RrkN | NCSJM | 1629aa | LPKTGLESTQKGLIFSSIIGIAGLMLLARRRKN |
KnkA | NCSJM | 629aa | LPKAGETIKEHWLPISVIVGAMGVLMIWLSRRNKLKNKA |
缩写:eMRSA-16;N,8325;C,COL;S,MSSA;J,N315,M,Mu50。
8个蛋白质中的6个存在于已经被测序的所有六个葡萄球菌的基因组中,剩余的2个存在于5/6的这些基因组中。
根据本发明,获得上述的蛋白质的氨基酸和编码它的核酸序列,如下所述:Ekes MRSA-SEQ ID NO:1(DNA序列);EkeS~MRSA-SEQ ID NO:2(蛋白质序列);DsqA(8325)-SEQ IDNO:3(DNA序列);DsqA(8325)-SEQ ID NO:4(蛋白质序列);KesK1(8325)-SEQ ID NO:5(DNA序列);KesK1(8325)-SEQ IDNO:6(蛋白质序列);KrkN2(8325)--SEQ ID NO:7(DNA序列);KrkN2(8325)-SEQ ID NO:8(蛋白质序列);KrkN(8325)-SEQ IDNO:9(DNA序列);KrkN(8325)-SEQ ID NO:10(蛋白质序列);RkaS(COL)-SEQ ID NO:11(DNA序列);RkaS(COL)-SEQ IDNO:12(蛋白质序列);RrkN(8325)-SEQ ID NO:13(DNA序列);RrkN(8325)-SEQ ID NO:14(蛋白质序列);KnkA(8325)-SEQ IDNO:15(DNA序列);KnkA(8325)-SEQII7 NO:16(蛋白质序列)。
根据本发明,可以从上述的蛋白质或他们的活性区域例如A区域产生分离的抗体以便能够识别上述的蛋白质和/或上述的功能区。这些抗体可以是单克隆的或多克隆的。如果需要多克隆抗体,可以本领域内熟知的许多常规方法的任何一种制备。一种典型的方法是,可以将需要的表面蛋白质或其活性的区域注射到合适的宿主动物,例如,小鼠或兔子,在合适的时间期间之后,可以从该宿主动物分离和回收想要的抗体。对于单克隆抗体,根据本发明,可以许多合适的方法包括例如熟知的Kohler和Milstein,Nature 256:495-497(1975)方法,本领域内已知的任何其他方法,例如美国专利Nos.6,331,415;5,981,216;5,807,715;和4,816,567;欧洲专利申请519,596;和PCT公开WO 00/71585公开的方法制备,所有这些专利文献都通过在此引述而合并于本文。这些方法包括其制备如以本领域内熟知的方式进行嵌合,人性化,或人的单克隆抗体。仍然进一步地,可以从一个单链,例如轻或重链制备,以及还可以从保持完整的抗体的结合特性(例如,特异性和/或亲合力)的抗体的活性的片段制备单克隆抗体。活性的片段是指具有与完全抗体相同的结合特异性的抗体片段,所述完全抗体结合到来自不同的类型的葡萄球菌细菌(即凝固酶阴性的,或凝固酶阳性的)的特定的表面蛋白质或其同系物。本文术语″抗体″包括所述的片段。另外,也可以利用本发明的单克隆或多克隆抗体制备抗血清,可以本领域内熟知的许多合适方式制备。
如上所述,可以本领域内熟知的许多合适的方式制备本发明的抗分离的表面蛋白质和/或其活性的区域的抗体,例如上述所述的完全建立的Kohler和Milstein方法,可用于产生单克隆抗体。例如,在这样的一种方法的预备的步骤中使用,可以在长时间的时期用本发明的纯化的重组MSCRAMM或其活性的部分长期给小鼠每一周腹膜内注射一次,随后测试从免疫接种的老鼠获得的血液以测定与纯化的蛋白质的反应性。在识别老鼠与该蛋白质的反应性之后,将从小鼠脾脏分离的淋巴细胞与小鼠脊髓细胞融合以产生抗本发明的表面蛋白质的抗体阳性的杂交瘤,然后分离和培养,随后纯化和使之形成同位型。
为了产生本发明的单克隆抗体,优选的是利用本发明的重组制备的MSCRAMM′s来制备,利用本领域内熟知的许多标准方法可以制备这些重组子并且分离。例如,一种这样的方法使用了大肠杆菌表达载体pQE-30作为克隆和表达重组蛋白质和肽的表达载体。在一个优选的方法中,利用PCR,从上面描述的序列扩增识别为DgsK或SasA的表面蛋白质的A区域,再克隆到大肠杆菌表达载体PQE-30(Qiagen),以允许表达一种含有六个组氨酸残基的重组融合蛋白质。 随后将该载体转化到大肠杆菌ATCC55151,在15-升发酵罐中生长到光密度(OD600)为0.7,用0.2mM异丙基-1β-D半乳糖苷(IPTG)诱导4小时。利用AGTechnologies中空纤维组件(孔大小0.45um)收集细胞,将细胞浆在-80C冷冻。利用2次穿过French Press,1100psi,将细胞在1×PBS(10mL缓冲液/1克的细胞浆)裂解。将裂解的细胞17,000rpm旋转30分钟以除去细胞碎片。将上清液经过装备了0.1M NiCI2的5-毫升Hi俘获Cheating(Pharmacia)柱。在上样之后,用5个柱体积的10mM Tris,pH 8.0,100mM NaCI(缓冲液A)洗涤柱子。利用超过30个柱体积的0-100%梯度的10mM Tris,pH 8.0,100mM NaCI,200mM咪唑(Buffer B)洗脱蛋白质。SdrGN1N2N3或SdrGN2N3在-13%Buffer B(~26mM咪唑)被洗脱。监测280nm处的吸光率。在1×PBS中透析含有SdrGN1 N2N3或SdrGN2N3的馏分。
接著,然后将各个蛋白质经过一个内毒素除去方案。在该方案中所使用的缓冲液通过一个5-毫升Mono-Q琼脂糖(Pharmacia)柱而没有内毒素。将蛋白质平衡地分到4×15毫升试管中。各个试管的体积用缓冲液A加到9毫升。将1毫升的10%Triton X-114加入到各个试管中,在4℃旋转保温1小时。将试管置于37℃水浴中以使相位分离。将试管以2,000rpm旋转10分钟,收集各个试管的上面的含水的相,用去污剂反复提取。将2次提取的含水相合并,传递过带有0.1M NiCl2的5-mL IDAcheating(Sigma)柱,以除去剩余的洗涤剂。用9个柱体积的Buffer A洗涤该柱,然后用3个柱体积的Buffer B洗脱该蛋白质。将洗脱液通过5-毫升的Detoxigel(Sigma)柱,收集流出物,再上样到柱。收集第二次过柱的流出物,在1×PBS中透析。分析纯化的产物的浓度,纯度和内毒素水平,然后给小鼠给药。
在该优选的方法,以下面的方式从上面识别的重组蛋白质可以制备本发明的单克隆抗体。在该方法中,将大肠杆菌表达的和纯化的重组SasA和DsgK蛋白质用于制备一组鼠的单克隆抗体,而将小鼠血清用作为多克隆抗体的来源。简单地说,一组Balb/C或SJL小鼠接收了一系列皮下的免疫接种1-10mg溶液蛋白质或与下面表2描述的佐剂混合的蛋白质。
表2免疫接种方案
RIMMS
注射 天数 数量(微克) 途径 佐剂
#1 0 5 皮下 FCA/RIBI
#2 2 1 皮下 FCA/RIBI
#3 4 1 皮下 FCA/RIBI
#4 7 1 皮下 FCA/RIBI
#5 9 1 皮下 FCA/RIBI
常规注射 天数 数量(微克) 途径 佐剂
原始 0 5 皮下 FCA
加强#1 14 1 腹膜内 RIBI
加强#2 28 1 腹膜内 RIBI
加强#3 42 1 腹膜内 RIBI
在杀死时(RIMMS)或加强后几天收集(常规的)血清,在ELISA测定中测定抗MSCRAMM蛋白质或对完整的细胞(表皮葡萄球菌和金黄色葡萄球菌)的效价。在最后的加强之后3天,去除脾脏或淋巴结,挑开成单细胞悬浮液,收集淋巴细胞。然后将淋巴细胞与P3X63Ag8.653骨髓瘤细胞系(ATCC & CRL-1580)融合。根据Current Protocols in Immunology(第2章,第2单元)中的生产单克隆抗体的方案进行细胞融合,随后涂覆平板和喂养,所述文献都通过在此引述而合并于本文。
然后利用标准的ELISA分析方法,从融合产生的任何克隆中筛选特异的抗-SasA抗体的产生。扩增阳性的克隆,进一步通过流式血细胞计数测试完整的细菌的细胞结合测定中的活性以及Biacore分析中SasA的结合。在整个Biacore分析中,流速保持在10毫升/分钟不变。在注射SasA或DgsK之前,借助于RAM-Fc结合,将测试抗体吸附到芯片。在时间0,将浓度为30mg/ml的SasA或DgsK注射过芯片3分钟,随后解离2分钟。对该阶段的分析测定Mab/SasA和DgsK相互作用的相对关系和解离常数。
接著,对上面提到的抗体与完整细菌的结合情况进行测试。在该测试中,用兔子IgG(50mg/ml)封闭之后,收集,洗涤细菌的样品金黄色葡萄球菌Newman,金黄色葡萄球菌60,金黄色葡萄球菌397(Sal6),金黄色葡萄球菌Wood,金黄色葡萄球菌8325-4,甲氧苯青霉素抗性的金黄色葡萄球菌MRSA 16,表皮葡萄球菌ATCC 35984,表皮葡萄球菌HB,表皮葡萄球菌CN-899和溶血葡萄球菌ATCC 43253,用浓度为2pg/ml的Mab或仅用PBS(对照)保温。在用抗体保温之后,将用作为检测抗体的山羊-F(ab′)2-抗-小鼠-F(ab′)2-FITC用于孵育细菌的细胞。在抗体标记之后,用FACS管径流式细胞计数器抽吸细菌的细胞以分析荧光射出(刺激:488,发射:570)。对于各个细菌的菌株,收集和检测10,000个样品。这些资料显示抗金黄色SasA的抗体能够识别凝固酶阴性的葡萄球菌的表面的同源的蛋白质。该资料支持Western印迹分析,表明抗金黄色葡萄球菌SasA的兔子多克隆抗体与从表皮葡萄球菌HB细胞表面释放的蛋白质以及来自于从表皮葡萄球菌克隆的DsgK的重组A-区域发生交叉反应(参见附图6和下表3)。
表3多克隆血清反应性
Newman | 67-0 | 397(SAL6) | Wood46 | 8325-4 | MRSA16 | ATCC3598 | HB | CN-899 | ATCC4325 | |
4 | 3 | |||||||||
常规小鼠血清 | - | - | - | - | - | - | - | - | - | |
小鼠抗SasA | + | + | +/- | - | + | + | + | + | + | + |
虽然利用重组形式的本发明的表面蛋白质生产抗体是优选的,但是该抗体可以从这些蛋白质天然分离的和纯化形式或其活性区域例如A区域制备抗体,以类似于上面所述的方式利用这些蛋白质或活性的区域可以产生单克隆抗体或多克隆抗体以获得这样的抗体。仍然其他的常规的方法,利用重组或天然的纯化蛋白质或其活性区域,可用于产生本发明的抗体,正如本领域内技术人员可以识别的。
正如本领域内技术人员可以认识到的,本发明的抗体也可以配制成可用于人或动物患者给药的合适的药学的组合物,以便治疗或预防葡萄球菌的细菌引起的感染。含有本发明的抗体的药物组合物,或其有效的片段,可以与本领域内常用的合适的药物介质,赋形剂或载体结合配制,包括例如盐水,葡萄糖,水,甘油,乙醇,其他的治疗化合物和其结合使用。本领域内技术人员应该认识到,所使用的特定的介质,赋形剂或载体将依据患者和患者的状况而改变,如本领域内技术人员将会认识到的各种各样的给药方式适用于本发明的组合物。在本申请中公开的以药物组合物给药的合适的方式包括,但不限于,局部的,口部的,肛门的,阴道的,静脉内的,腹膜内的,肌内的,皮下的,鼻内的和真皮内的给药。
对于局部的给药,将组合物配制成软膏,乳膏,凝胶,洗液,滴剂(例如眼药水和耳朵滴剂),或溶液(例如漱口剂)。可以将组合物埋植于伤口或外科的敷料,缝合线和气溶胶。该组合物可以含有常规的添加剂。例如防腐剂,溶剂以促进渗透和润滑药。局部的制剂也可以含有常规的载体例如乳膏或油膏基底,乙醇或油酰醇。另外,通常也可以将抗体组合物,和涉及其他MSCRAMM的组合物,疫苗,方法和应用的其他的信息用于本发明,涉及前面提到的MSCRAMM和它们的活性的区域和其抗体,这些其它的MSCRAMM公开于例如美国专利5,175,096;5,320,951;5,416,021;5,440,014;5,571,514;5,652,217;5,707,702;5,789,549;5,840,846;5,980,908;6,086,895;6,008,341;6,177,084;5,851,794和6,288,214;所有这些专利都通过在此引述而合并于本文。
本发明的抗体组合物也可以与其量可有效地加强致免疫的应答的合适的佐剂一起给药。例如,合适的佐剂可以包括广泛用于人的明矾(磷酸铝或氢氧化铝),和其他的佐剂例如皂甙和其纯化的组分Quil A,弗氏完全佐剂,RIBBI佐剂,和其它用于研究和兽医应用的佐剂,还有其他以化学方法定义的制剂例如muramyl二肽,一磷酰脂类A,磷脂轭合物例如Goodman-Snitkoff等人在J.Immunol.147:410-415(1991)描述的,该文献通过在此引述而合并于本文,蛋白脂质体内的偶合物的形成胶囊如Miller等人,J.Exp.Med.176:1739-1744(1992),该文献通过在此引述而合并于本文,脂类载体中蛋白质形成胶囊如NovasomeTM脂类载体(Micro Vescular System,Inc.,Nashua,NH)也可以使用。
在任何情况下,本发明的识别蛋白质或如上文提出的它们的活性的区域的抗体组合物可用于预防或治疗葡萄球菌的感染的方法,可用于抑制葡萄球菌的细菌与宿主组织和/或细胞的结合。根据本发明,提供了预防或治疗葡萄球菌的感染的方法,包括以有效量的抗体给本文提出的表面蛋白或其活性的亚区域以便治疗或预防葡萄球菌的感染。另外,这些单克隆抗体可用于损害葡萄球菌的细菌与宿主细胞的结合。
因此,根据本发明,将本发明的抗体以如上所述的任何常规的方法(例如,局部的,非肠道的,肌内的,等)给药,因此当将有效量的抗体组合物给人或动物患者给药时,提供了一种治疗或预防人类或动物患者的葡萄球菌的感染的非常地有用的方法。有效量是指足以阻止细菌粘合,抑制葡萄球菌的细菌结合到宿主细胞从而可用于治疗或阻止葡萄球菌的感染的使用水平,例如抗体效价的水平。如本领域内普通技术人员认识到的,有效地治疗或预防葡萄球菌的感染所必需的抗体效价的水平将依据患者的特性和健康状况,和/或预存在的葡萄球菌的感染的严重程度。
除了用于治疗或预防葡萄球菌的感染的方法中,本发明的抗体也可用于葡萄球菌的蛋白质的特定的检测或作为研究工具。本文所述的术语″抗体″包括单克隆,多克隆,嵌合,单链,双特异性,simianize,和人性化的或灵长目化的抗体以及Fab片段,例如保持抗体与上面详细说明的表面蛋白质的抗体的结合特异性的那些片段,包括Fab免疫球蛋白表达文库的产物。因此,本发明涉及单链的使用例如抗体的可变的重和轻链。这些类型的抗体或抗体片段的制备是本领域内技术人员熟知的。在本发明中,抗表面蛋白质或上面所述的它们的活性的区域的抗体可以制备,分离和/或纯化,然后用于治疗或免受葡萄球菌的感染。
上面描述的任何抗体可直接用可检测的标签进行标记以识别葡萄球菌细菌和对其定性。免疫测定中使用的标记物通常是本领域内技术人员已知的,并且包括酶,放射性同位素,荧光,发光的和产色的物质,包括有色的颗粒例如胶态的金或胶乳珠子。合适的免疫测定包括酶联免疫吸附(ELISA)。
或者,通过与具有免疫球蛋白亲合力的标记的物质可以间接标记该抗体。该抗体可以与第二物质偶合,用已标记的第三物质进行检测,该第三物质与偶合到抗体的第二物质具有亲和力。例如,可以将抗体结合到生物素,利用标记的抗生物素蛋白或链生抗生物素蛋白可以检测抗体-生物素偶合物。类似地,可以将该抗体偶合到半肝素,利用标记的抗半肝素抗体检测抗体-半肝素偶合物。这些和其他标记抗体和分析偶合物的其他方法是本领域内技术人员熟知的。
根据本发明,还提供了被设计为治疗或保护其抵抗葡萄球菌感染的主动或被动免疫接种疫苗,可以利用许多本领域内熟知的常规疫苗制备方法从以上提出的表面蛋白质或活性区域制备这些疫苗。对于典型的疫苗,将致免疫量的合适的表面蛋白或其活性片段与合适的药物学可接受载体,媒介物或赋形剂结合,合适的是可以以有效地免疫接种人或动物患者的疫苗的量给药。本领域技术人员认识到致免疫量是指能够在人或动物患者中产生免疫应答的蛋白质或活性片段或其亚片段的量。
除了借助于将免疫量的本发明的蛋白质或活性片段导入或给药产生的抗体的活性疫苗以外,也可以将本发明的分离的抗体或活性片段用于研制抗钩环感染的被动免疫接种的疫苗。在这样的情况下,可以将如上所述的抗体组合物,即有效量的抗体和药物学可接受的载体,媒介物或赋形剂以适当方式给药到人或动物患者。
因此,本发明的蛋白质或其活性片段可用作为活性疫苗,本发明的抗体可用作为被动疫苗,可用于提供合适的抗体以治疗或予防葡萄球菌感染。本领域内技术人员将会认识到,可以将一秒包装以适用于许多方式给药,例如非肠道的(即肌内的,透皮的或皮下的)给药或鼻咽的(即鼻内的)给药。一种这样的方式是将疫苗通过肌内注射到例如三角肌,但是,给药的特定方式将依赖于待治疗的细菌感染的特性和患者的状况。优选的是将该疫苗与药物学可接受的载体,媒介物或赋形剂结合以有助于给药,通常该载体是有或没有防腐剂的水,或缓冲盐水。该疫苗可以是在给药时重悬浮的冻干形式或溶液形式。
另外,在某些情况下,如必要可以将本发明的抗体进行修饰,以对给药患者的致免疫性降低,例如,如果该患者是人。通过将杂交瘤衍生的抗体的complimentarity表位移植到如Jones等人,Nature 321:522-525(1986)或Tempest等人/Biotechnology 9:266-273(1991)描述的人单克隆抗体而将抗体“人性化”或通过将免疫球蛋白可变区中的表面接触的鼠骨架残基改变为模拟同源的人骨架配体如由Padlan,Molecular Imm.28:489-498(1991)描述而进行″胶合″,这些文献都通过在此引述而合并于本文。甚至于进一步地,如果需要,本发明的单克隆抗体可以与合适的抗生素结合给药以进一步加强所述组合物抗击细菌感染的能力。
除了治疗人或动物患者以外,本发明的组合物也可以用于停止或予防医学装置或其他生物材料例如移植片的感染。待用抗体,蛋白质和活性片段包被的医学装置或聚合物生物材料包括,但不限于钩环,缝合线,复位心脏瓣膜,心脏的协助装置,硬的和软的接触透镜,眼内的透镜植入片(前的室或后的室),其他的植入片例如角膜的镶嵌物,kerato-修补物,血管的斯滕特氏印模,epikeratophalia装置,绿内障分流术,视网膜的钩环,巩膜的扣子,牙齿的修补物,thyroplastic装置,laryngoplastic装置,血管的移植片,软的和硬的组织修补物,包括但不限于,泵,电的装置包括刺激器和记录器,听觉的修复术,起搏器,人工的喉,牙齿的植入片,乳房的植入片,阴茎的植入片,cranio/脸的腱,人工的关节,腱,纽带,menisci,和磁盘,人工的骨骼,人工器官包括人工胰腺,人工心脏,人工的肢,和心脏瓣膜,斯滕特氏印模,金属丝,导向装置丝,静脉内的和中央的静脉的导管,激光和气球血管成形术装置,血管的和心脏装置(管子,导管,气球),室的协助,血透析组合物,血氧合器,尿道的/输尿管的/泌尿的装置(Foley导管,斯滕特氏印模,管和气球),导气管导管(气管内的和气管造口术管和胶管管头),肠内的喂养管(包括nasogastric,胃内的和空肠的管),伤口排水管,用于引流体腔的管例如胸膜的,腹膜的,颅侧的和心包的cavities,血袋,测试管,血收集管,vacutainers,注射器,针,吸移管,吸量管尖端,和血造管。
本领域内技术人员将会明白,本文所用的术语″被包被″或″包被″是指将抗体或活性片段或其衍生的药物组合物应用到装置的表面,优选的是与葡萄球菌细菌感染接触的外表面。该装置的表面不必完全被蛋白质,抗体或活性片段所覆盖。
本发明抗体给药的优选剂量是有效地抑制或治疗葡萄球菌感染的量,易于认识到该量将大大依赖于感染的特性和患者的状况。如上所述,用于本发明的抗体或药物制剂的“有效量”是指无毒但足以产生需要的予防或治疗效果的剂量。正如上文指出的,所需要的抗体或特定试剂的精确量将随患者而变化,取决于患者的种类,年龄,和总的状态,待治疗的状况的严重程度,所使用的特定的载体或赋形剂和给药方式等等。因此,特定抗体组合物的“有效量″将基于特定的环境而变化,普通技术人员利用唯一的常规试验可以测定各种应用情况下合适的有效量。可以将该剂量调节到适应于以该组合物给药的个体,并且随患者的年龄,重量,代谢而变化。该组合物还可以含有稳定剂或药物学可接受的防腐剂,例如硫汞撒(乙基(2-mercaptobenzoate-S)汞钠盐)(Sigma Chemical Company,St.Louis,MO)。
当与合适的标记物或其他合适的可检测的生物分子或化学物质一起使用时,本文描述单克隆抗体可用于体内或体外诊断葡萄球菌感染或检测葡萄球菌细菌的目的。通过这样的抗体的使用也有助于试验室研究。各种类型的标记物和将标记物偶合到本发明的抗体的方法是本领域内技术人员熟知的,例如下面列出的一种方法。
例如,可以将抗体偶合到(直接或通过螯合剂)放射性标记物例如,但不限于32P,3H,14C,35S,125I,或131I。通过例如闪烁计数,γ射线分光光度计放射自显影的方法可以检测标记物。也可以使用生物发光标记物,例如萤火虫荧光素衍生物。采用常规方法生物发光物质可以共价结合到该蛋白质,当酶例如荧光酶催化引起生物发光的与ATP的反应以散发光子时,可以检测标记物蛋白质。也可以将荧光团用于标记蛋白质。荧光团的例子包括荧光和衍生物,藻红蛋白,allo-藻蓝蛋白,藻蓝蛋白,硷性蕊香红,和德克萨斯红。通常荧光团可以通过荧光检测器进行检测。
通过对如上所述的抗体进行标记和根据本领域内技术人员熟知的方法例如免疫荧光显微镜,利用如Warren等人(Mol.Cell.Biol.,7:1326-1337,1987)描述的程序,对标记物进行检测可以测定细胞中配体的定位。
如上所述,本发明的单克隆抗体,或活性部分或其片段特别适用于干扰负责感染的葡萄球菌病原体和哺乳动物宿主之间的起始物理相互作用,这种对物理相互作用的干扰可用于治疗患者和in-dwelling医学装置予防或降低细菌感染以使它们在使用时更安全。
在本发明的另一个实施例中,提供了一种可用于分离和识别葡萄球菌细菌感染的试剂盒,包括在单个容器中的合适形式,例如冻干的本发明的抗体,然后通过加入怀疑含有葡萄球菌细菌的含水的样品而变成活性。这样的试剂盒通常包括用于储存合适形式抗体和合适的免疫检测试剂的合适的容器,所述的免疫检测试剂允许识别结合到本发明的表面蛋白质或抗体的复合物。通常,这些试剂盒含有本发明的抗体和识别当来自患者的样品导入到该抗体时识别结合的抗体的工具。例如,合适的免疫检测试剂可以包括合适的可检测的信号或标记物,例如生物素或产生可检测的颜色的酶等,可以连接到抗体或用于其他合适的方式中标记物以便当抗体结合到抗原时提供可检测的结果。
简单地说,识别和结合到本发明的表面蛋白质的本发明的抗体或其活性片段可用于治疗各种各样的人和动物患者的葡萄球菌感染,以及用于医疗或其他in-dwelling装置。根据本发明,由于这些蛋白质的特性,以及它们含有与其他类型的葡萄球菌细菌的蛋白质共有的表位,即来自凝血酶阴性葡萄球菌的蛋白质将产生识别来自金黄色葡萄球菌的同源蛋白的抗体或者相反,本发明的抗体将显示交叉反应性和应该有效地抗击广谱的葡萄球菌感染。因此,本发明提供了用于治疗或抵抗广谱葡萄球菌感染的方法和改善的方法中的组合物。
实施例
提供下面的实施例,举例说明本发明的优选的实施方式的各个方面。本领域内技术人员应该认识到实施例中公开的技术允许代表发明人发现的技术以实施本发明,因此可以认为构成了实施本发明的优选的方式。但是,本领域内技术人员应该认识到,在本发明公开的基础上,可以在公开的特定的实施方式中进行许多改变,仍然可获得类似的结构而不脱离本发明的精神和范围。
实施例1.金黄色葡萄球菌的MSCRAMM′s的分离和测序
已知金黄色葡萄球菌表达一类表面结合的蛋白质,所述的蛋白质通过允许细菌避免宿主防御和通过作为adhesins对致病性起重要作用。已知这些蛋白质是MSCRAMMs(识别粘附的基质的分子的微生物表面成分),在大多数情况下,可以共价结合到细胞壁肽葡聚糖。它们有几个共同的特征:(i)Sec-依赖性分秘所需要的N-末端信号肽(长度约40个残基),(ii)富含脯氨酸和甘氨酸残基或由丝氨酸和天冬酰胺二肽重复区组成的跨膜区,(iii)该蛋白质与肽葡聚糖中的五甘氨酸桥键共价结合需要的LPXTG基序,(iv)疏水的跨膜区,以及其后的(v)几个带正电荷的残基。
通过开发金黄色葡萄球菌的整个基因组序列,鉴别8个编码具有分秘和锚基基序指示MSCRAMMs的蛋白质的新的开放读框(即携带N-末端的信号肽和C-末端LPXTG基序,随后跟随一个疏水的功能域和一个带正电荷的尾部)。下面的表说明了所识别的蛋白质名录,包括他们在基因组中的分布,他们的蛋白质大小,和挑选C-末端细胞壁的序列。
名称 | 分布 | 大小 | C-末端 |
EkeS | ENCSJM | 2189aa | LPNTGSEEMDLPLKELALITGAALLARRRSKKEKES |
DsqA | ENCSJM | -1363-2283aa | LPDTGDSIKQNGLLGGVMTLLVGLGLMKRKKKKDENDQDDSQA |
KesK | ENCSJM | -909aa | LPKTGETTSSQSWWGLYALLGMLALFIPKFRKESK |
KrkN2 | ENCSJM | -278aa | LPKTGLTSVDNFISTVAFATLALLGSLSLLLFKRKESK |
KrkN | ENCSJM | -661aa | LPQTGEESNKDMTLPLMALIALSSIVAFVLPRKRKN |
RkaS | ENCSJM | -801aa | LPKTGTNQSSSPEAMFVLLAGIGLIATVRRRKAS |
RrkN | NCSJM | 1629aa | LPKTGLESTQKGLIFSSIIGIAGLMLLARRRKN |
KnkA | NCSJM | 629aa | LPKAGETIKEHWLPISVIVGAMGVLMIWLSRRNKLKNKA |
缩写:eMRSA-16;N,8325;C,COL;S,MSSA;J,N315,M,Mu50。
8个蛋白质中的6个存在于已经被测序的所有六个葡萄球菌的基因组中,剩余的2个存在于5/6的这些基因组中。
下面是DNA和蛋白质序列的名录:
Ekes MRSA(SEQ ID NO:1)
acaacacagcagagaatagacaaccaggaggaaaacgaaatgaatttgttaaagaaaaataaatatagtattag
aaaatataaagtagggatattctctactttaatcgggacagttttattactttcaaacccaaatggtgcacaagctttaac
tacggatcataatgtgcaaggtggttcaaatcaagcattacctggcaactcacaaaatacaaatgccgatactaatc
gagacatagtaaatgattcgcaaaatactcctaatgcacatgcaacagacaatacatcaacaaatcaagcattgac
taatcatcaaaacgttgatgtggcaaatcaagtcgggcctgctccaatacagcctagcgcgtcgcctgcgcaaaata
ataataattctaatgctaattcaacagcaacagagccagcggcgaatacaaataataatttagcatcaaataacaat
acattaaacgtgcctaataatacagataacaatgattcagcgcgtcatctgactttaaaagaaattcaagaagatgtt
cgtcattcgtctgataagccagagttagttgcgattgctgaagaagcatctaatagaccgaaaaagagaagcagac
gtgctgcgccaacagatcctaatgcaacaccagcagatccaacggctacaccagcagatccaacggcaggaaat
ggtagtgcaccagttgcaattacagcgccatacacgccaacaactgatcccaatgccaataatataggacaaaatg
cacctaacgaagtgctttcatttgatgataacaacattagaccaagtacgaaccgttctgtgcctacagtaactgttgtt
gataatttaccaggctacacactgattaatggtggtaaagtaggggtgtttagtcatgcaatggtaagaacgagcatgt
ttgattcaggagatgccaagaactatcaagcgcaaggcaatgtaattgcattgggtcgtattagaggaaatgataca
aatgatcatggcgattttaatggtatcgagaaaacattaacagtaaatccgaattctgaattaatctttgaatttaatact
atgactactaaaaactatcaaggtatgacaaatttaatcattaaaaatgctgataacgatactgttattggtgaaaaag
tagttgcttatggtccgatttggcgcttattaaaagtacctgaaaatgttagtcatctaaaaattcaatttgtacctaaaaat
gacgcaataacagatgcacgtggtatttatcaattacgagatggatataaatactatgactttgtagactcaatcggtct
tcattctgggtcacatgtctatgttgaaagacgtacaatggagccaacagcaacaaataataaagaatttacagttac
aacgtcattaaagaataatggtaactttggcgcttcattcaatacagatgattttgtatataaaattcaattacctgaaggt
gttgaatatgtaaataattcattgactaaagattttcctagcggtaattcaggtgttgatattaatgatatgaatgtgacgta
tgacgcagcaaatcgaattattacaattaaaagtactggtggaggtacagggaattcgccggcacgactaatgcctg
ataaaatattggatttgaagtataagctacgtgtgaacaatgtgccaacaccaagaacagtaacatttaacgatacat
taacgtataaaacatattcacaagattttattaattcacctgctgaaagtcatactgtaagtacaaatccatatacaattg
atatcatcatgaataaagacgcattgcaagccgaagtcgatagacgaattcaacaagcggattatacatttgcatcat
tagatatttttaatgatcttaaaagacgcgcacaaacaattttagatgaaaaccgtaacaatgtacctttaaacaaaag
agtttctcaagcagatatcgattcattagcaaatcagatgcaacatacgttaattcgcagtgttgacgctgaaaatgcc
gttaatagaaaagttgatgacatggaagatttagttaaccaaaatgatgaactgacagatgaagaaaaacaagca
gcgattcaagtcatcgaggaacataaaaatgaaattattgggaatattggtgaccaaacgactgatgatggcgttact
agaattaaagatcaaggtatacagactttaagtggagacactgcaacaccagttgttaaaccaaatgctaaacaag
ctatacgtgataaagcagcgaaacaaagagaaattatcaatcacacgccagatgctactcaagatgaaattcaag
atgcattaaatcaattaacaacggatgaaacagatgctattgataatgttacgaatgctactaccaatgctgatgttga
aacagctaaaaataatggtattaatacaattggtgcagttgcgccacaagtgacacacaaacaagctgcaagaga
tgcaattaatcaagcgacagcaacgaaacgacaacaaataaatagcaatagagaagcaacacaagaagaga
aaaatgcagcattgaatgaattaacgcaagccacgaaccacgcattagaacaaatcaatcaagcgacaaccaat
gatgatgtagatactgccaaaggtgatggtctgaatgccattaatcctattgcgcctgtaactgttgtcaagcaagcag
caagagatgccgtatcacatgatgcacaacagcatatcgcagagatcaatgcaaatcctgatgcgactcaagaag
aaagacaagcagcaatagagaaagtaaatgctgctgtagctgttgcgaatactaatatattaaatgctaataccaat
gctgatgttgagcaagtaaagacaaatgcaattcaaggtatacaagccattgaaccagctacaaaggttaaaaca
gatgctaaaaacgctattgatcaaagtgcggaaacgcaacataatgcgatatttaataataatgatgcgaccttaga
agagcaacaagcagcacaacaattgcttgatcaagctgtagccacagcgaagcaaaatattaatgcagcagata
cgaatcaagaagttgcacaagcaaaagatcagggcacacaaaatatagttgtgattcaaccggcaacacaagtta
aaacggatgcacgcaatgctgtaaatgaaaaagcgcgagaggcgataacaaatatcaatgctacacctggcgcg
actcgagaagagaaacaagaagccgataaatcgtgtcaatacacttaaaaatagagcattaaatgatattggtgtga
cgtctactactgcgatggtcaatagtattagagacgatgcagtcaatcaaatcggtgcagttcaaccgcatgtaacga
agaaacaaactgctacaggtgtattaacggacttagcaactgcaaaaaaacaagaaattaatcaaaatacaaatg
caaccactgaagaaaagcaagtagcattaaatcaagtagaccaagatttagcaacggcaattaataatataaatc
aagctgatactaatgcagaagtagatcaagcacaacaattaggtacaaaagcaattaatgcgattcagccaaatat
tgtaaaaaaacctgcagcattagcacaaaccaatcagcattatagtgctaaattagttgaaatcaatgctacaccag
atgcaacagatgatgagaaaaatgctgcgatcaatactttaaatcaagacagacaacaagctattgaaagtattaa
acaagcaaatacaaatgcggaagtagaccaagctgcgacagtggcagagaataatatcgatgctgttcaagttga
cgttgtaaaaaaacaagcagcgcgagataaaatcactgctgaagtagcgaagcgtattgaagcggttaaacaaa
cacctaatgcaactgacgaagaaaagcaggctgcagttaatcaaatcaatcaacttaaagatcaagcgtttaatca
aattaatcaaaaccaaacaaatgatcaggtagacgcaactacaaatcaagcgattaatgctatagataatgttgaa
gctgaagtagtaattaaaccaaaggcaattgcagatattgaaaaagctgttaaagaaaagcaacagcaaattgat
aatagtcttgattcaacagataatgagaaagaagttgctttacaagcattagctaaagaaaaagaaaaagcacttg
cagctattgaccaagctcaaacgaatagtcaggtgaatcaagcggcaacaaatggtgtatcagcgattaaaattatt
caacctgaaacaaaaattaaaccagcagcacgtgaaaaaatcaatcaaaaagcgaatgaattacgtgcgcaaa
ttaatcaagataaagaagcgacagcagaagaaagacaagcggcgttagataaaatcaatgatttagttgctaaag
ctatgacaaatatcacgaatgatagaacaaatcagcaagttaatgactcaacaaatcaagcgcttgacgacattgc
attagtgacgcctgaccatattgttagagcagctgctagagatgcagttaagcaacaatatgaagctaaaaagcac
gaaattgagcaagcggaacatg cgactgatgaagaaaaacaagttgctttaaatcaattagcgaataatgaaaaa
cgtgcattacaaaacattaatcaagcaatagcgaataatgatgtgaaacgtgttgaatcaaatggtattgctacgttaa
aaggcgtagaaccgcacattgtggttaaacctgaagctcaagaagccataaaagcgagcgcagataaccaagta
gaatctataaaagatacaccacatgctacgacagatgaattagatgaagcaaaccaacaaataaacgacacactt
aaacaaggtcaacaagatatagacaatacgacacaagatgcagctgtcaatgatgttagaaaccaaacgattaa
ggcaatcgaacaaattaaaccgaaagttagacgcaaacgtgcagcgttggataacattgatgaaagtaataataat
caactcgatgcaatacgaaatacgctagatacaacgcaagatgaacgaaatgttgctattgctgcgttaaataaaat
tgttaatgcaattaaaaatgatattgcacaaaacaaaacgaatgcagaagtggatcaaactgaggctgatggtaac
aacaacatcaaagtgattttacctaaagttcaagttaaaccagcagcgcgtcaatctgtcagcgcaaaagctgaag
ctcaaaatgcacttattgatcaaagtgatttatctaccgaagaagaaagattagctgctaaacatttagtagaacaag
cacttaatcaagctattgatcagatcaatcacgcagataagactgcgcaagttaatcaaaatagtatcgatgctcaaa
atattatttcaaaaattaaaccagcgacaacagttaaagcaacagcattacaacaaattcaaaatatcgctacaaat
aaaattaatttaattaaagcaaataacgaagcgacagatgaagaacaaaatgctgcaatagtacaagttgaaaaa
gagttaattaaagctaaacaacaaattgctggtgcagtgactaatgctgatgtggcatatttattgcatgatgggaaaa
acgaaattcgtgaaatcgaacctgttattaataaaaaagcaactgcgcgagaacaattaacaacattattcaacgat
aagaaacaagcaattgaagcgaatgttcaagcaacagtagaagaaagaaatagtattttagcacagttacaaaa
catttatgacactgctattggacaaattgatcaagatcgtagcaatgcacaagttgataaaacagcaacattaaatct
acaaacaatacatgatttagacgtacatcctattaaaaagccagatgctgaaaaaacgattaatgatgatcttgcac
gtgttacacatttagtgcaaaattatcgaaaagtaagtgatcgtaataaggctgatgcattaaaagctataactgcatt
aaaattacaaatggatgaagaattaaaaacagcacgcactaatgctgatgttgatgcagttttaaaacgatttaatgtt
gcattaggcgatatagaagcagtaattactgaaaaagaaaatagcttactgcgcattgataacattgctcaacaaac
atatgcgaaattcaaagcgatcgcaacaccagaacaattagctaaagtaaaagcattaattgatcaatatgttgcag
atggcaatagaatggttgatgaagatgcgacattaaatgacatcaaaaaagatacgcaactcattattgatgaaattt
tagcaattaaattacctgctgaagtgataaaagcgtcaccaaaagtggggcaacctgctccaaaagtttgtacgcct
attaaaaaagaagataaacaagaagtgcgaaaagttgtaaaagaacttccaaatactggttctgaagaaatggatt
taccattaaaagaattagcactaattacaggcgcagcattattagctagaagacgttctaaaaaagaaaaagaatc
ataa
EkeS_MRSA(SEQ ID NO:2)
MNLLKKNKYSIRKYKVGIFSTLIGTVLLLSNPNGAQALTTDHNVQGGSNQALPGNS
QNTNADTNRDIVNDSQNTPNAHATDNTSTNQALTNHQNVDVANQVGPAPIQPSA
SPAQNNNNSNANSTATEPAANTNNNLASNNNTLNVPNNTDNNDSARHLTLKEIQE
DVRHSSDKPELVAIAEEASNRPKKRSRRAAPTDPNATPADPTATPADPTAGNGSA
PVAITAPYTPTTDPNANNIGQNAPNEVLSFDDNNIRPSTNRSVPTVTVVDNLPGYTL
INGGKVGVFSHAMVRTSMFDSGDAKNYQAQGNVIALGRIRGNDTNDHGDFNGIEK
TLTVNPNSELIFEFNTMTTKNYQGMTNLIIKNADNDTVIGEKVVAYGPIWRLLKVPE
NVSHLKIQFVPKNDAITDARGIYQLRDGYKYYDFVDSIGLHSGSHVYVERRTMEPT
ATNNKEFTVTTSLKNNGNFGASFNTDDFVYKIQLPEGVEYVNNSLTKDFPSGNSG
VDINDMNVTYDAANRIITIKSTGGGTGNSPARLMPDKILDLKYKLRVNNVPTPRTVT
FNDTLTYKTYSQDFINSPAESHTVSTNPYTIDIIMNKDALQAEVDRRIQQADYTFASL
DIFNDLKRRAQTILDENRNNVPLNKRVSQADIDSLANQMQHTLIRSVDAENAVNRK
VDDMEDLVNQNDELTDEEKQAAIQVIEEHKNEIIGNIGDQTTDDGVTRIKDQGIQTL
SGDTATPVVKPNAKQAIRDKAAKQREIINHTPDATQDEIQDALNQLTTDETDAIDNV
TNATTNADVETAKNNGINTIGAVAPQVTHKQAARDAINQATATKRQQINSNREATQ
EEKNAALNELTQATNHALEQINQATTNDDVDTAKGDGLNAINPIAPVTVVKQAARD
AVSHDAQQHIAEINANPDATQEERQAAIEKVYAAVAVANTNILNANTNADVEQVKT
NAIQGIQAIEPATKVKTDAKNAIDQSAETQHNAIFNNNDATLEEQQAAQQLLDQAVA
TAKQNINAADTNQEVAQAKDQGTQNIVVIQPATQVKTDARNAVNEKAREAITNINA
TPGATREEKQEAINRVNTLKNRALNDIGVTSTTAMVNSIRDDAVNQIGAVQPHVTK
KQTATGVLTDLATAKKQEINQNTNATTEEKQVALNQVDQDLATAINNINQADTNAE
VDQAQQLGTKAINAIQPNIVKKPAALAQTNQHYSAKLVEINATPDATDDEKNAAINT
LNQDRQQAIESIKQANTNAEVDQAATVAENNIDAVQVDVVKKQAARDKITAEVAKR
IEAVKQTPNATDEEKQAAVNQINQLKDQAFNQINQNQTNDQVDATTNQAINAIDNV
EAEVVIKPKAIADIEKAVKEKQQQIDNSLDSTDNEKEVALQALAKEKEKALAAIDQA
QTNSQVNQAATNGVSAIKIIQPETKIKPAAREKINQKANELRAQINQDKEATAEERQ
AALDKINDLVAKAMTNITNDRTNQQVNDSTNQALDDIALVTPDHIVRAAARDAVKQ
QYEAKKHEIEQAEHATDEEKQVALNQLANNEKRALQNINQAIANNDVKRVESNGIA
TLKGVEPHIVVKPEAQEAIKASADNQVESIKDTPHATTDELDEANQQINDTLKQGQ
QDIDNTTQDAAVNDVRNQTIKAIEQIKPKVRRKRAALDNIDESNNNQLDAIRNTLDT
TQDERNVAIAALNKIVNAIKNDIAQNKTNAEVDQTEADGNNNIKVILPKVQVKPAAR
QSVSAKAEAQNALIDQSDLSTEEERLAAKHLVEQALNQAIDQINHADKTAQVNQNS
IDAQNIISKIKPATTVKATALQQIQNIATNKINLIKANNEATDEEQNAAIVQVEKELIKA
KQQIAGAVTNADVAYLLHDGKNEIREIEPVINKKATAREQLTTLFNDKKQAIEANVQ
ATVEERNSILAQLQNIYDTAIGQIDQDRSNAQVDKTATLNLQTIHDLDVHPIKKPDAE
KTINDDLARVTHLVQNYRKVSDRNKADALKAITALKLQMDEELKTARTNADVDAVL
KRFNVALGDIEAVITEKENSLLRIDNIAQQTYAKFKAIATPEQLAKVKALIDQYVADG
NRMVDEDATLNDIKKDTQLIIDEILAIKLPAEVIKASPKVGQPAPKVCTPIKKEDKQEV
RKVVKELPNTGSEEMDLPLKELALITGAALLARRRSKKEKES
DsqA(8325)(SEQ ID NO:3)
tctaatgaatgtaaagataatacaaggagttattacatgagtaaaagacagaaagcatttcatgacagcttagcaaa
cgaaaaaacaagagtaagactttataaatctggaaaaaattgggtaaaatccggaattaaagaaatagaaatgttc
aaaattatggggctaccatttattagtcatagtttagtgagtcaagataatcaaagcattagtaaaaaaatgacgggat
acggactgaaaactacggcggttattggtggtgcattcacggtaaatatgttgcatgaccagcaagcttttgcggcttct
gatgcaccattaacttctgaattaaacacacaaagtgaaacagtaggtaatcaaaactcaacgacaatcgaagcat
caacatcaacagccgattccacaagtgtaacgaaaaatagtagttcggtacaaacatcaaatagtgacacagtctc
aagtgaaaagtctgaaaaggtcacttcgacaactaatagtacaagcaatcaacaagagaaattgacatctacatc
agaatcaacatcctcaaagaatactacatcaagttctgatactaaatctgtagcttcaacttcaagtacagaacaacc
aattaatacatcaacaaatcaaagtactgcatcaaataacacttcacaaagcacaacgccatcttcggtcaacttaa
acaaaactagcacaacgtcaactagcaccgcaccagtaaaacttcgaactttcagtcgcttagctatgtcaacatttg
cgtcagcagcgacgacaaccgcagtaactgctaatacaattacagttaataaagataacttaaaacaatatatgac
aacgtcaggtaatgctacctatgatcaaagtaccggtattgtgacgttaacacaggatgcatacagccaaaaaggtg
ctattacattaggaacacgtattgactctaataagagttttcatttttctggaaaagtaaatttaggtaacaaatatgaag
ggcatggaaatggtggagatggtatcggttttgccttttcaccaggtgtattaggtgaaacagggttaaacggtgccgc
agtaggtattggtggcttaagtaacgcatttggcttcaaattggatacgtatcacaatacatctaaaccaaattcagctg
caaaggcgaatgctgacccatctaatgtagctggtggaggtgcgtttggtgcatttgtaacaacagatagttatggtgtt
gcgacaacgtatacatcaagttcaacagctgataatgctgcgaagttaaatgttcaacctacaaataacacgttcca
agattttgatattaactataatggtgatacaaaggttatgactgtcaaatatgcaggtcaaacatggacacgtaatattt
cagattggattgcgaaaagtggtacgaccaacttttcattatcaatgacagcctcaacaggtggcgcgacaaatttac
aacaagtacaatttggaacattcgaatatacagagtctgctgttacacaagtgagatacgttgatgtaacaacaggta
aagatattattccaccaaaaacatattcaggaaatgttgatcaagtcgtgacaatcgataatcagcaatctgcattga
ctgctaaaggatataactacacgtccgtcgatagttcatatgcgtcaacttataatgatacaaataaaactgtaaaaat
gacgaatgctggacaatcagtgacatattattttactgatgtaaaagcaccaactgtaactgtaggcaatcaaaccat
agaagtgggtaaaacaatgaatcctattgtattgactacaacggataatggtactgggactgtgacaaatacagttac
aggattaccaagcggattaagttacgatagtgcaacgaattcaatcattgggacaccaacaaaaattggtcaatca
acagtgacagttgtgtctactgaccaagcaaataacaaatcgacgacaacttttacaataaatgttgtggatacgaca
gcaccaacagtgacaccaataggagatcaatcatcagaagtgtattcaccaatatccccgattaaaattgctacgca
ag ataacagtggaaatgcggtgacgaatacagtgactggattgccatccggactaacatttgatagtacaaataata
ctattagtggtacaccaacaaacattggtacaagtactatatcaatcgtttctacagatgcgagcggtaacaaaacga
cgacaacttttaaatatgaagtaacaagaaatagcatgagtgattccgtatcaacatcaggaagtacacaacaatct
caaagtgtgtcaacaagtaaagctgactcacaaagtgcatcaacgagtacatcaggatcgattgtggtatctacatc
agctagtacctcgaaatcgacaagtgtaagcctatctgattctgtgagtgcatctaagtcattaagcacatctgaaagt
aatagtgtatcaagctcaacaagcacaagtttagtgaattcacaaagtgtatcatcaagcatgtcggattcagctagt
aaatcaacatcattaagcgattctatttcaaactctagcagtactgaaaaatccgaaagtctatcaacaagtacatctg
attcattgcgtacatcaacatcactcagtgactcattaagtatgagtacatcaggaagcttgtctaagtcacaaagctta
tcaacgagtatatcagggtcgtctagtacatcagcatcattaagtgacagtacatcgaatgcaattagtacatcaacat
cattgagcgagtcagctagcacctcggactctatcagtatttcaaatagcatagccaactctcaaagtgcgtcaacaa
gcaaatcagattcacaaagtacatcaatatcattaagtacaagtgattcaaaatcgatgagtacatcagaatcattga
gcgattcgacgagcacaagtggttctgtttctggatcactaagcatagcagcatcacaaagtgtctcaacaagtacat
cagactcgatgagtacttcagagatagtaagtgactctatcagtacaagtgggtcattatctgcatcagacagtaaatc
aatgtccgtaagtagttcaatgagcacgtctcagtcaggtagtacatcagaatcattaagtgattcacaaagtacatct
gattctgatagtaagtcattatcacaaagtactagtcaatcaggttcaacaagtacatcaacgtcgacaagtgcttcag
tacgtacttcggaatcacaaagtacgtctggttcaatgagtgcaagtcaatccgattcaatgagcatatcaacgtcgttt
agtgattcaacgagtgatagcaaatcagcatcaactgcatcaagtgaatcaatatcacaaagtgcttctacgagcac
atctggttcggtaagtacttcgacatcgttaagtacaagtaattcagaacgtacatcaacatctatgagtgattccacaa
gcttaagtacatcagagtctgattcaataagtgaatcaacgtcaacgagcgactctataagtgaagcaatatctgcttc
agagagcacgtttatatcattaagtgaatcaaatagtactagcgattcagaatcacaaagtgcatctgcctttttaagtg
aatcattaagtgaaagtacgtctgaatcaacatcagagtcagtgagtagttcgacaagtgagagtacgtcattatcag
acagtacatcagaatctggtagcacatcaacatcattaagtaattcaacaagtggtagtacgtccatttcaacatcga
caagtatcagtgaatcaacgtcaacgtttaagagcgagagtgtttcaacatcactgagtatgtcaacgagtacaagtt
tgtctgactctacaagtttgtcaacatcattaagtgattccacaagtgatagtaagtctgattcattaagtacatcaatgtc
gacaagtgattcaatcagtacaagtaaatctgattccattagtacatccacatcattaagtggttctacaagtgaaagt
gaatccgactcaacatcatcaagtgaaagtaaatccgattcaacatcaatgagcataagtatgtctcaatcaacatc
aggaagtacaagtacgtcaacgagtacaagtttgtctgactcaacgagtacatcattgtcactaagtgcctcaatgaa
tcaaagcggagtagactcaaactcagcaagccaaagtgcctcaaactcaacaagtacaagcacgagcgaatcc
gattcacaaagcacatcatcatatacaagtcagtcaacaagccaaagtgaatccacatcgacatcaacgtcactaa
gcgattcaacaagtatatctaaaagtacgagtcaatcaggttcggtaagcacatcagcgtcattaagtggttcagag
agtgaatctgattcacaaagtatctcaacaagtgcaagtgagtcaacatcagaaagtgcgtcaacatcactcagtga
ctcaacaagtacaagtaactcaggatcagcaagtacgtcaacatcgctcagtaactcagcaagcgcaagtgaatc
cgatttgtcgtcaacatctttaagtgattcaacatctgcgtcaatgcaaagcagtgaatccgattcacaaagcacatca
gcatcattaagtgattcgctaagtacatcaacttcaaaccgcatgtcgaccattgcaagtttatctacatcggtaagtac
atcagagtctggctcaacatcagaaagtacaagtgaatccgattcaacatcaacatcattaagcgattcacaaagc
acatcaagaagtacaagtgcatcaggatcagcaagtacatcaacatcaacaagtgactctcgtagtacatcagctt
caactagtacttcgatgcgtacaagtactagtgattcacaaagtatgtcgctttcgacaagtacatcaacaagtatgag
tgattcaacgtcattatctgatagtgttagtgattcaacatcagactcaacaagtgcgagtacatctggttcgatgagtgt
gtctatatcgttaagtgattcgacaagtacatcaacatcggctagtgaagtaatgagcgcaagcatatctgattcacaa
agtatgtcagaatctgtaaatgattcagaaagtgtaagtgaatctaattctgaaagtgactctaaatcgatgagtggctc
aacaagtgtcagtgattctggctcattgagcgtctcaacgtcattaagaaaatcagaaagtgtaagcgagtcaagttc
attgagttgctcacaatcgatgagcgattcagtaagcacaagcgattcgtcatcattaagtgtatcgacgtcactaaga
agttcagaaagcgtgagtgaatctgattcattaagtgattcaaaatcaacaagtggttcgacttcaacaagtacatctg
gttcattgagtacctcaacatcattaagtggttcagaaagcgtaagcgagtctacctcgctaagtgattcaatatcaatg
agtgattctactagtacaagtgactccgactcattaagtggatcaatatctttaagtggttccacaagtcttagcacttcg
gattcattaagtgattcaaaatcattgagtagctcgcaaagtatgagtggatcagaatcaacgtcaacaagtgtgagc
gattcgcagtcaagctcaacaagtaatagtcaatttgactctatgagcatcagtgcatcagaaagcgactcaatgtct
acaagtgattcgtctagcatcagtggatcaaattcaacgagtacatcactttcaacatctgactcaatgagcggaagc
gtatcagtttcaacatcgacaagtttaagtgactcaatatcaggttcaacaagtgtaagtgactcgagctcaacaagc
acatctacatcattaagtgattcaatgtcacaaagccagtcaacaagtacaagtgcatctggttccttaagtacatcga
tatcaacatcaatgtcaatgagtgctagtacatcgtcatcacaaagcacatcggtgtcgacatcattatcaacatcag
acagtatcagtgattctacttcaataagtatcagtggttcacaaagtacagtagaatcagaatctacaagtgattcaac
ttctatcagtgactcagaatcattgagtacatcagattcagactcgacatcgacaagtacatcggactcaacaagtgg
ttcaacttcaacaagcatatctgaatcattaagtacgtctggttcaggttcaacgagcgtatctgactcaacatcaatga
gtgaatctaattcatcgagtgtttcaatgtcacaagacaaatccgactcaacatcaattagtgactcagaatcagtgtc
aacaagcacatcaacgtcattgagcacatccgattcgacaagcacatccgaatcactgagtacatctatgtctggttc
acaaagcatttctgactcaacatcaacaagtatgtccggctcaacaagtacatctgaatctaactcaatgcatccgtc
agactcaatgagtatgcatcatactcacagcacgagcacatctcgcttatcaagtgaagcaacaacgagcacgagt
gaatctcagtctacattaagtgcaacatctgaagtgactaaacataatggcacaccagcacaaagtgaaaaaaga
ttgccagatacaggtgactcaataaaacaaaatggattactaggtggcgttatgacattattagttggtttaggtttaatg
aagagaaagaaaaagaaagatgaaaatgatcaagatgattctcaagcataa
DsqA(8325)(SEQ ID NO:4)
SNECKDNTRSYYMSKRQKAFHDSLANEKTRVRLYKSGKNWVKSGIKEIEMFKIMG
LPFISHSLVSQDNQSISKKMTGYGLKTTAVIGGAFTVNMLHDQQAFAASDAPLTSE
LNTQSETVGNQNSTTIEASTSTADSTSVTKNSSSVQTSNSDTVSSEKSEKVTSTTN
STSNQQEKLTSTSESTSSKNTTSSSDTKSVASTSSTEQPINTSTNQSTASNNTSQS
TTPSSVNLNKTSTTSTSTAPVKLRTFSRLAMSTFASAATTTAVTANTITVNKDNLKQ
YMTTSGNATYDQSTGIVTLTQDAYSQKGAITLGTRIDSNKSFHFSGKVNLGNKYEG
HGNGGDGIGFAFSPGVLGETGLNGAAVGIGGLSNAFGFKLDTYHNTSKPNSAAKA
NADPSNVAGGGAFGAFVTTDSYGVATTYTSSSTADNAAKLNVQPTNNTFQDFDIN
YNGDTKVMTVKYAGQTWTRNISDWIAKSGTTNFSLSMTASTGGATNLQQVQFGT
FEYTESAVTQVRYVDVTTGKDIIPPKTYSGNVDQVVTIDNQQSALTAKGYNYTSVD
SSYASTYNDTNKTVKMTNAGQSVTYYFTDVKAPTVTVGNQTIEVGKTMNPIVLTTT
DNGTGTVTNTVTGLPSGLSYDSATNSIIGTPTKIGQSTVTVVSTDQANNKSTTTFTI
NVVDTTAPTVTPIGDQSSEVYSPISPIKIATQDNSGNAVTNTVTGLPSGLTFDSTNN
TISGTPTNIGTSTISIVSTDASGNKTTTTFKYEVTRNSMSDSVSTSGSTQQSQSVST
SKADSQSASTSTSGSIVVSTSASTSKSTSVSLSDSVSASKSLSTSESNSVSSSTST
SLVNSQSVSSSMSDSASKSTSLSDSISNSSSTEKSESLSTSTSDSLRTSTSLSDSL
SMSTSGSLSKSQSLSTSISGSSSTSASLSDSTSNAISTSTSLSESASTSDSISISNSI
ANSQSASTSKSDSQSTSISLSTSDSKSMSTSESLSDSTSTSGSVSGSLSIAASQSV
STSTSDSMSTSEIVSDSISTSGSLSASDSKSMSVSSSMSTSQSGSTSESLSDSQST
SDSDSKSLSQSTSQSGSTSTSTSTSASVRTSESQSTSGSMSASQSDSMSISTSFS
DSTSDSKSASTASSESISQSASTSTSGSVSTSTSLSTSNSERTSTSMSDSTSLSTS
ESDSISESTSTSDSISEAISASESTFISLSESNSTSDSESQSASAFLSESLSESTSES
TSESVSSSTSESTSLSDSTSESGSTSTSLSNSTSGSTSISTSTSISESTSTFKSESV
STSLSMSTSTSLSDSTSLSTSLSDSTSDSKSDSLSTSMSTSDSISTSKSDSISTSTS
LSGSTSESESDSTSSSESKSDSTSMSISMSQSTSGSTSTSTSTSLSDSTSTSLSLS
ASMNQSGVDSNSASQSASNSTSTSTSESDSQSTSSYTSQSTSQSESTSTSTSLS
DSTSISKSTSQSGSVSTSASLSGSESESDSQSISTSASESTSESASTSLSDSTSTS
NSGSASTSTSLSNSASASESDLSSTSLSDSTSASMQSSESDSQSTSASLSDSLST
STSNRMSTIASLSTSVSTSESGSTSESTSESDSTSTSLSDSQSTSRSTSASGSAST
STSTSDSRSTSASTSTSMRTSTSDSQSMSLSTSTSTSMSDSTSLSDSVSDSTSDS
TSASTSGSMSVSISLSDSTSTSTSASEVMSASISDSQSMSESVNDSESVSESNSE
SDSKSMSGSTSVSDSGSLSVSTSLRKSESVSESSSLSCSQSMSDSVSTSDSSSLS
VSTSLRSSESVSESDSLSDSKSTSGSTSTSTSGSLSTSTSLSGSESVSESTSLSDS
ISMSDSTSTSDSDSLSGSISLSGSTSLSTSDSLSDSKSLSSSQSMSGSESTSTSVS
DSQSSSTSNSQFDSMSISASESDSMSTSDSSSISGSNSTSTSLSTSDSMSGSVSV
STSTSLSDSISGSTSVSDSSSTSTSTSLSDSMSQSQSTSTSASGSLSTSISTSMSM
SASTSSSQSTSVSTSLSTSDSISDSTSISISGSQSTVESESTSDSTSISDSESLSTSD
SDSTSTSTSDSTSGSTSTSISESLSTSGSGSTSVSDSTSMSESNSSSVSMSQDKS
DSTSISDSESVSTSTSTSLSTSDSTSTSESLSTSMSGSQSISDSTSTSMSGSTSTS
ESNSMHPSDSMSMHHTHSTSTSRLSSEATTSTSESQSTLSATSEVTKHNGTPAQ
SEKRLPDTGDSIKQNGLLGGVMTLLVGLGLMKRKKKKDENDQDDSQA
KesK1(8325)(SEQ ID NO:5)
ttattatcaattaaatataatcttataggagttgttaacaacatgaacaaacatcacccaaaattaaggtctttctattctat
tagaaaatcaactctaggcgttgcatcggtcattgtcagtacactatttttaattacttctcaacatcaagcacaagcag
cagaaaatacaaatacttcagataaaatctcggaaaatcaaaataataatgcaactacaactcagccacctaagg
atacaaatcaaacacaacctgctacgcaaccagcaaacactgcgaaaaactatcctgcagcggatgaatcactta
aagatgcaattaaagatcctgcattagaaaataaagaacatgatataggtccaagagaacaagtcaatttccagtta
ttagataaaaacaatgaaacgcagtactatcactttttcagcatcaaagatccagcagatgtgtattacactaaaaag
aaagcagaagttgaattagacatcaatactgcttcaacatggaagaagtttgaagtctatgaaaacaatcaaaaatt
gccagtgagacttgtatcatatagtcctgtaccagaagaccatgcctatattcgattcccagtttcagatggcacacaa
gaattgaaaattgtttcttcgactcaaattgatgatggagaagaaacaaattatgattatactaaattagtatttgctaaa
cctatttataacgatccttcacttgtaaaatcagatacaaatgatgcagtagtaacgaatgatcaatcaagttcagtcgc
aagtaatcaaacaaacacgaatacatctaatcaaaatatatcaacgatcaacaatgctaataatcaaccgcaggc
aacgaccaatatgagtcaacctgcacaaccaaaatcgtcaacgaatgcagatcaagcgtcaagccaaccagctc
atgaaacaaattctaatggtaatactaacgataaaacgaatgagtcaagtaatcagtcggatgttaatcaacagtatc
caccagcagatgaatcactacaagatgcaattaaaaacccggctatcatcgataaagaacatacagctgataattg
gcgaccaattgattttcaaatgaaaaatgataaaggtgaaagacagttctatcattatgctagtactgttgaaccagca
actgtcatttttacaaaaacaggaccaataattgaattaggtttaaagacagcttcaacatggaagaaatttgaagttt
atgaaggtgacaaaaagttaccagtcgaattagtatcatatgattctgataaagattatgcctatattcgtttcccagtat
ctaatggtacgagagaagttaaaattgtgtcatctattgaatatggtgagaacatccatgaagactatgattatacgcta
atggtctttgcacagcctattactaataacccagacgactatgtggatgaagaaacatacaatttacaaaaattattag
ctccgtatcacaaagctaaaacgttagaaagacaagtttatgaattagaaaaattacaagagaaattgccagaa
aaatataaggcggaatataaaaagaaattagatcaaactagagtagagttagctgatcaagttaaatcagcagtga
cggaatttgaaaatgttacacctacaaatgatcaattaacagatttacaagaagcgcattttgttgtttttgaaagtgaa
gaaaatagtgagtcagttatggacggctttgttgaacatccattctatacagcaactttaaatggtcaaaaatatgtagt
gatgaaaacaaaggatgacagttactggaaagatttaattgtagaaggtaaacgtgtcactactgtttctaaagatcct
aaaaataattctagaacgctgattttcccatatatacctgacaaagcagtttacaatgcgattgttaaagtcgttgtggc
aaacattggttatgaaggtcaatatcatgtcagaattataaatcaggatatcaatacaaaagatgatgatacatcaca
aaataacacgagtgaaccgctaaatgtacaaacaggacaagaaggtaaggttgctgatacagatgtagctgaaa
atagcagcactgcaacaaatcctaaagatgcgtctgataaagcagatgtgatagaaccagagtctgacgtggttaa
agatgctgataataatattgataaagatgtgcaacatgatgttgatcatttatccgatatgtcggataataatcacttcga
taaatatgatttaaaagaaatggatactcaaattgccaaagatactgatagaaatgtggataaagatgccgataat
agcgttggtatgtcatctaatgtcgatactgataaagactctaataaaaataaagacaaagtcatacagctgaatcat
attgccgataaaaataatcatactggaaaagcagcaaagcttgacgtagtgaaacaaaattataataatacagaca
aagttactgacaaaaaaacaactgaacatctgccgagtgatattcataaaactgtagataaaacagtgaaaacaa
aagaaaaagccggcacaccatcgaaagaaaacaaacttagtcaatctaaaatgctaccaaaaactggagaa
acaacttcaagccaatcatggtggggcttatatgcgttattaggtatgttagctttattcattcctaaattcagaaaagaat
ctaaataa
KesK1(8325)(SEQ ID NO:6)
LLSIKYNLIGVVNNMNKHHPKLRSFYSIRKSTLGVASVIVSTLFLITSQHQAQAAENT
NTSDKISENQNNNATTTQPPKDTNQTQPATQPANTAKNYPAADESLKDAIKDPALE
NKEHDIGPREQVNFQLLDKNNETQYYHFFSIKDPADVYYTKKKAEVELDINTASTW
KKFEVYENNQKLPVRLVSYSPVPEDHAYIRFPVSDGTQELKIVSSTQIDDGEETNY
DYTKLVFAKPIYNDPSLVKSDTNDAVVTNDQSSSVASNQTNTNTSNQNISTINNAN
NQPQATTNMSQPAQPKSSTNADQASSQPAHETNSNGNTNDKTNESSNQSDVNQ
QYPPADESLQDAIKNPAIIDKEHTADNWRPIDFQMKNDKGERQFYHYASTVEPATV
IFTKTGPIIELGLKTASTWKKFEVYEGDKKLPVELVSYDSDKDYAYIRFPVSNGTRE
VKIVSSIEYGENIHEDYDYTLMVFAQPITNNPDDYVDEETYNLQKLLAPYHKAKTLE
RQVYELEKLQEKLPEKYKAEYKKKLDQTRVELADQVKSAVTEFENVTPTNDQLTD
LQEAHFVVFESEENSESVMDGFVEHPFYTATLNGQKYVVMKTKDDSYWKDLIVEG
KRVTTVSKDPKNNSRTLIFPYIPDKAVYNAIVKVVVANIGYEGQYHVRIINQDINTKD
DDTSQNNTSEPLNVQTGQEGKVADTDVAENSSTATNPKDASDKADVIEPESDVVK
DADNNIDKDVQHDVDHLSDMSDNNHFDKYDLKEMDTQIAKDTDRNVDKDADNSV
GMSSNVDTDKDSNKNKDKVIQLNHIADKNNHTGKAAKLDVVKQNYNNTDKVTDKK
TTEHLPSDIHKTVDKTVKTKEKAGTPSKENKLSQSKMLPKTGETTSSQSWWGLYA
LLGMLALFIPKFRKESK
KrkN2(8325)(SEQ ID NO:7)
gaggaaaacaacatgacaaaacattatttaaacagtaagtatcaatcagaacaacgttca
tcagctatgaaaaagattacaatgggtacagcatctatcattttaggttcccttgtatac
ataggcgcagacagccaacaagtcaatgcggcaacagaagctacgaacgcaactaataat
caaagcacacaagtttctcaagcaacatcacaaccaattaatttccaagtgcaaaaagat
ggctcttcagagaagtcacacatggatgactatatgcaacaccctggtaaagtaattaaa
caaaataataaatattatttccaaaccgtgttaaacaatgcatcattctggaaagaatac
aaattttacaatgcaaacaatcaagaattagcaacaactgttgttaacgataataaaaaa
gcggatactagaacaatcaatgttgcagttgaacctggatataagagcttaactactaaa
gtacatattgtcgtgccacaaattaattacaatcatagatatactacgcatttggaattt
gaaaaagcaattcctacattagctgacgcagcaaaaccaaacaatgttaaaccggttcaa
ccaaaaccagctcaacctaaaacacctactgagcaaactaaaccagttcaacctaaagtt
gaaaaagttaaacctactgtaactacaacaagcaaagttgaagacaatcactctactaaa
gttgtaagtactgacacaacaaaagatcaaactaaaacacaaactgctcatacagttaaa
acagcacaaactgctcaagaacaaaataaagttcaaacacctgttaaagatgttgcaaca
gcgaaatctgaaagcaacaatcaagctgtaagtgataataaatcacaacaaactaacaaa
gttacaaaacataacgaaacgcctaaacaagcatctaaagctaaagaattaccaaaaact
ggtttaacttcagttgataactttattagcacagttgccttcgcaacacttgccctttta
ggttcattatctttattacttttcaaaagaaaagaatctaaataa
KrkN2(8325)(SEQ ID NO:8)
EENNMTKHYLNSKYQSEQRSSAMKKITMGTASIILGSLVYIGADSQQVNAATEATN
ATNNQSTQVSQATSQPINFQVQKDGSSEKSHMDDYMQHPGKVIKQNNKYYFQTV
LNNASFWKEYKFYNANNQELATTVVNDNKKADTRTINVAVEPGYKSLTTKVHIVVP
QINYNHRYTTHLEFEKAIPTLADAAKPNNVKPVQPKPAQPKTPTEQTKPVQPKVEK
VKPTVTTTSKVEDNHSTKVVSTDTTKDQTKTQTAHTVKTAQTAQEQNKVQTPVKD
VATAKSESNNQAVSDNKSQQTNKVTKHNETPKQASKAKELPKTGLTSVDNFISTV
AFATLALLGSLSLLLFKRKESK
KrkN(8325)(SEQ ID NO:9)
tatacaattaggagttgtttctacaacatgaacaaacagcaaaaagaatttaaatcattttattcaattagaaagtcatc
actaggcgttgcatctgtagcaattagtacacttttattattaatgtcaaatggcgaagcacaagcagcagctgaaga
aacaggtggtacaaatacagaagcacaaccaaaaactgaagcagttgcaagtccaacaacaacatctgaaaaa
gctccagaaactaaaccagtagctaatgctgtctcagtatctaataaagaagttgaggcccctacttctgaaacaaa
agaagctaaagaagttaaagaagttaaagcccctaaggaaacaaaagaagttaaaccagcagcaaaagccac
taacaatacatatcctattttgaatcaggaacttagagaagcgattaaaaaccctgcaataaaagacaaagatcata
gcgcaccaaactctcgtccaattgattttgaaatgaaaaagaaagatggaactcaacagttttatcattatgcaagttc
tgttaaacctgctagagttattttcactgattcaaaaccagaaattgaattaggattacaatcaggtcaattttggagaaa
atttgaagtttatgaaggtgacaaaaagttgccaattaaattagtatcatacgatactgttaaagattatgcttacattcg
cttctctgtatcaaacggaacaaaagctgttaaaattgttagttcaacacacttcaataacaaagaagaaaaatacg
attacacattaatggaattcgcacaaccaatttataacagtgcagataaattcaaaactgaagaagattataaagctg
aaaaattattagcgccatataaaaaagcgaaaacactagaaagacaagtttatgaattaaataaaattcaagataa
acttcctgaaaaattaaaggctgagtacaagaagaaattagaggatacaaagaaagctttagatgagcaagtgaa
atcagctattactgaattccaaaatgtacaaccaacaaatgaaaaaatgactgatttacaagatacaaaatatgttgtt
tatgaaagtgttgagaataacgaatctatgatggatacttttgttaaacaccctattaaaacaggtatgcttaacggcaa
aaaatatatggtcatggaaactactaatgacgattactggaaagatttcatggttgaaggtcaacgtgttagaactata
agcaaagatgctaaaaataatactagaacaattattttcccatatgttgaaggtaaaactctatatgatgctatcgttaa
agttcacgtaaaaacgattgattatgatggacaataccatgtcagaatcgttgataaagaagcatttacaaaagcca
ataccgataaatctaacaaaaaagaacaacaagataactcagctaagaaggaagctactccagctacgcctagc
aaaccaacaccatcacctgttgaaaaagaatcacaaaaacaagacagccaaaaagatgacaataaacaattac
caagtgttgaaaaagaaaatgacgcatctagtgagtcaggtaaagacaaaacgcctgctacaaaaccaactaaa
ggtgaagtagaatcaagtagtacaactccaactaaggtagtatctacgactcaaaatgttgcaaaaccaacaactg
cttcatcaaaaacaacaaaagatgttgttcaaacttcagcaggttctagcgaagcaaaagatagtgctccattacaa
aaagcaaacattaaaaacacaaatgatggacacactcaaagccaaaacaataaaaatacacaagaaaataaa
gcaaaatcattaccacaaactggtgaagaatcaaataaagatatgacattaccattaatggcattattagctttaagta
gcatcgttgcattcgtattacctagaaaacgtaaaaactaa
KrkN(8325)(SEQ ID NO:10)
YTIRSCFYNMNKQQKEFKSFYSIRKSSLGVASVAISTLLLLMSNGEAQAAAEETGG
TNTEAQPKTEAVASPTTTSEKAPETKPVANAVSVSNKEVEAPTSETKEAKEVKEV
KAPKETKEVKPAAKATNNTYPILNQELREAIKNPAIKDKDHSAPNSRPIDFEMKKKD
GTQQFYHYASSVKPARVIFTDSKPEIELGLQSGQFWRKFEVYEGDKKLPIKLVSYD
TVKDYAYIRFSVSNGTKAVKIVSSTHFNNKEEKYDYTLMEFAQPIYNSADKFKTEED
YKAEKLLAPYKKAKTLERQVYELNKIQDKLPEKLKAEYKKKLEDTKKALDEQVKSAI
TEFQNVQPTNEKMTDLQDTKYWYESVENNESMMDTFVKHPIKTGMLNGKKYMV
METTNDDYWKDFMVEGQRVRTISKDAKNNTRTIIFPYVEGKTLYDAIVKVHVKTIDY
DGQYHVRIVDKEAFTKANTDKSNKKEQQDNSAKKEATPATPSKPTPSPVEKESQK
QDSQKDDNKQLPSVEKENDASSESGKDKTPATKPTKGEVESSSTTPTKVVSTTQ
NVAKPTTASSKTTKDVVQTSAGSSEAKDSAPLQKANIKNTNDGHTQSQNNKNTQE
NKAKSLPQTGEESNKDMTLPLMALLALSSIVAFVLPRKRKN
RkaS(COL)(SEQ ID NO:11)
tttataaataatttacataaaatcaatcattttaatataaggattatgataatatattggtgtatgacagttaatggaggga
acgaaatgaaagctttattacttaaaacaagtgtatggctcgttttgctttttagtgtaatgggattatggcaagtctcgaa
cgcggctgagcagcatacaccaatgaaagcacatgcagtaacaacgatagacaaagcaacaacagataagca
acaagtaccgccaacaaaggaagcggctcatcattctggcaaagaagcggcaaccaacgtatcagcatcagcg
cagggaacagctgatgatacaaacagcaaagtaacatccaacgcaccatctaacaaaccatctacagtagtttca
acaaaagtaaacgaaacacgcgacgtagatacacaacaagcctcaacacaaaaaccaactcacacagcaac
gttcaaattatcaaatgctaaaacagcatcactttcaccacgaatgtttgctgctaatgcaccacaaacaacaacaca
taaaatattacatacaaatgatatccatggccgactagccgaagaaaaagggcgtgtcatcggtatggctaaattaa
aaacagtaaaagaacaagaaaagcctgatttaatgttagacgcaggagacgccttccaaggtttaccactttcaaa
ccagtctaaaggtgaagaaatggctaaagcaatgaatgcagtaggttatgatgctatggcagtcggtaaccatgaat
ttgactttggatacgatcagttgaaaaagttagagggtatgttagacttcccgatgctaagtactaacgtttataaagatg
gaaaacgcgcgtttaagccttcaacgattgtaacaaaaaatggtattcgttatggaattattggtgtaacgacaccag
aaacaaagacgaaaacaagacctgaaggcattaaaggcgttgaatttagagatccattacaaagtgtgacagcg
gaaatgatgcgtatttataaagacgtagatacatttgttgttatatcacatttaggaattgatccttcaacacaagaaaca
tggcgtggtgattacttagtgaaacaattaagtcaaaatccacaattgaagaaacgtattacagttattgatggtcattc
acatacagtacttcaaaatggtcaaatttataacaatgatgcattggcacaaacaggtacagcacttgcgaatatcgg
taagattacatttaattatcgcaatggagaggtatcgaatattaaaccgtcattgattaatgttaaagacgttgaaaatgt
aacaccgaacaaagcattagctgaacaaattaatcaagctgatcaaacatttagagcacaaactgcagaggtaat
tattccaaacaataccattgatttcaaaggagaaagagatgacgttagaacgcgtgaaacaaatttaggaaacgcg
attgcagatgctatggaagcgtatggcgttaagaatttctctaaaaagactgactttgccgtgacaaatggtggaggta
ttcgtgcctctatcgcaaaaggtaaggtgacacgctatgatttaatctcagtattaccatttggaaatacgattgcgcaa
attgatgtaaaaggttcagacgtctggacggctttcgaacatagtttaggcgcaccaacaacacaaaaggacggta
agacagtgttaacagcgaatggcggtttactacatatctctgattcaatccgtgtttactatgatataaataaaccgtctg
gcaaacgaattaatgctattcaaattttaaataaagagacaggtaagtttgaaaatattgatttaaaacgtgtatatcac
gtaacgatgaatgacttcacagcatcaggtggcgacggatatagtatgttcggtggtcctagagaagaaggtatttca
ttagatcaagtactagcaagttatttaaaaacagctaacttagctaagtatgatacgacagaaccacaacgtatgttat
taggtaaaccagcagtaagtgaacaaccagctaaaggacaacaaggtagcaaaggtagtaagtctggtaaagat
acacaaccaattggtgacgacaaagtgatggatccagcgaaaaaaccagctccaggtaaagttgtattgttgctag
cgcatagaggaactgttagtagcggtacagaaggttctggtcgcacaatagaaggagctactgtatcaagcaaga
gtgggaaacaattggctagaatgtcagtgcctaaaggtagcgcgcatgagaaacagttaccaaaaactggaacta
atcaaagttcaagcccagaagcgatgtttgtattattagcaggtataggtttaatcgcgactgtacgacgtagaaaag
ctagctaa
RkaS(COL)(SEQ ID NO:12)
FINNLHKINHFNIRIMIIYWCMTVNGGNEMKALLLKTSVWLVLLFSVMGLWQVSNAA
EQHTPMKAHAVTTIDKATTDKQQVPPTKEAAHHSGKEAATNVSASAQGTADDTN
SKVTSNAPSNKPSTVVSTKVNETRDVDTQQASTQKPTHTATFKLSNAKTASLSPR
MFAANAPQTTTHKILHTNDIHGRLAEEKGRVIGMAKLKTVKEQEKPDLMLDAGDAF
QGLPLSNQSKGEEMAKAMNAVGYDAMAVGNHEFDFGYDQLKKLEGMLDFPMLS
TNVYKDGKRAFKPSTIVTKNGIRYGIIGVTTPETKTKTRPEGIKGVEFRDPLQSVTA
EMMRIYKDVDTFVVISHLGIDPSTQETWRGDYLVKQLSQNPQLKKRITVIDGHSHT
VLQNGQIYNNDALAQTGTALANIGKITFNYRNGEVSNIKPSLINVKDVENVTPNKAL
AEQINQADQTFRAQTAEVIIPNNTIDFKGERDDVRTRETNLGNAIADAMEAYGVKN
FSKKTDFAVTNGGGIRASIAKGKVTRYDLISVLPFGNTIAQIDVKGSDVWTAFEHSL
GAPTTQKDGKTVLTANGGLLHISDSIRVYYDINKPSGKRINAIQILNKETGKFENIDL
KRVYHVTMNDFTASGGDGYSMFGGPREEGISLDQVLASYLKTANLAKYDTTEPQR
MLLGKPAVSEQPAKGQQGSKGSKSGKDTQPIGDDKVMDPAKKPAPGKVVLLLAH
RGTVSSGTEGSGRTIEGATVSSKSGKQLARMSVPKGSAHEKQLPKTGTNQSSSP
EAMFVLLAGIGLIATVRRRKAS
RrkN(8325)(SEQ ID NO:13)
agtggaaaatatggaaaaaggagtatgcaaatgagagataagaaaggaccggtaaataaaagagtagattttct
atcaaataaattgaataaatattcaataagaaaatttacagttggaacagcatctattttaattggctcactaatgtatttg
ggaactcaacaagaggcagaagcagctgaaaacaatattgagaatccaactacattaaaagataatgtccaatc
aaaagaagtgaagattgaagaagtaacaaacaaagacactgcaccacagggtgtagaagctaaatctgaagta
acttcaaacaaagacacaatcgaacatgaaccatcagtaaaagctgaagatatatcaaaaaaggaggatacac
caaaagaagtagctgatgttgctgaagttcagccgaaatcgtcagtcactcataacgcagagacacctaaggttag
aaaagctcgttctgttgatgaaggctcttttgatattacaagagattctaaaaatgtagttgaatctaccccaattacaatt
caaggtaaagaacattttgaaggttacggaagtgttgatatacaaaaaaaaccaacagatttaggggtatcagagg
taaccaggtttaatgttggtaatgaaagtaatggtttgataggagctttacaattaaaaaataaaatagattttagtaag
gatttcaattttaaagttagagtggcaaataaccatcaatcaaataccacaggtgctgatggttgggggttcttatttagt
aaaggaaatgcagaagaatatttaactaatggtggaatccttggggataaaggtctggtaaattcaggcggatttaa
aattgatactggatacatttatacaagttccatggacaaaactgaaaagcaagctggacaaggttatagaggatacg
gagcttttgtgaaaaatgacagttctggtaattcacaaatggttggagaaaatattgataaatcaaaaactaattttttaa
actatgcggacaattcaactaatacatcagatggaaagtttcatgggcaacgtttaaatgatgtcatcttaacttatgttg
cttcaactggtaaaatgagagcagaatatgctggtaaaacttgggagacttcaataacagatttaggtttatctaaaaa
tcaggcatataatttcttaattacatctagtcaaagatggggccttaatcaagggataaatgcaaatggctggatgaga
actgacttgaaaggttcagagtttacttttacaccagaagcgccaaaaacaataacagaattagaaaaaaaagttg
aagagattccattcaagaaagaacgtaaatttaatccggatttagcaccagggacagaaaaagtaacaagagaa
ggacaaaaaggtgagaagacaataacgacaccaacactaaaaaatccattaactggagtaattattagtaaaggt
gaaccaaaagaagagattacaaaagatccgattaatgaattaacagaatacggacctgaaacaatagcgccag
gtcatcgagacgaatttgatccgaagttaccaacaggagagaaagaggaagttccaggtaaaccaggaattaag
aatccagaaacaggagacgtagttagaccgccggtcgatagcgtaacaaaatatggacctgtaaaaggagactc
gattgtagaaaaagaagagattccattcgagaaagaacgtaaatttaatcctgatttagcaccagggacagaaaaa
gtaacaagagaaggacaaaaaggtgagaagacaataacgacgccaacactaaaaaatccattaactggagaa
attattagtaaaggtgaatcgaaagaagaaatcacaaaagatccgattaatgaattaacagaatacggaccagaa
acgataacaccaggtcatcgagacgaatttgatccgaagttaccaacaggagagaaagaggaagttccaggtaa
accaggaattaagaatccagaaacaggagatgtagttagaccaccggtcgatagcgtaacaaaatatggacctgt
aaaaggagactcgattgtagaaaaagaagagattccattcgagaaagaacgtaaatttaatcctgatttagcacca
gggacagaaaaagtaacaagagaaggacaaaaaggtgagaagacaataacgacaccaacactaaaaaatc
cattaactggagtaattattagtaaaggtgaaccaaaagaagaaatcacaaaagatccgattaatgaattaacaga
atacggaccagaaacgataacaccaggtcatcgagacgaatttgatccgaagttaccaacaggagagaaagaa
gaagttccaggtaaaccaggaattaagaatccagaaacaggagacgtagttagaccaccggtcgatagcgtaac
aaaatatggacctgtaaaaggagactcgattgtagaaaaagaagagattccattcaagaaagaacgtaaatttaat
ccggatttagcaccagggacagaaaaagtaacaagagaaggacaaaaaggtgagaagacaataacgacgcc
aacactaaaaaatccattaactggagaaattattagtaaaggtgaatcgaaagaagaaatcacaaaagatccgat
taatgaattaacagaatacggaccagaaacgataacaccaggtcatcgagacgaatttgatccgaagttaccaac
aggagagaaagaggaagttccaggtaaaccaggaattaagaatccagaaacaggagatgtagttagaccaccg
gtcgatagcgtaacaaaatatggacctgtaaaaggagactcgattgtagaaaaagaagagattccattcgagaaa
gaacgtaaatttaatcctgatttagcaccagggacagaaaaagtaacaagagaaggacaaaaaggtgagaaga
caataacgacgccaacactaaaaaatccattaactggagaaattattagtaaaggtgaatcgaaagaagaaatca
caaaagatccgattaatgaattaacagaatacggaccagaaacgataacaccaggtcatcgagacgaatttgatc
cgaagttaccaacaggagagaaagaggaagttccaggtaaaccaggaattaagaatccagaaacaggagacg
tagttagaccaccggtcgatagcgtaacaaaatatggacctgtaaaaggagactcgattgtagaaaaagaagaaa
ttccattcaagaaagaacgtaaatttaatcctgatttagcaccagggacagaaaaagtaacaagagaaggacaaa
aaggtgagaagacaataacgacgccaacactaaaaaatccattaactggagaaattattagtaaaggtgaatcga
aagaagaaatcacaaaagatccgattaatgaattaacagaatacggaccagaaacgataacaccaggtcatcg
agacgaatttgatccgaagttaccaacaggagagaaagaggaagttccaggtaaaccaggaattaagaatccag
aaacaggagatgtagttagaccaccggtcgatagcgtaacaaaatatggacctgtaaaaggagactcgattgtag
aaaaagaagaaattccattcgagaaagaacgtaaatttaatcctgatttagcaccagggacagaaaaagtaacaa
gagaaggacaaaaaggtgagaagacaataacgacgccaacactaaaaaatccattaactggagaaattattagt
aaaggtgaatcgaaagaagaaatcacaaaagatccgattaatgaattaacagaatacggaccagaaacgataa
caccaggtcatcgagacgaatttgatccgaagttaccaacaggagagaaagaggaagttccaggtaaaccagga
attaagaatccagaaacaggagatgtagttagaccaccggtcgatagcgtaacaaaatatggacctgtaaaagga
gactcgattgtagaaaaagaagaaattccattcgagaaagaacgtaaatttaatcctgatttagcaccagggacag
aaaaagtaacaagagaaggacaaaaaggtgagaagacaataacgacgccaacactaaaaaatccattaactg
gagaaattattagtaaaggtgaatcgaaagaagaaatcacaaaagatccagttaatgaattaacagaattcggtgg
cgagaaaataccgcaaggtcataaagatatctttgatccaaacttaccaacagatcaaacggaaaaagtaccagg
taaaccaggaatcaagaatccagacacaggaaaagtgatcgaagagccagtggatgatgtgattaaacacgga
ccaaaaacgggtacaccagaaacaaaaacagtagagataccgtttgaaacaaaacgtgagtttaatccaaaatt
acaacctggtgaagagcgagtgaaacaagaaggacaaccaggaagtaagacaatcacaacaccaatcacagt
gaacccattaacaggtgaaaaagttggcgagggtcaaccaacagaagagatcacaaaacaaccagtagataa
gattgtagagttcggtggagagaaaccaaaagatccaaaaggacctgaaaacccagagaagccgagcagacc
aactcatccaagtggcccagtaaatcctaacaatccaggattatcgaaagacagagcaaaaccaaatggcccagt
tcattcaatggataaaaatgataaagttaaaaaatctaaaattgctaaagaatcagtagctaatcaagagaaaaaa
cgagcagaattaccaaaaacaggtttagaaagcacgcaaaaaggtttgatctttagtagtataattggaattgctgga
ttaatgttattgg ctcgtagaagaaagaattaa
RrkN(8325)(SEQ ID NO:14)
SGKYGKRSMQMRDKKGPVNKRVDFLSNKLNKYSIRKFTVGTASILIGSLMYLGTQ
QEAEAAENNIENPTTLKDNVQSKEVKIEEVTNKDTAPQGVEAKSEVTSNKDTIEHE
PSVKAEDISKKEDTPKEVADVAEVQPKSSVTHNAETPKVRKARSVDEGSFDITRDS
KNVVESTPITIQGKEHFEGYGSVDIQKKPTDLGVSEVTRFNVGNESNGLIGALQLK
NKIDFSKDFNFKVRVANNHQSNTTGADGWGFLFSKGNAEEYLTNGGILGDKGLVN
SGGFKIDTGYIYTSSMDKTEKQAGQGYRGYGAFVKNDSSGNSQMVGENIDKSKT
NFLNYADNSTNTSDGKFHGQRLNDVILTYVASTGKMRAEYAGKTVVETSITDLGLS
KNQAYNFLITSSQRWGLNQGINANGWMRTDLKGSEFTFTPEAPKTITELEKKVEEI
PFKKERKFNPDLAPGTEKVTREGQKGEKTITTPTLKNPLTGVIISKGEPKEEITKDPI
NELTEYGPETIAPGHRDEFDPKLPTGEKEEVPGKPGIKNPETGDVVRPPVDSVTKY
GPVKGDSIVEKEEIPFEKERKFNPDLAPGTEKVTREGQKGEKTITTPTLKNPLTGEII
SKGESKEEITKDPINELTEYGPETITPGHRDEFDPKLPTGEKEEVPGKPGIKNPETG
DVVRPPVDSVTKYGPVKGDSIVEKEEIPFEKERKFNPDLAPGTEKVTREGQKGEK
TITTPTLKNPLTGVIISKGEPKEEITKDPINELTEYGPETITPGHRDEFDPKLPTGEKE
EVPGKPGIKNPETGDVVRPPVDSVTKYGPVKGDSIVEKEEIPFKKERKFNPDLAPG
TEKVTREGQKGEKTITTPTLKNPLTGEIISKGESKEEITKDPINELTEYGPETITPGH
RDEFDPKLPTGEKEEVPGKPGIKNPETGDVVRPPVDSVTKYGPVKGDSIVEKEEIP
FEKERKFNPDLAPGTEKVTREGQKGEKTITTPTLKNPLTGEIISKGESKEEITKDPIN
ELTEYGPETITPGH RDEFDPKLPTGEKEEVPGKPGIKNPETGDVVRPPVDSVTKYG
PVKGDSIVEKEEIPFKKERKFNPDLAPGTEKVTREGQKGEKTITTPTLKNPLTGEIIS
KGESKEEITKDPINELTEYGPETITPGHRDEFDPKLPTGEKEEVPGKPGIKNPETGD
VVRPPVDSVTKYGPVKGDSIVEKEEIPFEKERKFNPDLAPGTEKVTREGQKGEKTI
TTPTLKNPLTGEIISKGESKEEITKDPINELTEYGPETITPGHRDEFDPKLPTGEKEE
VPGKPGIKNPETGDVVRPPVDSVTKYGPVKGDSIVEKEEIPFEKERKFNPDLAPGT
EKVTREGQKGEKTITTPTLKNPLTGEIISKGESKEEITKDPVNELTEFGGEKIPQGH
KDIFDPNLPTDQTEKVPGKPGIKNPDTGKVIEEPVDDVIKHGPKTGTPETKTVEIPF
ETKREFNPKLQPGEERVKQEGQPGSKTITTPITVNPLTGEKVGEGQPTEEITKQPV
DKIVEFGGEKPKDPKGPENPEKPSRPTHPSGPVNPNNPGLSKDRAKPNGPVHSM
DKNDKVKKSKIAKESVANQEKKRAELPKTGLESTQKGLIFSSIIGIAGLMLLARRRK
N
KnkA(8325)(SEQ ID NO:15)
ggaaggagtatgttgatggctaaatatcgagggaaaccgtttcaattatatgtaaagttatcgtgttcgacaatgatggc
gacaagtatcattttaacgaatatcttgccgtacgatgcccaagctgcatctgaaaaggatactgaaattacaaaaga
gatattatctaagcaagatttattagacaaagttgacaaggcaattcgtcaaattgagcaattaaaacagttatcggctt
catctaaagaacattataaagcacaactaaatgaagcgaaaacagcatcgcaaatagatgaaatcataaaacga
gctaatgagttggatagcaaagacaataaaagttctcacactgaaatgaacggtcaaagtgatatagacagtaaatt
agatcaattgcttaaagatttaaatgaggtttcttcaaatgttgataggggtcaacaaagtggcgaggacgatcttaat
gcaatgaaaaatgatatgtcacaaacggctacaacaaaacatggagaaaaagatgataaaaatgatgaagca
atggtaaataaggcgttagaagacctagaccatttgaatcagcaaatacacaaatcgaaagatgcatcgaaagat
acatcggaagatccagcagtgtctacaacagataataatcatgaagtagctaaaacgccaaataatgatggttctg
gacatgttgtgttaaataaattcctttcaaatgaagagaatcaaagccatagtaatcgactcactgataaattacaagg
aagcgataaaattaatcatgctatgattgaaaaattagctaaaagtaatgcctcaacgcaacattacacatatcataa
actgaatacgttacaatctttagatcaacgtattgcaaatacgcaacttcctaaaaatcaaaaatcagacttaatgagc
gaagtaaataagacgaaagagcgtataaaaagtcaacgaaatattattttggaagaacttgcacgtactgatgata
aaaagtatgctacacaaagcattttagaaagtatatttaataaagacgaggcagttaaaattctaaaagatatacgt
gttgatggtaaaacagatcaacaaattgcagatcaaattactcgtcatattgatcaattatctctgacaacgagtgatg
atttattaacgtcattgattgatcaatcacaagataagtcgctattgatttctcaaattttacaaacgaaattaggaaaag
ctgaagcagataaattggctaaagattggacgaataaaggattatcaaatcgccaaatcgttgaccaattgaagaa
acattttgcatcaactggcgacacgtcttcagatgatatattaaaagcaattttgaataatgccaaagataaaaaaca
agcaattgaaacgattttagcaacacgtatagaaagacaaaaggcaaaattactggcagatttaattactaaaata
gaaacagatcaaaataaaatttttaatttagttaaatcggcattgaatggtaaagcggatgatttattgaatttacaaaa
gagactcaatcaaacgaaaaaagatatagattatattttatcaccaatagtaaatcgtccaagtttactagatcgattg
aataaaaatgggaaaacgacagatttaaataagttagcaaatttaatgaatcaaggatcagatttattagacagtatt
ccagatatacccacaccaaagccagaaaagacgttaacacttggtaaaggtaatggattgttaagtggattattaaa
tgctgatggtaatgtatctttgcctaaagcgggggaaacgataaaagaacattggttgccgatatctgtaattgttggtg
caatgggtgtactaatgatttggttatcacgacgcaataagttgaaaaataaagcataa
KnkA(8325)(SEQ ID NO:16)
GRSMLMAKYRGKPFQLYVKLSCSTMMATSIILTNILPYDAQAASEKDTEITKEILSK
QDLLDKVDKAIRQIEQLKQLSASSKEHYKAQLNEAKTASQIDEIIKRANELDSKDNK
SSHTEMNGQSDIDSKLDQLLKDLNEVSSNVDRGQQSGEDDLNAMKNDMSQTATT
KHGEKDDKNDEAMVNKALEDLDHLNQQIHKSKDASKDTSEDPAVSTTDNNHEVA
KTPNNDGSGHVVLNKFLSNEENQSHSNRLTDKLQGSDKINHAMIEKLAKSNASTQ
HYTYHKLNTLQSLDQRIANTQLPKNQKSDLMSEVNKTKERIKSQRNIILEELARTDD
KKYATQSILESIFNKDEAVKILKDIRVDGKTDQQIADQITRHIDQLSLTTSDDLLTSLID
QSQDKSLLISQILQTKLGKAEADKLAKDWTNKGLSNRQIVDQLKKHFASTGDTSSD
DILKAILNNAKDKKQAIETILATRIERQKAKLLADLITKIETDQNKIFNLVKSALNGKAD
DLLNLQKRLNQTKKDIDYILSPIVNRPSLLDRLNKNGKTTDLNKLANLMNQGSDLLD
SIPDIPTPKPEKTLTLGKGNGLLSGLLNADGNVSLPKAGETIKEHWLPISVIVGAMG
VLMIWLSRRNKLKNKA
一级结构分析:
将生物信息方法(bioinformatic approach)用于一级结构和功能预测(附图1)。蛋白质RrkN和DsqA具有与先前描述的MSCRAMMs相似的结构组织。RrkN的结构类似于分别为金黄色葡萄球菌和表皮葡萄球菌的Pls/Aap蛋白质。它在N-末端含有200个残基的区域显示与Pis和Aap有40%相同。该蛋白质的C-末端突出地由128个残基重复区域组成,菌株与菌株之间重复区的数量是变化的。这些重复也存在于Pis和Aap。推定的sar同源区和fnbpA和fnbpB正好位于基因组上RrkN的上游。
DsqA的结构的组织相似于蛋白质的Sdr家族。它含有典型的A区域,其后跟随TYYFTDVK基序,该基序类似于在所有Sdr蛋白质中存在的保守的TYTFTVYVD基序。该基序的功能至今没有被测定。2个88个残基的重复区域居留在该蛋白质的中心,其后跟随类似于在所Sdr蛋白质中存在的SD-重复基序的C-末端SX-重复基序。该重复区的大小随菌株变化。在基因组上DsqA邻接secY和secA。DsqA同系物(>90%同一性)也存在于表皮葡萄球菌。
KnkA的序列中不含有重复区域。次级的结构预测分析显示该蛋白质主要地由α-螺旋。
RkaS的序列中不含有重复区域。BLAST分析显示它类似于5′核苷酸酶UDP-糖水解酶。编码RkaS的基因正好地位于fromoryx的上游,mec元件的插入位点。
KesK在该蛋白质的N-末端含有二个140个残基的重复区域,有38%相同。水疗法绘制图分析(Kyte和Doolittle,1982)显示在该蛋白质的中心点有一个大的亲水的区域(残基500-560)。
EkeS在该蛋白质的N-末端含有二个300个残基的重复区域,有38%相同。Blast分析显示该蛋白质的N-末端(残基1-1268,携带两种重复)与FmtB有49%等同,所述的FmtBan是具有17个串联的重复的LPXTG蛋白质。FmtB被推测间接参与甲氧苯青霉素抗性,因为fmt8的灭活去除了甲氧苯青霉素抗性。这似乎是由于通过增加细胞壁前体葡萄糖胺-1-磷酸盐的产生可以减轻对细胞壁组成的影响如甲氧苯青霉素敏感性(Komatsuzawa等人,2000)。
KrkN和KrkN2在基因组上互相邻接。
表达分析:
由于与蛋白质数据库之序列没有同源性,不能预知这些蛋白质中每一个的推定的功能,因此以分子的近似值为依据。利用Qiagen pQE-30表达系统,四个开放读框的独特的区域可以在大肠杆菌中表达为重组his-标记的融合蛋白质。附图2表示纯化的N-末端his-标记的融合蛋白的考马斯亮蓝染色的SDS-PAGE凝胶。将重组蛋白质RrkN1,DsqA2,KesK1和KnkA用于在兔子中产生抗体。金黄色葡萄球菌细胞壁提取物的Western印迹分析显示KesK,KnkA和DsqA被表达并且细胞壁相关(附图3)。菌株eMRSA-16代表aknkA-阴性的菌株,因为它缺乏knkA基因。65kDa的免疫反应谱带与菌株8325-4的指数和静止的时期细胞的细胞壁提取物起反应(附图3,B)。菌株eMRSA-16中没有该谱带暗示它代表了knkA的基因产物。
在指数和静止期的培养物中,利用抗-KesK抗体进行的菌株8325-4的细胞壁成分的Western免疫印迹识别了150kDa免疫反应谱带。表达质粒(pKS80)上全长KesK的表达获得的从乳酸乳球菌的细胞壁成分释放的类似大小的免疫反应蛋白质暗示该150kDa谱带代表kesK基因产物(数据未显示)。需要金黄色葡萄球菌的kesK敲出突变体来证实细胞壁释放的KesK蛋白质的大小。
利用抗-DsqA抗体,金黄色葡萄球菌菌株MSSA和eMRSA-16的细胞壁成分的Western免疫印迹结果识别了一个130kDa免疫反应谱带。在静止期细胞中表达水平更高。
在乳酸乳球菌中异源表达:
以前已经将金黄色葡萄球菌的的表面蛋白质在乳酸乳球菌(L.lactis)中的异源表达用作为研究蛋白质功能的工具(Sinha等人,2000)。在该研究中,也将该替代系统用于在乳酸乳球菌表面表达各个in silico-预知的MSCRAMMs以查出功能。已经将KesK和KnkA克隆到乳酸乳球菌,并且通过点印迹显示是在表面表达的(附图4)。阴性的对照中没有观察到交叉反应(pKS80质粒没有插入物),显示这是一个特异反应。通过用溶菌酶和mutanolysin消化产生了携带pKS-KnkA和pKS-KesK的乳酸乳球菌的细胞壁和原生质体成分,并且用于分别利用抗-KnkA和抗-KesK的抗体进行的Western印迹研究。与在金黄色葡萄球菌中观察到的不同,在乳酸乳球菌细胞壁成分中没有检测到KnkA,但是发现与原生质体成分相关。KnkA的固定用基序不同于一致LPXTG序列,其中含有一个丙氨酸残基而不是苏氨酸(即LPKAG)(表1)。最近已经公开了金黄色葡萄球菌含有二个sortase基因,srtA和srtB(Pallen,2001)。由第二个sortase基因加工LPXTG基序的变异形式是可能的,乳酸乳球菌中没有该基因。这也可以解释在原生质体成分中观察到的KnkA蛋白质大小的轻微的增加,而细胞壁分类拣选信号没有被裂解。
在乳酸乳球菌的细胞壁成分中探测到KesK,但是迁移的分子量小于从金黄色葡萄球菌细胞壁释放的KesK蛋白质。在乳酸乳球菌表面表达的大多数MSCRAMMs被证明在细胞壁提取程序中发生蛋白水解(Louise O′Brien,个人通讯)。因此,从乳酸乳球菌表面释放KesK蛋白质表示截短形式的KesK是可能的。已经证明用溶菌酶和mutanolysin缩短消化时间以限制蛋白水解的程度。
in silico-预测的MSCRAMMs体内表达:
在ELISA分析中对来自金黄色葡萄球菌感染痊愈的33个患者的康复的人-时期血清进行测试,以检测其识别纯化的N-末端his-标记的融合蛋白质的能力。将从儿童和健康的供血者采掘的血清用作为阴性的对照。将阳性的反应其值作为等同于或高于阴性的对照的二倍。附图5A-5D阐明在27-42%患者中识别了所有的蛋白质,这暗示这些蛋白质在体内表达并且在宿主感染期间是致免疫的。
引证文献
Komatsuzawa,H.,Ohta,K.,Sugai,M.,Fujiwara,T.,Glanzmann,P.,Berger-Bachi,B.,Suginaka,H.(2000)编码细胞壁相关的蛋白质的fmt B基因的Tn551-介导的插入失活消除了金黄色葡萄球菌的甲氧苯青霉素抗性。J.Antimicrob.Chemother.45:421-31。
Sinha,B.,Francois,P.,Que,Y.A.,Hussain,M.,Heilmann,C.,Moreillon,P.,Lew,D.,Krause,K.H.,Peters,G.,Herrmann,M.(2000)异源表达的金黄色葡萄球菌粘连蛋白结合蛋白质足以侵入宿主细胞Infect.Immun.68:6871-6878。
Pallen,M.J.,Lam,A.C.,Antonio,M.,Dunbar,K.(2000)sortases的阻碍-一种丰富的反应物?Trends.Microbiol.9:97-101。
实施例2
从金黄色葡萄球菌和从凝固酶阴性的葡萄球菌分离交叉反应的蛋白质并且进行测序
最近已经证明表皮葡萄球菌含有结构上与金黄色葡萄球菌MSCRAMM蛋白质相关的表面蛋白质(US09/386,962)。从金黄色葡萄球菌中分离一个蛋白质特别有利,因为它与表皮葡萄球菌紧密同源。该蛋白质被称为DsqA或SasA(金黄色葡萄球菌)和DgsK(表皮葡萄球菌)。它们的特征是包括一个大约500个氨基酸残基的典型的″A″区域,其后跟随约有40%相同有,各为88个残基的二个B重复区,和一个独特的SXSX二肽重复区,该区域的长度随菌株而变化。金黄色葡萄球菌的DsqA/SasA的A区域内含有一个180残基的区域,该区域与金黄色葡萄球菌蛋白质的RrkN,Pls和表皮葡萄球菌蛋白质Aap的A区域内的一个相似的大小的区域有40%一致性。DsqA/SasA和DgsK蛋白质的A区域在氨基酸水平上有46%的一致性,BB重复区是50%一致性。所包括的主动和被动免疫接种策略;疫苗,识别金黄色葡萄球菌和凝固酶阴性的葡萄球菌的蛋白质的多克隆抗体和单克隆抗体是本发明的主题。
与凝固酶阴性的葡萄球菌和金黄色葡萄球菌发生交叉反应的抗体的特异性例子:
凝固酶阴性的葡萄球菌DgsK A-区域:
氨基酸序列(SEQID NO:17)
ASETPITSEISSNSETVANQNSTTIKNSQKETVNSTSLESNHSNS
TNKQMSSEVTNTAQSSEKAGISQQSSETSNQSSKLNTYASTDH
VESTTINNDNTAQQDQNKSSNVTSKSTQSNTSSSEKNISSNLTQ
SIETKATDSLATSEARTSTNQISNLTSTSTSNQSSPTSFANLRTFS
RFTVLNTMAAPTTTSTTTTSSLTSNSVWNKDNFNEHMNLSGS
ATYDPKTGIATLTPDAYSQKGAISLNTRLDSNRSFRFIGKVNLG
NRYEGYSPDGVAGGDGIGFAFSPGPLGQIGKEGAAVGIGGLNN
AFGFKLDTYHNTSTPRSDAKAKADPRNVGGGGAFGAFVSTD
RNGMATTEESTAAKLNVQPTDNSFQDFVIDYNGDTKVMTVTY
AGQTFTRNLTDWIKNSGGTTFSLSMTASTGGAKNLQQVQFGT
FEYTESAVAKVRYVDANTGKDIIPPPKTIAGEVDGTVNIDKQL
NNFKNLGYSYVGTDALKAPNYTETSGTPTLKLTNSSQTVIYKF
KDVQ
金黄色葡萄球菌SasA A-区域:
氨基酸序列(SEQ ID NO:18)
ASDAPLTSELNTQSETVGNQNSTTIEASTSTADSTSVTKNSSSV
QTSNSDTVSSEKSEKVTSTTNSTSNQQEKLTSTSESTSSKNTTS
SSDTKSVASTSSTEQPINTSTNQSTASNNTSQSTTPSSVNLNKTS
TTSTSTAPVKLRTFSRLAMSTFASAATTTAVTANTITVNKDNLK
QYMTTSGNATYDQSTGIVTLTQDAYSQKGAITLGTRIDSNKSF
HFSGKVNLGNKYEGHGNGGDGIGFAFSPGVLGETGLNGAAVG
IGGLSNAFGFKLDTYHNTSKPNSAAKANADPSNVAGGGAFGA
FVTTDSYGVATTYTSSSTADNAAKLNVQPTNNTFQDFDINYNG
DTKVMTVKYAGQTWTRNISDWIAKSGTTNFSLSMTASTGGAT
NLQQVQFGTFEYTESAVTQVRYVDVTTGKDIIPPKTYSGNVDQ
VVTIDNQQSALTAKGYNYTSVDSSYASTYNDTNKTVKMTNA
GQSVTYYFTDW
Aap蛋白质的完整序列和它的编码DNA(指示有A区域存在)显示如下:
表皮葡萄球菌Aap蛋白质(加下划线的为A-区域)(SEQ IDNO:19)
MGKRRQGPINKKVDFLPNKLNKYSIRKFTVGTASILLGSTLIFGSSSHEAKAAE
EKQ
VDPITQANQNDSSERSLENTNQPTVNNEAPQMSSTLQAEEGSNAEAPQSEPTKA
EEGGNAEAAQSEPTKAEEGGNAEAPQSEPTKAEEGGNAEAAQSEPTKTEEGSNV
KAAQSEPTKAEEGSNAEAPQSEPTKTEEGSNAKAAQSEPTKAEEGGNAEAAQSE
PTKTEEGSNAEAPQSEPTKAEEGGNAEAPQSEPTKTEEGGNAEAPNVPTIKANSD
NDTQTQFSEAPTRNDLARKEDIPAVSKNEELQSSQPNTDSKIEPTTSEPVNLNYSS
PFMSLLSMPADSSSNNTKNTIDIPPTTVKGRDNYDFYGRVDIESNPTDLNATNLTR
YNYGQPPGTTTAGAVQFKNQVSFDKDFDFNIRVANNRQSNTTGADGWGFMFSK
KDGDDFLKNGGILREKGTPSAAGFRIDTGYYNNDPLDKIQKQAGQGYRGYGTFVK
NDSQGNTSKVGSGTPSTDFLNYADNTTNDLDGKFHGQKLNNVNLKYNASNQTFT
ATYAGKTWTATLSELGLSPTDSYNFLVTSSQYGNGNSGTYASGVMRADLDGATL
TYTPKAVDGDPIISTKEIPFNKKREFDPNLAPGTEKVVQKGEPGIETTTTPTYVNPN
TGEKVGEGEPTEKITKQPVDEIVHYGGEEIKPGHKDEFDPNAPKGSQTTQPGKPG
VKNPDTGEVVTPPVDDVTKYGPVDGDPITSTEEIPFDKKREFNPDLKPGEERVKQ
KGEPGTKTITTPTTKNPLTGEKVGEGEPTEKITKQPVDEITEYGGEEIKPGHKDEFD
PNAPKGSQEDVPGKPGVKNPGTGEVVTPPVDDVTKYGPVDGDPITSTEEIPFDKK
REFNPDLKPGEERVKQKGEPGTKTITTPTTKNPLTGEKVGEGEPTEKITKQPVDEI
VHYGGEQIPQGHKDEFDPNAPVDSKTEVPGKPGVKNPDTGEVVTPPVDDVTKYG
PVDGDSITSTEEIPFDKKREFDPNLAPGTEKVVQKGEPGTKTITTPTTKNPLTGEKV
GEGKSTEKVTKQPVDEIVEYGPTKAEPGKPAEPGKPAEPGKPAEPGTPAEPGKPA
EPGTPAEPGKPAEPGKPAEPGKPAEPGKPAEPGTPAEPGTPAEPGKPAEPGTPA
EPGKPAEPGTPAEPGKPAESGKPVEPGTPAQSGAPEQPNRSMHSTDNKNQLPD
TGENRQANEGTLVGSLLAIVGSLFIFGRRKKGNEK
表皮葡萄球菌aap DNA(SEQ ID NO:20)
atgggcaaac gtagacaagg tcctattaat aaaaaagtgg
attttttacc taacaaatta aacaagtatt ctataagaaa attcactgtt ggtacggcct
caatattact tggttcgaca cttatttttg gaagtagtag ccatgaagcg aaagctgcag
aagaaaaaca agttgatcca attacacaag ctaatcaaaa tgatagtagt gaaagatcac
ttgaaaacac aaatcaacct actgtaaaca atgaagcacc acagatgtct tctacattgc
aagcagaaga aggaagcaat gcagaagcac ctcaatctga gccaacgaag gcagaagaag
gaggcaatgc agaagcagct caatctgagc caacgaaggc agaagaagga ggcaatgcag
aagcacctca atctgagcca acgaaggcag aagaaggagg caatgcagaa gcagctcaat
ctgagccaac gaagacagaa gaaggaagca acgtaaaagc agctcaatct gagccaacga
aggcagaaga aggaagcaat gcagaagcac ctcaatctga gccaacgaag acagaagaag
gaagcaacgc aaaagcagct caatctgagc caacgaaggc agaagaagga ggcaatgcag
aagcagctca atctgagcca acgaagacag aagaaggaag caatgcagaa gcacctcaat
ctgagccaac gaaggcagaa gaaggaggca atgcagaagc acctcaatct gagccaacga
agacagaaga aggaggcaat gcagaagcac cgaatgttcc aactatcaaa gctaattcag
ataatgatac acaaacacaa ttttcagaag cccctacaag aaatgaccta gctagaaaag
aagatatccc tgctgtttct aaaaacgagg aattacaatc atcacaacca aacactgaca
gtaaaataga acctacaact tcagaacctg tgaatttaaa ttatagttct ccgtttatgt
ccttattaag catgcctgct gatagttcat ccaataacac taaaaataca atagatatac
cgccaactac ggttaaaggt agagataatt acgattttta cggtagagta gatatcgaaa
gtaatcctac agatttaaat gcgacaaatt taacgagata taattatgga cagccacctg
gtacaacaac agctggtgca gttcaattta aaaatcaagt tagttttgat aaagatttcg
actttaacat tagagtagca aacaatcgtc aaagtaatac aactggtgca gatggttggg
gctttatgtt cagcaagaaa gatggggatg atttcctaaa aaacggtggt atcttacgtg
aaaaaggtac acctagtgca gctggtttca gaattgatac aggatattat aataacgatc
cattagataa aatacagaaa caagctggtc aaggctatag agggtatggg acatttgtta
aaaatgactc ccaaggtaat acttctaaag taggatcagg tactccatca acagattttc
ttaactacgc agataatact actaatgatt tagatggtaa attccatggt caaaaattaa
ataatgttaa tttgaaatat aatgcttcaa atcaaacttt tacagctact tatgctggta
aaacttggac ggctacgtta tctgaattag gattgagtcc aactgatagt tacaattttt
tagttacatc aagtcaatat ggaaatggta atagtggtac atacgcaagt ggcgttatga
gagctgattt agatggtgca acattgacat acactcctaa agcagtcgat ggagatccaa
ttatatcaac taaggaaata ccatttaata agaaacgtga atttgatcca aacttagccc
caggtacaga aaaagtagtc caaaaaggtg aaccaggaat tgaaacaaca acaacaccaa
cttatgtcaa tcctaataca ggagaaaaag ttggcgaagg tgaaccaaca gaaaaaataa
caaaacaacc agtggatgaa atcgttcatt atggtggcga agaaatcaag ccaggccata
aggatgaatt tgatccaaat gcaccgaaag gtagtcaaac aacgcaacca ggtaagccgg
gggttaaaaa tcctgataca ggcgaagtag ttactccacc tgtggatgat gtgacaaaat
atggtccagt tgatggagat ccgatcacgt caacggaaga aattccattc gacaagaaac
gtgaattcaa tcctgattta aaaccaggtg aagagcgtgt taaacaaaaa ggtgaaccag
gaacaaaaac aattacaaca ccaacaacta agaacccatt aacaggggaa aaagttggcg
aaggtgaacc aacagaaaaa ataacaaaac aaccagtaga tgaaatcaca gaatatggtg
gcgaagaaat caagccaggc cataaggatg aatttgatcc aaatgcaccg aaaggtagcc
aagaggacgt tccaggtaaa ccaggagtta aaaaccctgg aacaggcgaa gtagtcacac
caccagtgga tgatgtgaca aaatatggtc cagttgatgg agatccgatc acgtcaacgg
aagaaattcc attcgacaag aaacgtgaat tcaatcctga tttaaaacca ggtgaagagc
gcgttaaaca gaaaggtgaa ccaggaacaa aaacaattac aacgccaaca actaagaacc
cattaacagg agaaaaagtt ggcgaaggtg aaccaacaga aaaaataaca aaacaaccag
tggatgagat tgttcattat ggtggtgaac aaataccaca aggtcataaa gatgaatttg
atccaaatgc acctgtagat agtaaaactg aagttccagg taaaccagga gttaaaaatc
ctgatacagg tgaagttgtt accccaccag tggatgatgt gacaaaatat ggtccagttg
atggagattc gattacgtca acggaagaaa ttccgtttga taaaaaacgc gaatttgatc
caaacttagc gccaggtaca gagaaagtcg ttcaaaaagg tgaaccagga acaaaaacaa
ttacaacgcc aacaactaag aacccattaa caggagaaaa agttggcgaa ggtaaatcaa
cagaaaaagt cactaaacaa cctgttgacg aaattgttga gtatggtcca acaaaagcag
aaccaggtaa accagcggaa ccaggtaaac cagcggaacc aggtaaacca gcggaaccag
gtacgccagc agaaccaggt aaaccagcgg aaccaggtac gccagcagaa ccaggtaaac
cagcggaacc aggtaaacca gcggaaccag gtaaaccagc ggaaccaggt aaaccagcgg
aaccaggtac gccagcagaa ccaggtacgc cagcagaacc aggtaaacca gcggaaccag
gtacgccagc agaaccaggt aaaccagcgg aaccaggtac gccagcagaa ccaggtaaac
cagcggaatc aggtaaacca gtggaaccag gtacgccagc acaatcaggt gcaccagaac
aaccaaatag atcaatgcat tcaacagata ataaaaatca attacctgat acaggtgaaa
atcgtcaagc taatgaggga actttagtcg gatctctatt agcaattgtc ggatcattgt
tcatatttgg tcgtcgtaaa aaaggtaatg aaaaataatt tcatataaaa actttctgcc
attaa
从A-区域到表皮葡萄球菌Aap(氨基酸55-600)(SEQ IDNO:21)
55EKQVDPITQANQNDSSERSLENTNQPTVNNEAPQMSSTLQAEEGSNAEAPQSE
PTKAEEGGNAEAAQSEPTKAEEGGNAEAPQSEPTKAEEGGNAEAAQSEPTKTEE
GSNVKAAQSEPTKAEEGSNAEAPQSEPTKTEEGSNAKAAQSEPTKAEEGGNAEA
AQSEPTKTEEGSNAEAPQSEPTKAEEGGNAEAPQSEPTKTEEGGNAEAPNVPTIK
ANSDNDTQTQFSEAPTRNDLARKEDIPAVSKNEELQSSQPNTDSKIEPTTSEPVNL
NYSSPFMSLLSMPADSSSNNTKNTIDIPPTTVKGRDNYDFYGRVDIESNPTDLNAT
NLTRYNYGQPPGTTTAGAVQFKNQVSFDKDFDFNIRVANNRQSNTTGADGWGF
MFSKKDGDDFLKNGGILREKGTPSAAGFRIDTGYYNNDPLDKIQKQAGQGYRGYG
TFVKNDSQGNTSKVGSGTPSTDFLNYADNTTNDLDGKFHGQKLNNVNLKYNASN
QTFTATYAGKTWTATLSELGLSPTDSYNFLVTSSQYGNGNSGTYASGVMRADLD
GA600
蛋白质的生产和纯化
利用PCR,从上面描述的序列扩增识别为DgsK或SasA的表面蛋白质的A区域,再克隆到大肠杆菌表达载体PQE-30(Qiagen),以允许表达一种含有六个组氨酸残基的重组融合蛋白质。随后将该载体转化到大肠杆菌ATCC 55151,在15-升发酵罐中生长到光密度(OD600)为0.7,用0.2mM异丙基-1β-D半乳糖苷(IPTG)诱导4小时。利用AG Technologies中空纤维组件(孔大小0.45um)收集细胞,将细胞浆在-80C冷冻。利用2次穿过French Press,1100psi,将细胞在1×PBS(10mL缓冲液/1克的细胞浆)裂解。将裂解的细胞17,000rpm旋转30分钟以除去细胞碎片。将上清液经过装备了0.1M NiCI2的5-mL Hi俘获Cheating(Pharmacia)柱。在上样之后,用5个柱体积的10mM Tris,pH 8.0,100mM NaCI(缓冲液A)洗涤柱子。利用超过30个柱体积的0-100%梯度的10mM Tris,pH 8.0,100mM NaCI,200mM咪唑(Buffer B)洗脱蛋白质。SdrGN1N2N3或SdrGN2N3在~13%Buffer B(~26mM咪唑)被洗脱。监测280nm处的吸光率。在1×PBS中透析含有SdrGN1N2N3或SdrGN2N3的馏分。
然后将各个蛋白质经过一个内毒素除去方案。在该方案中所使用的缓冲液通过一个5-mL Mono-Q琼脂糖(Pharmacia)柱而没有内毒素。将蛋白质平衡地分到4×15毫升试管中。各个试管的体积用缓冲液A加到9毫升。将1毫升的10%Triton X-114加入到各个试管中,在4℃旋转保温1小时。将试管置于37℃水浴中以使相位分离。将试管以2,000rpm旋转10分钟,收集各个试管的上面的含水的相,用去污剂反复提取。将2次提取的含水相合并,传递过带有0.1M NiCl2的5-毫升IDA cheating(Sigma)柱,以除去剩余的洗涤剂。用9个柱体积的Buffer A洗涤该柱,然后用3个柱体积的Buffer B洗脱该蛋白质。将洗脱液通过5-毫升的Detoxigel(Sigma)柱,收集流出物,再上样到柱。收集第二次过柱的流出物,在1×PBS中透析。分析纯化的产物的浓度,纯度和内毒素水平,然后给小鼠给药。
单克隆抗体的生产
将大肠杆菌表达的和纯化的重组SasA和DsgK蛋白质用于制备一组鼠的单克隆抗体,而将小鼠血清用作为多克隆抗体的来源。简单地说,一组Balb/C或SJL小鼠接收了一系列皮下的免疫接种1-10mg溶液蛋白质或与下面表描述的佐剂混合的蛋白质。
免疫接种方案
RIMMS
注射 天数 数量(微克) 途径 佐剂
#1 0 5 皮下 FCA/RIBI
#2 2 1 皮下 FCA/RIBI
#3 4 1 皮下 FCA/RIBI
#4 7 1 皮下 FCA/RIBI
#5 9 1 皮下 FCA/RIBI
常规注射 天数 数量(微克) 途径 佐剂
原始 0 5 皮下 FCA
加强#1 14 1 腹膜内 RIBI
加强#2 28 1 腹膜内 RIBI
加强#3 42 1 腹膜内 RIBI
在杀死时(RIMMS)或加强后几天收集(常规的)血清,在ELISA测定中测定抗MSCRAMM蛋白质或对完整的细胞(表皮葡萄球菌和金黄色葡萄球菌)的效价。在最后的加强之后3天,去除脾脏或淋巴结,挑开成单细胞悬浮液,收集淋巴细胞。然后将淋巴细胞与P3X63Ag8.653骨髓瘤细胞系(ATCC &CRL-1580)融合。根据Current Protocols in Immunology(第2章,第2单元)中的生产单克隆抗体的方案进行细胞融合,随后涂覆平板和喂养。
然后利用标准的ELISA分析方法,从融合产生的任何克隆中筛选特异的抗-SasA抗体的产生。扩增阳性的克隆,进一步通过流式血细胞计数测试完整的细菌的细胞结合测定中的活性以及Biacore分析中SasA的结合。
Biacore分析
在整个分析中,流速保持在10毫升/分钟不变。在注射SasA或DgsK之前,借助于RAM-Fc结合,将测试抗体吸附到芯片。在时间0,将浓度为30mg/ml的SasA或DgsK注射过芯片3分钟,随后解离2分钟。该阶段的分析测定了Mab/SasA或DgsK相互作用的相对关系和分离动力学。
与完整细菌的结合
用兔子IgG(50mg/ml)封闭之后,收集,洗涤细菌的样品金黄色葡萄球菌Newman,金黄色葡萄球菌60,金黄色葡萄球菌397(Sal6),金黄色葡萄球菌Wood,金黄色葡萄球菌8325-4,甲氧苯青霉素抗性的金黄色葡萄球菌MRSA 16,表皮葡萄球菌ATCC 35984,表皮葡萄球菌HB,表皮葡萄球菌CN-899和溶血葡萄球菌ATCC 43253,用浓度为2pg/ml的Mab或仅用PBS(对照)保温。在用抗体保温之后,将用作为检测抗体的山羊-F(ab′)2-抗-小鼠-F(ab′)2-FITC用于孵育细菌的细胞。在抗体标记之后,用FACS caliber流式细胞计数器抽吸细菌的细胞以分析荧光射出(刺激:488,发射:570)。对于各个细菌的菌株,收集和检测10,000个样品。这些资料显示抗金黄色SasA的抗体能够识别凝固酶阴性的葡萄球菌的表面的同源的蛋白质。该资料支持Western印迹分析,表明抗金黄色葡萄球菌SasA的兔子多克隆抗体与从表皮葡萄球菌HB细胞表面释放的蛋白质以及来自于从表皮葡萄球菌克隆的DsgK的重组A-区域发生交叉反应(参见附图6和下表)。
多克隆血清反应性
Newman | 67-0 | 397(SAL6) | Wood46 | 8325-4 | MRSA16 | ATCC3598 | HB | CN-899 | ATCC4325 | |
4 | 3 | |||||||||
常规小鼠血清 | - | - | - | - | - | - | - | - | - | - |
小鼠抗SasA | + | + | +/- | - | + | + | + | + | + | + |
序列表
<110>蒂莫西·J·福斯特等人
<120>识别凝血酶阴性的葡萄球菌和金黄色葡萄球菌的表面蛋白的交叉反应性单克隆抗体和多克隆抗体
<130>P07263US01/BAS
<140>US 10/172,502
<141>2002-06-17
<150>US 60/298,098
<151>2001-06-15
<160>29
<170>Patent In version 3.1
<210>1
<211>6609
<212>DNA
<213>Staphylococcus epidermidis
<400>1
acaacacagc agagaataga caaccaggag gaaaacgaaa tgaatttgtt aaagaaaaat 60
aaatatagta ttagaaaata taaagtaggg atattctcta ctttaatcgg gacagtttta 120
ttactttcaa acccaaatgg tgcacaagct ttaactacgg atcataatgt gcaaggtggt 180
tcaaatcaag cattacctgg caactcacaa aatacaaatg ccgatactaa tcgagacata 240
gtaaatgatt cgcaaaatac tcctaatgca catgcaacag acaatacatc aacaaatcaa 300
gcattgacta atcatcaaaa cgttgatgtg gcaaatcaag tcgggcctgc tccaatacag 360
cctagcgcgt cgcctgcgca aaataataat aattctaatg ctaattcaac agcaacagag 420
ccagcggcga atacaaataa taatttagca tcaaataaca atacattaaa cgtgcctaat 480
aatacagata acaatgattc agcgcgtcat ctgactttaa aagaaattca agaagatgtt 540
cgtcattcgt ctgataagcc agagttagtt gcgattgctg aagaagcatc taatagaccg 600
aaaaagagaa gcagacgtgc tgcgccaaca gatcctaatg caacaccagc agatccaacg 660
gctacaccag cagatccaac ggcaggaaat ggtagtgcac cagttgcaat tacagcgcca 720
tacacgccaa caactgatcc caatgccaat aatataggac aaaatgcacc taacgaagtg 780
ctttcatttg atgataacaa cattagacca agtacgaacc gttctgtgcc tacagtaact 840
gttgttgata atttaccagg ctacacactg attaatggtg gtaaagtagg ggtgtttagt 900
catgcaatgg taagaacgag catgtttgat tcaggagatg ccaagaacta tcaagcgcaa 960
ggcaatgtaa ttgcattggg tcgtattaga ggaaatgata caaatgatca tggcgatttt 1020
aatggtatcg agaaaacatt aacagtaaat ccgaattctg aattaatctt tgaatttaat 1080
actatgacta ctaaaaacta tcaaggtatg acaaatttaa tcattaaaaa tgctgataac 1140
gatactgtta ttggtgaaaa agtagttgct tatggtccga tttggcgctt attaaaagta 1200
cctgaaaatg ttagtcatct aaaaattcaa tttgtaccta aaaatgacgc aataacagat 1260
gcacgtggta tttatcaatt acgagatgga tataaatact atgactttgt agactcaatc 1320
ggtcttcatt ctgggtcaca tgtctatgtt gaaagacgta caatggagcc aacagcaaca 1380
aataataaag aatttacagt tacaacgtca ttaaagaata atggtaactt tggcgcttca 1440
ttcaatacag atgattttgt atataaaatt caattacctg aaggtgttga atatgtaaat 1500
aattcattga ctaaagattt tcctagcggt aattcaggtg ttgatattaa tgatatgaat 1560
gtgacgtatg acgcagcaaa tcgaattatt acaattaaaa gtactggtgg aggtacaggg 1620
aattcgccgg cacgactaat gcctgataaa atattggatt tgaagtataa gctacgtgtg 1680
aacaatgtgc caacaccaag aacagtaaca tttaacgata cattaacgta taaaacatat 1740
tcacaagatt ttattaattc acctgctgaa agtcatactg taagtacaaa tccatataca 1800
attgatatca tcatgaataa agacgcattg caagccgaag tcgatagacg aattcaacaa 1860
gcggattata catttgcatc attagatatt tttaatgatc ttaaaagacg cgcacaaaca 1920
attttagatg aaaaccgtaa caatgtacct ttaaacaaaa gagtttctca agcagatatc 1980
gattcattag caaatcagat gcaacatacg ttaattcgca gtgttgacgc tgaaaatgcc 2040
gttaatagaa aagttgatga catggaagat ttagttaacc aaaatgatga actgacagat 2100
gaagaaaaac aagcagcgat tcaagtcatc gaggaacata aaaatgaaat tattgggaat 2160
attggtgacc aaacgactga tgatggcgtt actagaatta aagatcaagg tatacagact 2220
ttaagtggag acactgcaac accagttgtt aaaccaaatg ctaaacaagc tatacgtgat 2280
aaagcagcga aacaaagaga aattatcaat cacacgccag atgctactca agatgaaatt 2340
caagatgcat taaatcaatt aacaacggat gaaacagatg ctattgataa tgttacgaat 2400
gctactacca atgctgatgt tgaaacagct aaaaataatg gtattaatac aattggtgca 2460
gttgcgccac aagtgacaca caaacaagct gcaagagatg caattaatca agcgacagca 2520
acgaaacgac aacaaataaa tagcaataga gaagcaacac aagaagagaa aaatgcagca 2580
ttgaatgaat taacgcaagc cacgaaccac gcattagaac aaatcaatca agcgacaacc 2640
aatgatgatg tagatactgc caaaggtgat ggtctgaatg ccattaatcc tattgcgcct 2700
gtaactgttg tcaagcaagc agcaagagat gccgtatcac atgatgcaca acagcatatc 2760
gcagagatca atgcaaatcc tgatgcgact caagaagaaa gacaagcagc aatagagaaa 2820
gtaaatgctg ctgtagctgt tgcgaatact aatatattaa atgctaatac caatgctgat 2880
gttgagcaag taaagacaaa tgcaattcaa ggtatacaag ccattgaacc agctacaaag 2940
gttaaaacag atgctaaaaa cgctattgat caaagtgcgg aaacgcaaca taatgcgata 3000
tttaataata atgatgcgac cttagaagag caacaagcag cacaacaatt gcttgatcaa 3060
gctgtagcca cagcgaagca aaatattaat gcagcagata cgaatcaaga agttgcacaa 3120
gcaaaagatc agggcacaca aaatatagtt gtgattcaac cggcaacaca agttaaaacg 3180
gatgcacgca atgctgtaaa tgaaaaagcg cgagaggcga taacaaatat caatgctaca 3240
cctggcgcga ctcgagaaga gaaacaagaa gcgataaatc gtgtcaatac acttaaaaat 3300
agagcattaa atgatattgg tgtgacgtct actactgcga tggtcaatag tattagagac 3360
gatgcagtca atcaaatcgg tgcagttcaa ccgcatgtaa cgaagaaaca aactgctaca 3420
ggtgtattaa cggacttagc aactgcaaaa aaacaagaaa ttaatcaaaa tacaaatgca 3480
accactgaag aaaagcaagt agcattaaat caagtagacc aagatttagc aacggcaatt 3540
aataatataa atcaagctga tactaatgca gaagtagatc aagcacaaca attaggtaca 3600
aaagcaatta atgcgattca gccaaatatt gtaaaaaaac ctgcagcatt agcacaaacc 3660
aatcagcatt atagtgctaa attagttgaa atcaatgcta caccagatgc aacagatgat 3720
gagaaaaatg ctgcgatcaa tactttaaat caagacagac aacaagctat tgaaagtatt 3780
aaacaagcaa atacaaatgc ggaagtagac caagctgcga cagtggcaga gaataatatc 3840
gatgctgttc aagttgacgt tgtaaaaaaa caagcagcgc gagataaaat cactgctgaa 3900
gtagcgaagc gtattgaagc ggttaaacaa acacctaatg caactgacga agaaaagcag 3960
gctgcagtta atcaaatcaa tcaacttaaa gatcaagcgt ttaatcaaat taatcaaaac 4020
caaacaaatg atcaggtaga cgcaactaca aatcaagcga ttaatgctat agataatgtt 4080
gaagctgaag tagtaattaa accaaaggca attgcagata ttgaaaaagc tgttaaagaa 4140
aagcaacagc aaattgataa tagtcttgat tcaacagata atgagaaaga agttgcttta 4200
caagcattag ctaaagaaaa agaaaaagca cttgcagcta ttgaccaagc tcaaacgaat 4260
agtcaggtga atcaagcggc aacaaatggt gtatcagcga ttaaaattat tcaacctgaa 4320
acaaaaatta aaccagcagc acgtgaaaaa atcaatcaaa aagcgaatga attacgtgcg 4380
caaattaatc aagataaaga agcgacagca gaagaaagac aagcggcgtt agataaaatc 4440
aatgatttag ttgctaaagc tatgacaaat atcacgaatg atagaacaaa tcagcaagtt 4500
aatgactcaa caaatcaagc gcttgacgac attgcattag tgacgcctga ccatattgtt 4560
agagcagctg ctagagatgc agttaagcaa caatatgaag ctaaaaagca cgaaattgag 4620
caagcggaac atgcgactga tgaagaaaaa caagttgctt taaatcaatt agcgaataat 4680
gaaaaacgtg cattacaaaa cattaatcaa gcaatagcga ataatgatgt gaaacgtgtt 4740
gaatcaaatg gtattgctac gttaaaaggc gtagaaccgc acattgtggt taaacctgaa 4800
gctcaagaag ccataaaagc gagcgcagat aaccaagtag aatctataaa agatacacca 4860
catgctacga cagatgaatt agatgaagca aaccaacaaa taaacgacac acttaaacaa 4920
ggtcaacaag atatagacaa tacgacacaa gatgcagctg tcaatgatgt tagaaaccaa 4980
acgattaagg caatcgaaca aattaaaccg aaagttagac gcaaacgtgc agcgttggat 5040
aacattgatg aaagtaataa taatcaactc gatgcaatac gaaatacgct agatacaacg 5100
caagatgaac gaaatgttgc tattgctgcg ttaaataaaa ttgttaatgc aattaaaaat 5160
gatattgcac aaaacaaaac gaatgcagaa gtggatcaaa ctgaggctga tggtaacaac 5220
aacatcaaag tgattttacc taaagttcaa gttaaaccag cagcgcgtca atctgtcagc 5280
gcaaaagctg aagctcaaaa tgcacttatt gatcaaagtg atttatctac cgaagaagaa 5340
agattagctg ctaaacattt agtagaacaa gcacttaatc aagctattga tcagatcaat 5400
cacgcagata agactgcgca agttaatcaa aatagtatcg atgctcaaaa tattatttca 5460
aaaattaaac cagcgacaac agttaaagca acagcattac aacaaattca aaatatcgct 5520
acaaataaaa ttaatttaat taaagcaaat aacgaagcga cagatgaaga acaaaatgct 5580
gcaatagtac aagttgaaaa agagttaatt aaagctaaac aacaaattgc tggtgcagtg 5640
actaatgctg atgtggcata tttattgcat gatgggaaaa acgaaattcg tgaaatcgaa 5700
cctgttatta ataaaaaagc aactgcgcga gaacaattaa caacattatt caacgataag 5760
aaacaagcaa ttgaagcgaa tgttcaagca acagtagaag aaagaaatag tattttagca 5820
cagttacaaa acatttatga cactgctatt ggacaaattg atcaagatcg tagcaatgca 5880
caagttgata aaacagcaac attaaatcta caaacaatac atgatttaga cgtacatcct 5940
attaaaaagc cagatgctga aaaaacgatt aatgatgatc ttgcacgtgt tacacattta 6000
gtgcaaaatt atcgaaaagt aagtgatcgt aataaggctg atgcattaaa agctataact 6060
gcattaaaat tacaaatgga tgaagaatta aaaacagcac gcactaatgc tgatgttgat 6120
gcagttttaa aacgatttaa tgttgcatta ggcgatatag aagcagtaat tactgaaaaa 6180
gaaaatagct tactgcgcat tgataacatt gctcaacaaa catatgcgaa attcaaagcg 6240
atcgcaacac cagaacaatt agctaaagta aaagcattaa ttgatcaata tgttgcagat 6300
ggcaatagaa tggttgatga agatgcgaca ttaaatgaca tcaaaaaaga tacgcaactc 6360
attattgatg aaattttagc aattaattta cctgctgaag tgataaaagc gtcaccaaaa 6420
gtggggcaac ctgctccaaa agtttgtacg cctattaaaa aagaagataa acaagaagtg 6480
cgaaaagttg taaaagaact tccaaatact ggttctgaag aaatggattt accattaaaa 6540
gaattagcac taattacagg cgcagcatta ttagctagaa gacgttctaa aaaagaaaaa 6600
gaatcataa 6609
<210>2
<211>2189
<212>PRT
<213>Staphylococcus epidermidis
<400>2
Met Asn Leu Leu Lys Lys Asn Lys Tyr Ser Ile Arg Lys Tyr Lys Val
1 5 10 15
Gly Ile Phe Ser Thr Leu Ile Gly Thr Val Leu Leu Leu Ser Asn Pro
20 25 30
Asn Gly Ala Gln Ala Leu Thr Thr Asp His Asn Val Gln Gly Gly Ser
35 40 45
Asn Gln Ala Leu Pro Gly Asn Ser Gln Asn Thr Asn Ala Asp Thr Asn
50 55 60
Arg Asp Ile Val Asn Asp Ser Gln Asn Thr Pro Asn Ala His Ala Thr
65 70 75 80
Asp Asn Thr Ser Thr Asn Gln Ala Leu Thr Asn His Gln Asn Val Asp
85 90 95
Val Ala Asn Gln Val Gly Pro Ala Pro Ile Gln Pro Ser Ala Ser Pro
100 105 110
Ala Gln Asn Asn Asn Asn Ser Asn Ala Asn Ser Thr Ala Thr Glu Pro
115 120 125
Ala Ala Asn Thr Asn Asn Asn Leu Ala Ser Asn Asn Asn Thr Leu Asn
130 135 140
Val Pro Asn Asn Thr Asp Asn Asn Asp Ser Ala Arg His Leu Thr Leu
145 150 155 160
Lys Glu Ile Gln Glu Asp Val Arg His Ser Ser Asp Lys Pro Glu Leu
165 170 175
Val Ala Ile Ala Glu Glu Ala Ser Asn Arg Pro Lys Lys Arg Ser Arg
180 185 190
Arg Ala Ala Pro Thr Asp Pro Asn Ala Thr Pro Ala Asp Pro Thr Ala
195 200 205
Thr Pro Ala Asp Pro Thr Ala Gly Asn Gly Ser Ala Pro Val Ala Ile
210 215 220
Thr Ala Pro Tyr Thr Pro Thr Thr Asp Pro Asn Ala Asn Asn Ile Gly
225 230 235 240
Gln Asn Ala Pro Asn Glu Val Leu Ser Phe Asp Asp Asn Asn Ile Arg
245 250 255
Pro Ser Thr Asn Arg Ser Val Pro Thr Val Thr Val Val Asp Asn Leu
260 265 270
Pro Gly Tyr Thr Leu Ile Asn Gly Gly Lys Val Gly Val Phe Ser His
275 280 285
Ala Met Val Arg Thr Ser Met Phe Asp Ser Gly Asp Ala Lys Asn Tyr
290 295 300
Gln Ala Gln Gly Asn Val Ile Ala Leu Gly Arg Ile Arg Gly Asn Asp
305 310 315 320
Thr Asn Asp His Gly Asp Phe Asn Gly Ile Glu Lys Thr Leu Thr Val
325 330 335
Asn Pro Asn Ser Glu Leu Ile Phe Glu Phe Asn Thr Met Thr Thr Lys
340 345 350
Asn Tyr Gln Gly Met Thr Asn Leu Ile Ile Lys Asn Ala Asp Asn Asp
355 360 365
Thr Val Ile Gly Glu Lys Val Val Ala Tyr Gly Pro Ile Trp Arg Leu
370 375 380
Leu Lys Val Pro Glu Asn Val Ser His Leu Lys Ile Gln Phe Val Pro
385 390 395 400
Lys Asn Asp Ala Ile Thr Asp Ala Arg Gly Ile Tyr Gln Leu Arg Asp
405 410 415
Gly Tyr Lys Tyr Tyr Asp Phe Val Asp Ser Ile Gly Leu His Ser Gly
420 425 430
Ser His Val Tyr Val Glu Arg Arg Thr Met Glu Pro Thr Ala Thr Asn
435 440 445
Asn Lys Glu Phe Thr Val Thr Thr Ser Leu Lys Asn Asn Gly Asn Phe
450 455 460
Gly Ala Ser Phe Asn Thr Asp Asp Phe Val Tyr Lys Ile Gln Leu Pro
465 470 475 480
Glu Gly Val Glu Tyr Val Asn Asn Ser Leu Thr Lys Asp Phe Pro Ser
485 490 495
Gly Asn Ser Gly Val Asp Ile Asn Asp Met Asn Val Thr Tyr Asp Ala
500 505 510
Ala Asn Arg Ile Ile Thr Ile Lys Ser Thr Gly Gly Gly Thr Gly Asn
515 520 525
Ser Pro Ala Arg Leu Met Pro Asp Lys Ile Leu Asp Leu Lys Tyr Lys
530 535 540
Leu Arg Val Asn Asn Val Pro Thr Pro Arg Thr Val Thr Phe Asn Asp
545 550 555 560
Thr Leu Thr Tyr Lys Thr Tyr Ser Gln Asp Phe Ile Asn Ser Pro Ala
565 570 575
Glu Ser His Thr Val Ser Thr Asn Pro Tyr Thr Ile Asp Ile Ile Met
580 585 590
Asn Lys Asp Ala Leu Gln Ala Glu Val Asp Arg Arg Ile Gln Gln Ala
595 600 605
Asp Tyr Thr Phe Ala Ser Leu Asp Ile Phe Asn Asp Leu Lys Arg Arg
610 615 620
Ala Gln Thr Ile Leu Asp Glu Asn Arg Asn Asn Val Pro Leu Asn Lys
625 630 635 640
Arg Val Ser Gln Ala Asp Ile Asp Ser Leu Ala Asn Gln Met Gln His
645 650 655
Thr Leu Ile Arg Ser Val Asp Ala Glu Asn Ala Val Asn Arg Lys Val
660 665 670
Asp Asp Met Glu Asp Leu Val Asn Gln Asn Asp Glu Leu Thr Asp Glu
675 680 685
Glu Lys Gln Ala Ala Ile Gln Val Ile Glu Glu His Lys Asn Glu Ile
690 695 700
Ile Gly Asn Ile Gly Asp Gln Thr Thr Asp Asp Gly Val Thr Arg Ile
705 710 715 720
Lys Asp Gln Gly Ile Gln Thr Leu Ser Gly Asp Thr Ala Thr Pro Val
725 730 735
Val Lys Pro Asn Ala Lys Gln Ala Ile Arg Asp Lys Ala Ala Lys Gln
740 745 750
Arg Glu Ile Ile Asn His Thr Pro Asp Ala Thr Gln Asp Glu Ile Gln
755 760 765
Asp Ala Leu Asn Gln Leu Thr Thr Asp Glu Thr Asp Ala Ile Asp Asn
770 775 780
Val Thr Asn Ala Thr Thr Asn Ala Asp Val Glu Thr Ala Lys Asn Asn
785 790 795 800
Gly Ile Asn Thr Ile Gly Ala Val Ala Pro Gln Val Thr His Lys Gln
805 810 815
Ala Ala Arg Asp Ala Ile Asn Gln Ala Thr Ala Thr Lys Arg Gln Gln
820 825 830
Ile Asn Ser Asn Arg Glu Ala Thr Gln Glu Glu Lys Asn Ala Ala Leu
835 840 845
Asn Glu Leu Thr Gln Ala Thr Asn His Ala Leu Glu Gln Ile Asn Gln
850 855 860
Ala Thr Thr Asn Asp Asp Val Asp Thr Ala Lys Gly Asp Gly Leu Asn
865 870 875 880
Ala Ile Asn Pro Ile Ala Pro Val Thr Val Val Lys Gln Ala Ala Arg
885 890 895
Asp Ala Val Ser His Asp Ala Gln Gln His Ile Ala Glu Ile Asn Ala
900 905 910
Asn Pro Asp Ala Thr Gln Glu Glu Arg Gln Ala Ala Ile Glu Lys Val
915 920 925
Tyr Ala Ala Val Ala Val Ala Asn Thr Asn Ile Leu Asn Ala Asn Thr
930 935 940
Asn Ala Asp Val Glu Gln Val Lys Thr Asn Ala Ile Gln Gly Ile Gln
945 950 955 960
Ala Ile Glu Pro Ala Thr Lys Val Lys Thr Asp Ala Lys Asn Ala Ile
965 970 975
Asp Gln Ser Ala Glu Thr Gln His Asn Ala Ile Phe Asn Asn Asn Asp
980 985 990
Ala Thr Leu Glu Glu Gln Gln Ala Ala Gln Gln Leu Leu Asp Gln Ala
995 1000 1005
Val Ala Thr Ala Lys Gln Asn Ile Asn Ala Ala Asp Thr Asn Gln
1010 1015 1020
Glu Val Ala Gln Ala Lys Asp Gln Gly Thr Gln Asn Ile Val Val
1025 1030 1035
Ile Gln Pro Ala Thr Gln Val Lys Thr Asp Ala Arg Asn Ala Val
1040 1045 1050
Asn Glu Lys Ala Arg Glu Ala Ile Thr Asn Ile Asn Ala Thr Pro
1055 1060 1065
Gly Ala Thr Arg Glu Glu Lys Gln Glu Ala Ile Asn Arg Val Asn
1070 1075 1080
Thr Leu Lys Asn Arg Ala Leu Asn Asp Ile Gly Val Thr Ser Thr
1085 1090 1095
Thr Ala Met Val Asn Ser Ile Arg Asp Asp Ala Val Asn Gln Ile
1100 1105 1110
Gly Ala Val Gln Pro His Val Thr Lys Lys Gln Thr Ala Thr Gly
1115 1120 1125
Val Leu Thr Asp Leu Ala Thr Ala Lys Lys Gln Glu Ile Asn Gln
1130 1135 1140
Asn Thr Asn Ala Thr Thr Glu Glu Lys Gln Val Ala Leu Asn Gln
1145 1150 1155
Val Asp Gln Asp Leu Ala Thr Ala Ile Asn Asn Ile Asn Gln Ala
1160 1165 1170
Asp Thr Asn Ala Glu Val Asp Gln Ala Gln Gln Leu Gly Thr Lys
1175 1180 1185
Ala Ile Asn Ala Ile Gln Pro Asn Ile Val Lys Lys Pro Ala Ala
1190 1195 1200
Leu Ala Gln Thr Asn Gln His Tyr Ser Ala Lys Leu Val Glu Ile
1205 1210 1215
Asn Ala Thr Pro Asp Ala Thr Asp Asp Glu Lys Asn Ala Ala Ile
1220 1225 1230
Asn Thr Leu Asn Gln Asp Arg Gln Gln Ala Ile Glu Ser Ile Lys
1235 1240 1245
Gln Ala Asn Thr Asn Ala Glu Val Asp Gln Ala Ala Thr Val Ala
1250 1255 1260
Glu Asn Asn Ile Asp Ala Val Gln Val Asp Val Val Lys Lys Gln
1265 1270 1275
Ala Ala Arg Asp Lys Ile Thr Ala Glu Val Ala Lys Arg Ile Glu
1280 1285 1290
Ala Val Lys Gln Thr Pro Asn Ala Thr Asp Glu Glu Lys Gln Ala
1295 1300 1305
Ala Val Asn Gln Ile Asn Gln Leu Lys Asp Gln Ala Phe Asn Gln
1310 1315 1320
Ile Asn Gln Asn Gln Thr Asn Asp Gln Val Asp Ala Thr Thr Asn
1325 1330 1335
Gln Ala Ile Asn Ala Ile Asp Asn Val Glu Ala Glu Val Val Ile
1340 1345 1350
Lys Pro Lys Ala Ile Ala Asp Ile Glu Lys Ala Val Lys Glu Lys
1355 1360 1365
Gln Gln Gln Ile Asp Asn Ser Leu Asp Ser Thr Asp Asn Glu Lys
1370 1375 1380
Glu Val Ala Leu Gln Ala Leu Ala Lys Glu Lys Glu Lys Ala Leu
1385 1390 1395
Ala Ala Ile Asp Gln Ala Gln Thr Asn Ser Gln Val Asn Gln Ala
1400 1405 1410
Ala Thr Asn Gly Val Ser Ala Ile Lys Ile Ile Gln Pro Glu Thr
1415 1420 1425
Lys Ile Lys Pro Ala Ala Arg Glu Lys Ile Asn Gln Lys Ala Asn
1430 1435 1440
Glu Leu Arg Ala Gln Ile Asn Gln Asp Lys Glu Ala Thr Ala Glu
1445 1450 1455
Glu Arg Gln Ala Ala Leu Asp Lys Ile Asn Asp Leu Val Ala Lys
1460 1465 1470
Ala Met Thr Asn Ile Thr Asn Asp Arg Thr Asn Gln Gln Val Asn
1475 1480 1485
Asp Ser Thr Asn Gln Ala Leu Asp Asp Ile Ala Leu Val Thr Pro
1490 1495 1500
Asp His Ile Val Arg Ala Ala Ala Arg Asp Ala Val Lys Gln Gln
1505 1510 1515
Tyr Glu Ala Lys Lys His Glu Ile Glu Gln Ala Glu His Ala Thr
1520 1525 1530
Asp Glu Glu Lys Gln Val Ala Leu Asn Gln Leu Ala Asn Asn Glu
1535 1540 1545
Lys Arg Ala Leu Gln Asn Ile Asn Gln Ala Ile Ala Asn Asn Asp
1550 1555 1560
Val Lys Arg Val Glu Ser Asn Gly Ile Ala Thr Leu Lys Gly Val
1565 1570 1575
Glu Pro His Ile Val Val Lys Pro Glu Ala Gln Glu Ala Ile Lys
1580 1585 1590
Ala Ser Ala Asp Asn Gln Val Glu Ser Ile Lys Asp Thr Pro His
1595 1600 1605
Ala Thr Thr Asp Glu Leu Asp Glu Ala Asn Gln Gln Ile Asn Asp
1610 1615 1620
Thr Leu Lys Gln Gly Gln Gln Asp Ile Asp Asn Thr Thr Gln Asp
1625 1630 1635
Ala Ala Val Asn Asp Val Arg Asn Gln Thr Ile Lys Ala Ile Glu
1640 1645 1650
Gln Ile Lys Pro Lys Val Arg Arg Lys Arg Ala Ala Leu Asp Asn
1655 1660 1665
Ile Asp Glu Ser Asn Asn Asn Gln Leu Asp Ala Ile Arg Asn Thr
1670 1675 1680
Leu Asp Thr Thr Gln Asp Glu Arg Asn Val Ala Ile Ala Ala Leu
1685 1690 1695
Asn Lys Ile Val Asn Ala Ile Lys Asn Asp Ile Ala Gln Asn Lys
1700 1705 1710
Thr Asn Ala Glu Val Asp Gln Thr Glu Ala Asp Gly Asn Asn Asn
1715 1720 1725
Ile Lys Val Ile Leu Pro Lys Val Gln Val Lys Pro Ala Ala Arg
1730 1735 1740
Gln Ser Val Ser Ala Lys Ala Glu Ala Gln Asn Ala Leu Ile Asp
1745 1750 1755
Gln Ser Asp Leu Ser Thr Glu Glu Glu Arg Leu Ala Ala Lys His
1760 1765 1770
Leu Val Glu Gln Ala Leu Asn Gln Ala Ile Asp Gln Ile Asn His
1775 1780 1785
Ala Asp Lys Thr Ala Gln Val Asn Gln Asn Ser Ile Asp Ala Gln
1790 1795 1800
Asn Ile Ile Ser Lys Ile Lys Pro Ala Thr Thr Val Lys Ala Thr
1805 1810 1815
Ala Leu Gln Gln Ile Gln Asn Ile Ala Thr Asn Lys Ile Asn Leu
1820 1825 1830
Ile Lys Ala Asn Asn Glu Ala Thr Asp Glu Glu Gln Asn Ala Ala
1835 1840 1845
Ile Val Gln Val Glu Lys Glu Leu Ile Lys Ala Lys Gln Gln Ile
1850 1855 1860
Ala Gly Ala Val Thr Asn Ala Asp Val Ala Tyr Leu Leu His Asp
1865 1870 1875
Gly Lys Asn Glu Ile Arg Glu Ile Glu Pro Val Ile Asn Lys Lys
1880 1885 1890
Ala Thr Ala Arg Glu Gln Leu Thr Thr Leu Phe Asn Asp Lys Lys
1895 1900 1905
Gln Ala Ile Glu Ala Asn Val Gln Ala Thr Val Glu Glu Arg Asn
1910 1915 1920
Ser Ile Leu Ala Gln Leu Gln Asn Ile Tyr Asp Thr Ala Ile Gly
1925 1930 1935
Gln Ile Asp Gln Asp Arg Ser Asn Ala Gln Val Asp Lys Thr Ala
1940 1945 1950
Thr Leu Asn Leu Gln Thr Ile His Asp Leu Asp Val His Pro Ile
1955 1960 1965
Lys Lys Pro Asp Ala Glu Lys Thr Ile Asn Asp Asp Leu Ala Arg
1970 1975 1980
Val Thr His Leu Val Gln Asn Tyr Arg Lys Val Ser Asp Arg Asn
1985 1990 1995
Lys Ala Asp Ala Leu Lys Ala Ile Thr Ala Leu Lys Leu Gln Met
2000 2005 2010
Asp Glu Glu Leu Lys Thr Ala Arg Thr Asn Ala Asp Val Asp Ala
2015 2020 2025
Val Leu Lys Arg Phe Asn Val Ala Leu Gly Asp Ile Glu Ala Val
2030 2035 2040
Ile Thr Glu Lys Glu Asn Ser Leu Leu Arg Ile Asp Asn Ile Ala
2045 2050 2055
Gln Gln Thr Tyr Ala Lys Phe Lys Ala Ile Ala Thr Pro Glu Gln
2060 2065 2070
Leu Ala Lys Val Lys Ala Leu Ile Asp Gln Tyr Val Ala Asp Gly
2075 2080 2085
Asn Arg Met Val Asp Glu Asp Ala Thr Leu Asn Asp Ile Lys Lys
2090 2095 2100
Asp Thr Gln Leu Ile Ile Asp Glu Ile Leu Ala Ile Lys Leu Pro
2105 2110 2115
Ala Glu Val Ile Lys Ala Ser Pro Lys Val Gly Gln Pro Ala Pro
2120 2125 2130
Lys Val Cys Thr Pro Ile Lys Lys Glu Asp Lys Gln Glu Val Arg
2135 2140 2145
Lys Val Val Lys Glu Leu Pro Asn Thr Gly Ser Glu Glu Met Asp
2150 2155 2160
Leu Pro Leu Lys Glu Leu Ala Leu Ile Thr Gly Ala Ala Leu Leu
2165 2170 2175
Ala Arg Arg Arg Ser Lys Lys Glu Lys Glu Ser
2180 2185
<210>3
<211>6852
<212>DNA
<213>Staphylococcus epidermidis
<400>3
tctaatgaat gtaaagataa tacaaggagt tattacatga gtaaaagaca gaaagcattt 60
catgacagct tagcaaacga aaaaacaaga gtaagacttt ataaatctgg aaaaaattgg 120
gtaaaatccg gaattaaaga aatagaaatg ttcaaaatta tggggctacc atttattagt 180
catagtttag tgagtcaaga taatcaaagc attagtaaaa aaatgacggg atacggactg 240
aaaactacgg cggttattgg tggtgcattc acggtaaata tgttgcatga ccagcaagct 300
tttgcggctt ctgatgcacc attaacttct gaattaaaca cacaaagtga aacagtaggt 360
aatcaaaact caacgacaat cgaagcatca acatcaacag ccgattccac aagtgtaacg 420
aaaaatagta gttcggtaca aacatcaaat agtgacacag tctcaagtga aaagtctgaa 480
aaggtcactt cgacaactaa tagtacaagc aatcaacaag agaaattgac atctacatca 540
gaatcaacat cctcaaagaa tactacatca agttctgata ctaaatctgt agcttcaact 600
tcaagtacag aacaaccaat taatacatca acaaatcaaa gtactgcatc aaataacact 660
tcacaaagca caacgccatc ttcggtcaac ttaaacaaaa ctagcacaac gtcaactagc 720
accgcaccag taaaacttcg aactttcagt cgcttagcta tgtcaacatt tgcgtcagca 780
gcgacgacaa ccgcagtaac tgctaataca attacagtta ataaagataa cttaaaacaa 840
tatatgacaa cgtcaggtaa tgctacctat gatcaaagta ccggtattgt gacgttaaca 900
caggatgcat acagccaaaa aggtgctatt acattaggaa cacgtattga ctctaataag 960
agttttcatt tttctggaaa agtaaattta ggtaacaaat atgaagggca tggaaatggt 1020
ggagatggta tcggttttgc cttttcacca ggtgtattag gtgaaacagg gttaaacggt 1080
gccgcagtag gtattggtgg cttaagtaac gcatttggct tcaaattgga tacgtatcac 1140
aatacatcta aaccaaattc agctgcaaag gcgaatgctg acccatctaa tgtagctggt 1200
ggaggtgcgt ttggtgcatt tgtaacaaca gatagttatg gtgttgcgac aacgtataca 1260
tcaagttcaa cagctgataa tgctgcgaag ttaaatgttc aacctacaaa taacacgttc 1320
caagattttg atattaacta taatggtgat acaaaggtta tgactgtcaa atatgcaggt 1380
caaacatgga cacgtaatat ttcagattgg attgcgaaaa gtggtacgac caacttttca 1440
ttatcaatga cagcctcaac aggtggcgcg acaaatttac aacaagtaca atttggaaca 1500
ttcgaatata cagagtctgc tgttacacaa gtgagatacg ttgatgtaac aacaggtaaa 1560
gatattattc caccaaaaac atattcagga aatgttgatc aagtcgtgac aatcgataat 1620
cagcaatctg cattgactgc taaaggatat aactacacgt ccgtcgatag ttcatatgcg 1680
tcaacttata atgatacaaa taaaactgta aaaatgacga atgctggaca atcagtgaca 1740
tattatttta ctgatgtaaa agcaccaact gtaactgtag gcaatcaaac catagaagtg 1800
ggtaaaacaa tgaatcctat tgtattgact acaacggata atggtactgg gactgtgaca 1860
aatacagtta caggattacc aagcggatta agttacgata gtgcaacgaa ttcaatcatt 1920
gggacaccaa caaaaattgg tcaatcaaca gtgacagttg tgtctactga ccaagcaaat 1980
aacaaatcga cgacaacttt tacaataaat gttgtggata cgacagcacc aacagtgaca 2040
ccaataggag atcaatcatc agaagtgtat tcaccaatat ccccgattaa aattgctacg 2100
caagataaca gtggaaatgc ggtgacgaat acagtgactg gattgccatc cggactaaca 2160
tttgatagta caaataatac tattagtggt acaccaacaa acattggtac aagtactata 2220
tcaatcgttt ctacagatgc gagcggtaac aaaacgacga caacttttaa atatgaagta 2280
acaagaaata gcatgagtga ttccgtatca acatcaggaa gtacacaaca atctcaaagt 2340
gtgtcaacaa gtaaagctga ctcacaaagt gcatcaacga gtacatcagg atcgattgtg 2400
gtatctacat cagctagtac ctcgaaatcg acaagtgtaa gcctatctga ttctgtgagt 2460
gcatctaagt cattaagcac atctgaaagt aatagtgtat caagctcaac aagcacaagt 2520
ttagtgaatt cacaaagtgt atcatcaagc atgtcggatt cagctagtaa atcaacatca 2580
ttaagcgatt ctatttcaaa ctctagcagt actgaaaaat ccgaaagtct atcaacaagt 2640
acatctgatt cattgcgtac atcaacatca ctcagtgact cattaagtat gagtacatca 2700
ggaagcttgt ctaagtcaca aagcttatca acgagtatat cagggtcgtc tagtacatca 2760
gcatcattaa gtgacagtac atcgaatgca attagtacat caacatcatt gagcgagtca 2820
gctagcacct cggactctat cagtatttca aatagcatag ccaactctca aagtgcgtca 2880
acaagcaaat cagattcaca aagtacatca atatcattaa gtacaagtga ttcaaaatcg 2940
atgagtacat cagaatcatt gagcgattcg acgagcacaa gtggttctgt ttctggatca 3000
ctaagcatag cagcatcaca aagtgtctca acaagtacat cagactcgat gagtacttca 3060
gagatagtaa gtgactctat cagtacaagt gggtcattat ctgcatcaga cagtaaatca 3120
atgtccgtaa gtagttcaat gagcacgtct cagtcaggta gtacatcaga atcattaagt 3180
gattcacaaa gtacatctga ttctgatagt aagtcattat cacaaagtac tagtcaatca 3240
ggttcaacaa gtacatcaac gtcgacaagt gcttcagtac gtacttcgga atcacaaagt 3300
acgtctggtt caatgagtgc aagtcaatcc gattcaatga gcatatcaac gtcgtttagt 3360
gattcaacga gtgatagcaa atcagcatca actgcatcaa gtgaatcaat atcacaaagt 3420
gcttctacga gcacatctgg ttcggtaagt acttcgacat cgttaagtac aagtaattca 3480
gaacgtacat caacatctat gagtgattcc acaagcttaa gtacatcaga gtctgattca 3540
ataagtgaat caacgtcaac gagcgactct ataagtgaag caatatctgc ttcagagagc 3600
acgtttatat cattaagtga atcaaatagt actagcgatt cagaatcaca aagtgcatct 3660
gcctttttaa gtgaatcatt aagtgaaagt acgtctgaat caacatcaga gtcagtgagt 3720
agttcgacaa gtgagagtac gtcattatca gacagtacat cagaatctgg tagcacatca 3780
acatcattaa gtaattcaac aagtggtagt acgtccattt caacatcgac aagtatcagt 3840
gaatcaacgt caacgtttaa gagcgagagt gtttcaacat cactgagtat gtcaacgagt 3900
acaagtttgt ctgactctac aagtttgtca acatcattaa gtgattccac aagtgatagt 3960
aagtctgatt cattaagtac atcaatgtcg acaagtgatt caatcagtac aagtaaatct 4020
gattccatta gtacatccac atcattaagt ggttctacaa gtgaaagtga atccgactca 4080
acatcatcaa gtgaaagtaa atccgattca acatcaatga gcataagtat gtctcaatca 4140
acatcaggaa gtacaagtac gtcaacgagt acaagtttgt ctgactcaac gagtacatca 4200
ttgtcactaa gtgcctcaat gaatcaaagc ggagtagact caaactcagc aagccaaagt 4260
gcctcaaact caacaagtac aagcacgagc gaatccgatt cacaaagcac atcatcatat 4320
acaagtcagt caacaagcca aagtgaatcc acatcgacat caacgtcact aagcgattca 4380
acaagtatat ctaaaagtac gagtcaatca ggttcggtaa gcacatcagc gtcattaagt 4440
ggttcagaga gtgaatctga ttcacaaagt atctcaacaa gtgcaagtga gtcaacatca 4500
gaaagtgcgt caacatcact cagtgactca acaagtacaa gtaactcagg atcagcaagt 4560
acgtcaacat cgctcagtaa ctcagcaagc gcaagtgaat ccgatttgtc gtcaacatct 4620
ttaagtgatt caacatctgc gtcaatgcaa agcagtgaat ccgattcaca aagcacatca 4680
gcatcattaa gtgattcgct aagtacatca acttcaaacc gcatgtcgac cattgcaagt 4740
ttatctacat cggtaagtac atcagagtct ggctcaacat cagaaagtac aagtgaatcc 4800
gattcaacat caacatcatt aagcgattca caaagcacat caagaagtac aagtgcatca 4860
ggatcagcaa gtacatcaac atcaacaagt gactctcgta gtacatcagc ttcaactagt 4920
acttcgatgc gtacaagtac tagtgattca caaagtatgt cgctttcgac aagtacatca 4980
acaagtatga gtgattcaac gtcattatct gatagtgtta gtgattcaac atcagactca 5040
acaagtgcga gtacatctgg ttcgatgagt gtgtctatat cgttaagtga ttcgacaagt 5100
acatcaacat cggctagtga agtaatgagc gcaagcatat ctgattcaca aagtatgtca 5160
gaatctgtaa atgattcaga aagtgtaagt gaatctaatt ctgaaagtga ctctaaatcg 5220
atgagtggct caacaagtgt cagtgattct ggctcattga gcgtctcaac gtcattaaga 5280
aaatcagaaa gtgtaagcga gtcaagttca ttgagttgct cacaatcgat gagcgattca 5340
gtaagcacaa gcgattcgtc atcattaagt gtatcgacgt cactaagaag ttcagaaagc 5400
gtgagtgaat ctgattcatt aagtgattca aaatcaacaa gtggttcgac ttcaacaagt 5460
acatctggtt cattgagtac ctcaacatca ttaagtggtt cagaaagcgt aagcgagtct 5520
acctcgctaa gtgattcaat atcaatgagt gattctacta gtacaagtga ctccgactca 5580
ttaagtggat caatatcttt aagtggttcc acaagtctta gcacttcgga ttcattaagt 5640
gattcaaaat cattgagtag ctcgcaaagt atgagtggat cagaatcaac gtcaacaagt 5700
gtgagcgatt cgcagtcaag ctcaacaagt aatagtcaat ttgactctat gagcatcagt 5760
gcatcagaaa gcgactcaat gtctacaagt gattcgtcta gcatcagtgg atcaaattca 5820
acgagtacat cactttcaac atctgactca atgagcggaa gcgtatcagt ttcaacatcg 5880
acaagtttaa gtgactcaat atcaggttca acaagtgtaa gtgactcgag ctcaacaagc 5940
acatctacat cattaagtga ttcaatgtca caaagccagt caacaagtac aagtgcatct 6000
ggttccttaa gtacatcgat atcaacatca atgtcaatga gtgctagtac atcgtcatca 6060
caaagcacat cggtgtcgac atcattatca acatcagaca gtatcagtga ttctacttca 6120
ataagtatca gtggttcaca aagtacagta gaatcagaat ctacaagtga ttcaacttct 6180
atcagtgact cagaatcatt gagtacatca gattcagact cgacatcgac aagtacatcg 6240
gactcaacaa gtggttcaac ttcaacaagc atatctgaat cattaagtac gtctggttca 6300
ggttcaacga gcgtatctga ctcaacatca atgagtgaat ctaattcatc gagtgtttca 6360
atgtcacaag acaaatccga ctcaacatca attagtgact cagaatcagt gtcaacaagc 6420
acatcaacgt cattgagcac atccgattcg acaagcacat ccgaatcact gagtacatct 6480
atgtctggtt cacaaagcat ttctgactca acatcaacaa gtatgtccgg ctcaacaagt 6540
acatctgaat ctaactcaat gcatccgtca gactcaatga gtatgcatca tactcacagc 6600
acgagcacat ctcgcttatc aagtgaagca acaacgagca cgagtgaatc tcagtctaca 6660
ttaagtgcaa catctgaagt gactaaacat aatggcacac cagcacaaag tgaaaaaaga 6720
ttgccagata caggtgactc aataaaacaa aatggattac taggtggcgt tatgacatta 6780
ttagttggtt taggtttaat gaagagaaag aaaaagaaag atgaaaatga tcaagatgat 6840
tctcaagcat aa 6852
<210>4
<211>2283
<212>PRT
<213>Staphylococcus epidermidis
<400>4
Ser Asn Glu Cys Lys Asp Asn Thr Arg Ser Tyr Tyr Met Ser Lys Arg
1 5 10 15
Gln Lys Ala Phe His Asp Ser Leu Ala Asn Glu Lys Thr Arg Val Arg
20 25 30
Leu Tyr Lys Ser Gly Lys Asn Trp Val Lys Ser Gly Ile Lys Glu Ile
35 40 45
Glu Met Phe Lys Ile Met Gly Leu Pro Phe Ile Ser His Ser Leu Val
50 55 60
Ser Gln Asp Asn Gln Ser Ile Ser Lys Lys Met Thr Gly Tyr Gly Leu
65 70 75 80
Lys Thr Thr Ala Val Ile Gly Gly Ala Phe Thr Val Asn Met Leu His
85 90 95
Asp Gln Gln Ala Phe Ala Ala Ser Asp Ala Pro Leu Thr Ser Glu Leu
100 105 110
Asn Thr Gln Ser Glu Thr Val Gly Asn Gln Asn Ser Thr Thr Ile Glu
115 120 125
Ala Ser Thr Ser Thr Ala Asp Ser Thr Ser Val Thr Lys Asn Ser Ser
130 135 140
Ser Val Gln Thr Ser Asn Ser Asp Thr Val Ser Ser Glu Lys Ser Glu
145 150 155 160
Lys Val Thr Ser Thr Thr Asn Ser Thr Ser Asn Gln Gln Glu Lys Leu
165 170 175
Thr Ser Thr Ser Glu Ser Thr Ser Ser Lys Asn Thr Thr Ser Ser Ser
180 185 190
Asp Thr Lys Ser Val Ala Ser Thr Ser Ser Thr Glu Gln Pro Ile Asn
195 200 205
Thr Ser Thr Asn Gln Ser Thr Ala Ser Asn Asn Thr Ser Gln Ser Thr
210 215 220
Thr Pro Ser Ser Val Asn Leu Asn Lys Thr Ser Thr Thr Ser Thr Ser
225 230 235 240
Thr Ala Pro Val Lys Leu Arg Thr Phe Ser Arg Leu Ala Met Ser Thr
245 250 255
Phe Ala Ser Ala Ala Thr Thr Thr Ala Val Thr Ala Asn Thr Ile Thr
260 265 270
Val Asn Lys Asp Asn Leu Lys Gln Tyr Met Thr Thr Ser Gly Asn Ala
275 280 285
Thr Tyr Asp Gln Ser Thr Gly Ile Val Thr Leu Thr Gln Asp Ala Tyr
290 295 300
Ser Gln Lys Gly Ala Ile Thr Leu Gly Thr Arg Ile Asp Ser Asn Lys
305 310 315 320
Ser Phe His Phe Ser Gly Lys Val Asn Leu Gly Asn Lys Tyr Glu Gly
325 330 335
His Gly Asn Gly Gly Asp Gly Ile Gly Phe Ala Phe Ser Pro Gly Val
340 345 350
Leu Gly Glu Thr Gly Leu Asn Gly Ala Ala Val Gly Ile Gly Gly Leu
355 360 365
Ser Asn Ala Phe Gly Phe Lys Leu Asp Thr Tyr His Asn Thr Ser Lys
370 375 380
Pro Asn Ser Ala Ala Lys Ala Asn Ala Asp Pro Ser Asn Val Ala Gly
385 390 395 400
Gly Gly Ala Phe Gly Ala Phe Val Thr Thr Asp Ser Tyr Gly Val Ala
405 410 415
Thr Thr Tyr Thr Ser Ser Ser Thr Ala Asp Asn Ala Ala Lys Leu Asn
420 425 430
Val Gln Pro Thr Asn Asn Thr Phe Gln Asp Phe Asp Ile Asn Tyr Asn
435 440 445
Gly Asp Thr Lys Val Met Thr Val Lys Tyr Ala Gly Gln Thr Trp Thr
450 455 460
Arg Asn Ile Ser Asp Trp Ile Ala Lys Ser Gly Thr Thr Asn Phe Ser
465 470 475 480
Leu Ser Met Thr Ala Ser Thr Gly Gly Ala Thr Asn Leu Gln Gln Val
485 490 495
Gln Phe Gly Thr Phe Glu Tyr Thr Glu Ser Ala Val Thr Gln Val Arg
500 505 510
Tyr Val Asp Val Thr Thr Gly Lys Asp Ile Ile Pro Pro Lys Thr Tyr
515 520 525
Ser Gly Asn Val Asp Gln Val Val Thr Ile Asp Asn Gln Gln Ser Ala
530 535 540
Leu Thr Ala Lys Gly Tyr Asn Tyr Thr Ser Val Asp Ser Ser Tyr Ala
545 550 555 560
Ser Thr Tyr Asn Asp Thr Asn Lys Thr Val Lys Met Thr Asn Ala Gly
565 570 575
Gln Ser Val Thr Tyr Tyr Phe Thr Asp Val Lys Ala Pro Thr Val Thr
580 585 590
Val Gly Asn Gln Thr Ile Glu Val Gly Lys Thr Met Asn Pro Ile Val
595 600 605
Leu Thr Thr Thr Asp Asn Gly Thr Gly Thr Val Thr Asn Thr Val Thr
610 615 620
Gly Leu Pro Ser Gly Leu Ser Tyr Asp Ser Ala Thr Asn Ser Ile Ile
625 630 635 640
Gly Thr Pro Thr Lys Ile Gly Gln Ser Thr Val Thr Val Val Ser Thr
645 650 655
Asp Gln Ala Asn Asn Lys Ser Thr Thr Thr Phe Thr Ile Asn Val Val
660 665 670
Asp Thr Thr Ala Pro Thr Val Thr Pro Ile Gly Asp Gln Ser Ser Glu
675 680 685
Val Tyr Ser Pro Ile Ser Pro Ile Lys Ile Ala Thr Gln Asp Asn Ser
690 695 700
Gly Asn Ala Val Thr Asn Thr Val Thr Gly Leu Pro Ser Gly Leu Thr
705 710 715 720
Phe Asp Ser Thr Asn Asn Thr Ile Ser Gly Thr Pro Thr Asn IIe Gly
725 730 735
Thr Ser Thr Ile Ser Ile Val Ser Thr Asp Ala Ser Gly Asn Lys Thr
740 745 750
Thr Thr Thr Phe Lys Tyr Glu Val Thr Arg Asn Ser Met Ser Asp Ser
755 760 765
Val Ser Thr Ser Gly Ser Thr Gln Gln Ser Gln Ser Val Ser Thr Ser
770 775 780
Lys Ala Asp Ser Gln Ser Ala Ser Thr Ser Thr Ser Gly Ser Ile Val
785 790 795 800
Val Ser Thr Ser Ala Ser Thr Ser Lys Ser Thr Ser Val Ser Leu Ser
805 810 815
Asp Ser Val Ser Ala Ser Lys Ser Leu Ser Thr Ser Glu Ser Asn Ser
820 825 830
Val Ser Ser Ser Thr Ser Thr Ser Leu Val Asn Ser Gln Ser Val Ser
835 840 845
Ser Ser Met Ser Asp Ser Ala Ser Lys Ser Thr Ser Leu Ser Asp Ser
850 855 860
Ile Ser Asn Ser Ser Ser Thr Glu Lys Ser Glu Ser Leu Ser Thr Ser
865 870 875 880
Thr Ser Asp Ser Leu Arg Thr Ser Thr Ser Leu Ser Asp Ser Leu Ser
885 890 895
Met Ser Thr Ser Gly Ser Leu Ser Lys Ser Gln Ser Leu Ser Thr Ser
900 905 910
Ile Ser Gly Ser Ser Ser Thr Ser Ala Ser Leu Ser Asp Ser Thr Ser
915 920 925
Asn Ala Ile Ser Thr Ser Thr Ser Leu Ser Glu Ser Ala Ser Thr Ser
930 935 940
Asp Ser Ile Ser Ile Ser Asn Ser Ile Ala Asn Ser Gln Ser Ala Ser
945 950 955 960
Thr Ser Lys Ser Asp Ser Gln Ser Thr Ser Ile Ser Leu Ser Thr Ser
965 970 975
Asp Ser Lys Ser Met Ser Thr Ser Glu Ser Leu Ser Asp Ser Thr Ser
980 985 990
Thr Ser Gly Ser Val Ser Gly Ser Leu Ser Ile Ala Ala Ser Gln Ser
995 1000 1005
Val Ser Thr Ser Thr Ser Asp Ser Met Ser Thr Ser Glu Ile Val
1010 1015 1020
Ser Asp Ser Ile Ser Thr Ser Gly Ser Leu Ser Ala Ser Asp Ser
1025 1030 1035
Lys Ser Met Ser Val Ser Ser Ser Met Ser Thr Ser Gln Ser Gly
1040 1045 1050
Ser Thr Ser Glu Ser Leu Ser Asp Ser Gln Ser Thr Ser Asp Ser
1055 1060 1065
Asp Ser Lys Ser Leu Ser Gln Ser Thr Ser Gln Ser Gly Ser Thr
1070 1075 1080
Ser Thr Ser Thr Ser Thr Ser Ala Ser Val Arg Thr Ser Glu Ser
1085 1090 1095
Gln Ser Thr Ser Gly Ser Met Ser Ala Ser Gln Ser Asp Ser Met
1100 1105 1110
Ser Ile Ser Thr Ser Phe Ser Asp Ser Thr Ser Asp Ser Lys Ser
1115 1120 1125
Ala Ser Thr Ala Ser Ser Glu Ser Ile Ser Gln Ser Ala Ser Thr
1130 1135 1140
Ser Thr Ser Gly Ser Val Ser Thr Ser Thr Ser Leu Ser Thr Ser
1145 1150 1155
Asn Ser Glu Arg Thr Ser Thr Ser Met Ser Asp Ser Thr Ser Leu
1160 1165 1170
Ser Thr Ser Glu Ser Asp Ser Ile Ser Glu Ser Thr Ser Thr Ser
1175 1180 1185
Asp Ser Ile Ser Glu Ala Ile Ser Ala Ser Glu Ser Thr Phe Ile
1190 1195 1200
Ser Leu Ser Glu Ser Asn Ser Thr Ser Asp Ser Glu Ser Gln Ser
1205 1210 1215
Ala Ser Ala Phe Leu Ser Glu Ser Leu Ser Glu Ser Thr Ser Glu
1220 1225 1230
Ser Thr Ser Glu Ser Val Ser Ser Ser Thr Ser Glu Ser Thr Ser
1235 1240 1245
Leu Ser Asp Ser Thr Ser Glu Ser Gly Ser Thr Ser Thr Ser Leu
1250 1255 1260
Ser Asn Ser Thr Ser Gly Ser Thr Ser Ile Ser Thr Ser Thr Ser
1265 1270 1275
Ile Ser Glu Ser Thr Ser Thr Phe Lys Ser Glu Ser Val Ser Thr
1280 1285 1290
Ser Leu Ser Met Ser Thr Ser Thr Ser Leu Ser Asp Ser Thr Ser
1295 1300 1305
Leu Ser Thr Ser Leu Ser Asp Ser Thr Ser Asp Ser Lys Ser Asp
1310 1315 1320
Ser Leu Ser Thr Ser Met Ser Thr Ser Asp Ser Ile Ser Thr Ser
1325 1330 1335
Lys Ser Asp Ser Ile Ser Thr Ser Thr Ser Leu Ser Gly Ser Thr
1340 1345 1350
Ser Glu Ser Glu Ser Asp Ser Thr Ser Ser Ser Glu Ser Lys Ser
1355 1360 1365
Asp Ser Thr Ser Met Ser Ile Ser Met Ser Gln Ser Thr Ser Gly
1370 1375 1380
Ser Thr Ser Thr Ser Thr Ser Thr Ser Leu Ser Asp Ser Thr Ser
1385 1390 1395
Thr Ser Leu Ser Leu Ser Ala Ser Met Asn Gln Ser Gly Val Asp
1400 1405 1410
Ser Asn Ser Ala Ser Gln Ser Ala Ser Asn Ser Thr Ser Thr Ser
1415 1420 1425
Thr Ser Glu Ser Asp Ser Gln Ser Thr Ser Ser Tyr Thr Ser Gln
1430 1435 1440
Ser Thr Ser Gln Ser Glu Ser Thr Ser Thr Ser Thr Ser Leu Ser
1445 1450 1455
Asp Ser Thr Ser Ile Ser Lys Ser Thr Ser Gln Ser Gly Ser Val
1460 1465 1470
Ser Thr Ser Ala Ser Leu Ser Gly Ser Glu Ser Glu Ser Asp Ser
1475 1480 1485
Gln Ser Ile Ser Thr Ser Ala Ser Glu Ser Thr Ser Glu Ser Ala
1490 1495 1500
Ser Thr Ser Leu Ser Asp Ser Thr Ser Thr Ser Asn Ser Gly Ser
1505 1510 1515
Ala Ser Thr Ser Thr Ser Leu Ser Asn Ser Ala Ser Ala Ser Glu
1520 1525 1530
Ser Asp Leu Ser Ser Thr Ser Leu Ser Asp Ser Thr Ser Ala Ser
1535 1540 1545
Met Gln Ser Ser Glu Ser Asp Ser Gln Ser Thr Ser Ala Ser Leu
1550 1555 1560
Ser Asp Ser Leu Ser Thr Ser Thr Ser Asn Arg Met Ser Thr Ile
1565 1570 1575
Ala Ser Leu Ser Thr Ser Val Ser Thr Ser Glu Ser Gly Ser Thr
1580 1585 1590
Ser Glu Ser Thr Ser Glu Ser Asp Ser Thr Ser Thr Ser Leu Ser
1595 1600 1605
Asp Ser Gln Ser Thr Ser Arg Ser Thr Ser Ala Ser Gly Ser Ala
1610 1615 1620
Ser Thr Ser Thr Ser Thr Ser Asp Ser Arg Ser Thr Ser Ala Ser
1625 1630 1635
Thr Ser Thr Ser Met Arg Thr Ser Thr Ser Asp Ser Gln Ser Met
1640 1645 1650
Ser Leu Ser Thr Ser Thr Ser Thr Ser Met Ser Asp Ser Thr Ser
1655 1660 1665
Leu Ser Asp Ser Val Ser Asp Ser Thr Ser Asp Ser Thr Ser Ala
1670 1675 1680
Ser Thr Ser Gly Ser Met Ser Val Ser Ile Ser Leu Ser Asp Ser
1685 1690 1695
Thr Ser Thr Ser Thr Ser Ala Ser Glu Val Met Ser Ala Ser Ile
1700 1705 1710
Ser Asp Ser Gln Ser Met Ser Glu Ser Val Asn Asp Ser Glu Ser
1715 1720 1725
Val Ser Glu Ser Asn Ser Glu Ser Asp Ser Lys Ser Met Ser Gly
1730 1735 1740
Ser Thr Ser Val Ser Asp Ser Gly Ser Leu Ser Val Ser Thr Ser
1745 1750 1755
Leu Arg Lys Ser Glu Ser Val Ser Glu Ser Ser Ser Leu Ser Cys
1760 1765 1770
Ser Gln Ser Met Ser Asp Ser Val Ser Thr Ser Asp Ser Ser Ser
1775 1780 1785
Leu Ser Val Ser Thr Ser Leu Arg Ser Ser Glu Ser Val Ser Glu
1790 1795 1800
Ser Asp Ser Leu Ser Asp Ser Lys Ser Thr Ser Gly Ser Thr Ser
1805 1810 1815
Thr Ser Thr Ser Gly Ser Leu Ser Thr Ser Thr Ser Leu Ser Gly
1820 1825 1830
Ser Glu Ser Val Ser Glu Ser Thr Ser Leu Ser Asp Ser Ile Ser
1835 1840 1845
Met Ser Asp Ser Thr Ser Thr Ser Asp Ser Asp Ser Leu Ser Gly
1850 1855 1860
Ser Ile Ser Leu Ser Gly Ser Thr Ser Leu Ser Thr Ser Asp Ser
1865 1870 1875
Leu Ser Asp Ser Lys Ser Leu Ser Ser Ser Gln Ser Met Ser Gly
1880 1885 1890
Ser Glu Ser Thr Ser Thr Ser Val Ser Asp Ser Gln Ser Ser Ser
1895 1900 1905
Thr Ser Asn Ser Gln Phe Asp Ser Met Ser Ile Ser Ala Ser Glu
1910 1915 1920
Ser Asp Ser Met Ser Thr Ser Asp Ser Ser Ser Ile Ser Gly Ser
1925 1930 1935
Asn Ser Thr Ser Thr Ser Leu Ser Thr Ser Asp Ser Met Ser Gly
1940 1945 1950
Ser Val Ser Val Ser Thr Ser Thr Ser Leu Ser Asp Ser Ile Ser
1955 1960 1965
Gly Ser Thr Ser Val Ser Asp Ser Ser Ser Thr Ser Thr Ser Thr
1970 1975 1980
Ser Leu Ser Asp Ser Met Ser Gln Ser Gln Ser Th Ser Thr Ser
1985 1990 1995
Ala Ser Gly Ser Leu Ser Thr Ser Ile Ser Thr Ser Met Ser Met
2000 2005 2010
Ser Ala Ser Thr Ser Ser Ser Gln Ser Thr Ser Val Ser Thr Ser
2015 2020 2025
Leu Ser Thr Ser Asp Ser Ile Ser Asp Ser Thr Ser Ile Ser Ile
2030 2035 2040
Ser Gly Ser Gln Ser Thr Val Glu Ser Glu Ser Thr Ser Asp Ser
2045 2050 2055
Thr Ser Ile Ser Asp Ser Glu Ser Leu Ser Thr Ser Asp Ser Asp
2060 2065 2070
Ser Thr Ser Thr Ser Thr Ser Asp Ser Thr Ser Gly Ser Thr Ser
2075 2080 2085
Thr Ser Ile Ser Glu Ser Leu Ser Thr Ser Gly Ser Gly Ser Thr
2090 2095 2100
Ser Val Ser Asp Ser Thr Ser Met Ser Glu Ser Asn Ser Ser Ser
2105 2110 2115
Val Ser Met Ser Gln Asp Lys Ser Asp Ser Thr Ser Ile Ser Asp
2120 2125 2130
Ser Glu Ser Val Ser Thr Ser Thr Ser Thr Ser Leu Ser Thr Ser
2135 2140 2145
Asp Ser Thr Ser Thr Ser Glu Ser Leu Ser Thr Ser Met Ser Gly
2150 2155 2160
Ser Gln Ser Ile Ser Asp Ser Thr Ser Thr Ser Met Ser Gly Ser
2165 2170 2175
Thr Ser Thr Ser Glu Ser Asn Ser Met His Pro Ser Asp Ser Met
2180 2185 2190
Ser Met His His Thr His Ser Thr Ser Thr Ser Arg Leu Ser Ser
2195 2200 2205
Glu Ala Thr Thr Ser Thr Ser Glu Ser Gln Ser Thr Leu Ser Ala
2210 2215 2220
Thr Ser Glu Val Thr Lys His Asn Gly Thr Pro Ala Gln Ser Glu
2225 2230 2235
Lys Arg Leu Pro Asp Thr Gly Asp Ser Ile Lys Gln Asn Gly Leu
2240 2245 2250
Leu Gly Gly Val Met Thr Leu Leu Val Gly Leu Gly Leu Met Lys
2255 2260 2265
Arg Lys Lys Lys Lys Asp Glu Asn Asp Gln Asp Asp Ser Gln Ala
2270 2275 2280
<210>5
<211>2730
<212>DNA
<213>Staphylococcus epidermidis
<400>5
ttattatcaa ttaaatataa tcttatagga gttgttaaca acatgaacaa acatcaccca 60
aaattaaggt ctttctattc tattagaaaa tcaactctag gcgttgcatc ggtcattgtc 120
agtacactat ttttaattac ttctcaacat caagcacaag cagcagaaaa tacaaatact 180
tcagataaaa tctcggaaaa tcaaaataat aatgcaacta caactcagcc acctaaggat 240
acaaatcaaa cacaacctgc tacgcaacca gcaaacactg cgaaaaacta tcctgcagcg 300
gatgaatcac ttaaagatgc aattaaagat cctgcattag aaaataaaga acatgatata 360
ggtccaagag aacaagtcaa tttccagtta ttagataaaa acaatgaaac gcagtactat 420
cactttttca gcatcaaaga tccagcagat gtgtattaca ctaaaaagaa agcagaagtt 480
gaattagaca tcaatactgc ttcaacatgg aagaagtttg aagtctatga aaacaatcaa 540
aaattgccag tgagacttgt atcatatagt cctgtaccag aagaccatgc ctatattcga 600
ttcccagttt cagatggcac acaagaattg aaaattgttt cttcgactca aattgatgat 660
ggagaagaaa caaattatga ttatactaaa ttagtatttg ctaaacctat ttataacgat 720
ccttcacttg taaaatcaga tacaaatgat gcagtagtaa cgaatgatca atcaagttca 780
gtcgcaagta atcaaacaaa cacgaataca tctaatcaaa atatatcaac gatcaacaat 840
gctaataatc aaccgcaggc aacgaccaat atgagtcaac ctgcacaacc aaaatcgtca 900
acgaatgcag atcaagcgtc aagccaacca gctcatgaaa caaattctaa tggtaatact 960
aacgataaaa cgaatgagtc aagtaatcag tcggatgtta atcaacagta tccaccagca 1020
gatgaatcac tacaagatgc aattaaaaac ccggctatca tcgataaaga acatacagct 1080
gataattggc gaccaattga ttttcaaatg aaaaatgata aaggtgaaag acagttctat 1140
cattatgcta gtactgttga accagcaact gtcattttta caaaaacagg accaataatt 1200
gaattaggtt taaagacagc ttcaacatgg aagaaatttg aagtttatga aggtgacaaa 1260
aagttaccag tcgaattagt atcatatgat tctgataaag attatgccta tattcgtttc 1320
ccagtatcta atggtacgag agaagttaaa attgtgtcat ctattgaata tggtgagaac 1380
atccatgaag actatgatta tacgctaatg gtctttgcac agcctattac taataaccca 1440
gacgactatg tggatgaaga aacatacaat ttacaaaaat tattagctcc gtatcacaaa 1500
gctaaaacgt tagaaagaca agtttatgaa ttagaaaaat tacaagagaa attgccagaa 1560
aaatataagg cggaatataa aaagaaatta gatcaaacta gagtagagtt agctgatcaa 1620
gttaaatcag cagtgacgga atttgaaaat gttacaccta caaatgatca attaacagat 1680
ttacaagaag cgcattttgt tgtttttgaa agtgaagaaa atagtgagtc agttatggac 1740
ggctttgttg aacatccatt ctatacagca actttaaatg gtcaaaa ta tgtagtgatg 1800
aaaacaaagg atgacagtta ctggaaagat ttaattgtag aaggtaaacg tgtcactact 1860
gtttctaaag atcctaaaaa taattctaga acgctgattt tcccatatat acctgacaaa 1920
gcagtttaca atgcgattgt taaagtcgtt gtggcaaaca ttggttatga aggtcaatat 1980
catgtcagaa ttataaatca ggatatcaat acaaaagatg atgatacatc acaaaataac 2040
acgagtgaac cgctaaatgt acaaacagga caagaaggta aggttgctga tacagatgta 2100
gctgaaaata gcagcactgc aacaaatcct aaagatgcgt ctgataaagc agatgtgata 2160
gaaccagagt ctgacgtggt taaagatgct gataataata ttgataaaga tgtgcaacat 2220
gatgttgatc atttatccga tatgtcggat aataatcact tcgataaata tgatttaaaa 2280
gaaatggata ctcaaattgc caaagatact gatagaaatg tggataaaga tgccgataat 2340
agcgttggta tgtcatctaa tgtcgatact gataaagact ctaataaaaa taaagacaaa 2400
gtcatacagc tgaatcatat tgccgataaa aataatcata ctggaaaagc agcaaagctt 2460
gacgtagtga aacaaaatta taataataca gacaaagtta ctgacaaaaa aacaactgaa 2520
catctgccga gtgatattca taaaactgta gataaaacag tgaaaacaaa agaaaaagcc 2580
ggcacaccat cgaaagaaaa caaacttagt caatctaaaa tgctaccaaa aactggagaa 2640
acaacttcaa gccaatcatg gtggggctta tatgcgttat taggtatgtt agctttattc 2700
attcctaaat tcagaaaaga atctaaataa 2730
<210>6
<211>909
<212>PRT
<213>Staphylococcus epidermidis
<400>6
Leu Leu Ser Ile Lys Tyr Asn Leu Ile Gly Val Val Asn Asn Met Asn
1 5 10 15
Lys His His Pro Lys Leu Arg Ser Phe Tyr Ser Ile Arg Lys Ser Thr
20 25 30
Leu Gly Val Ala Ser Val Ile Val Ser Thr Leu Phe Leu Ile Thr Ser
35 40 45
Gln His Gln Ala Gln Ala Ala Glu Asn Thr Asn Thr Ser Asp Lys Ile
50 55 60
Ser Glu Asn Gln Asn Asn Asn Ala Thr Thr Thr Gln Pro Pro Lys Asp
65 70 75 80
Thr Asn Gln Thr Gln Pro Ala Thr Gln Pro Ala Asn Thr Ala Lys Asn
85 90 95
Tyr Pro Ala Ala Asp Glu Ser Leu Lys Asp Ala Ile Lys Asp Pro Ala
100 105 110
Leu Glu Asn Lys Glu His Asp Ile Gly Pro Arg Glu Gln Val Asn Phe
115 120 125
Gln Leu Leu Asp Lys Asn Asn Glu Thr Gln Tyr Tyr His Phe Phe Ser
130 135 140
Ile Lys Asp Pro Ala Asp Val Tyr Tyr Thr Lys Lys Lys Ala Glu Val
145 150 155 160
Glu Leu Asp Ile Asn Thr Ala Ser Thr Trp Lys Lys Phe Glu Val Tyr
165 170 175
Glu Asn Asn Gln Lys Leu Pro Val Arg Leu Val Ser Tyr Ser Pro Val
180 185 190
Pro Glu Asp His Ala Tyr Ile Arg Phe Pro Val Ser Asp Gly Thr Gln
195 200 205
Glu Leu Lys Ile Val Ser Ser Thr Gln Ile Asp Asp Gly Glu Glu Thr
210 215 220
Asn Tyr Asp Tyr Thr Lys Leu Val Phe Ala Lys Pro Ile Tyr Asn Asp
225 230 235 240
Pro Ser Leu Val Lys Ser Asp Thr Asn Asp Ala Val Val Thr Asn Asp
245 250 255
Gln Ser Ser Ser Val Ala Ser Asn Gln Thr Asn Thr Asn Thr Ser Asn
260 265 270
Gln Asn Ile Ser Thr Ile Asn Asn Ala Asn Asn Gln Pro Gln Ala Thr
275 280 285
Thr Asn Met Ser Gln Pro Ala Gln Pro Lys Ser Ser Thr Asn Ala Asp
290 295 300
Gln Ala Ser Ser Gln Pro Ala His Glu Thr Asn Ser Asn Gly Asn Thr
305 310 315 320
Asn Asp Lys Thr Asn Glu Ser Ser Asn Gln Ser Asp Val Asn Gln Gln
325 330 335
Tyr Pro Pro Ala Asp Glu Ser Leu Gln Asp Ala Ile Lys Asn Pro Ala
340 345 350
Ile Ile Asp Lys Glu His Thr Ala Asp Asn Trp Arg Pro Ile Asp Phe
355 360 365
Gln Met Lys Asn Asp Lys Gly Glu Arg Gln Phe Tyr His Tyr Ala Ser
370 375 380
Thr Val Glu Pro Ala Thr Val Ile Phe Thr Lys Thr Gly Pro Ile Ile
385 390 395 400
Glu Leu Gly Leu Lys Thr Ala Ser Thr Trp Lys Lys Phe Glu Val Tyr
405 410 415
Glu Gly Asp Lys Lys Leu Pro Val Glu Leu Val Ser Tyr Asp Ser Asp
420 425 430
Lys Asp Tyr Ala Tyr Ile Arg Phe Pro Val Ser Asn Gly Thr Arg Glu
435 440 445
Val Lys Ile Val Ser Ser Ile Glu Tyr Gly Glu Asn Ile His Glu Asp
450 455 460
Tyr Asp Tyr Thr Leu Met Val Phe Ala Gln Pro Ile Thr Asn Asn Pro
465 470 475 480
Asp Asp Tyr Val Asp Glu Glu Thr Tyr Asn Leu Gln Lys Leu Leu Ala
485 490 495
Pro Tyr His Lys Ala Lys Thr Leu Glu Arg Gln Val Tyr Glu Leu Glu
500 505 510
Lys Leu Gln Glu Lys Leu Pro Glu Lys Tyr Lys Ala Glu Tyr Lys Lys
515 520 525
Lys Leu Asp Gln Thr Arg Val Glu Leu Ala Asp Gln Val Lys Ser Ala
530 535 540
Val Thr Glu Phe Glu Asn Val Thr Pro Thr Asn Asp Gln Leu Thr Asp
545 550 555 560
Leu Gln Glu Ala His Phe Val Val Phe Glu Ser Glu Glu Asn Ser Glu
565 570 575
Ser Val Met Asp Gly Phe Val Glu His Pro Phe Tyr Thr Ala Thr Leu
580 585 590
Asn Gly Gln Lys Tyr Val Val Met Lys Thr Lys Asp Asp Ser Tyr Trp
595 600 605
Lys Asp Leu Ile Val Glu Gly Lys Arg Val Thr Thr Val Ser Lys Asp
610 615 620
Pro Lys Asn Asn Ser Arg Thr Leu Ile Phe Pro Tyr Ile Pro Asp Lys
625 630 635 640
Ala Val Tyr Asn Ala Ile Val Lys Val Val Val Ala Asn Ile Gly Tyr
645 650 655
Glu Gly Gln Tyr His Val Arg Ile Ile Asn Gln Asp Ile Asn Thr Lys
660 665 670
Asp Asp Asp Thr Ser Gln Asn Asn Thr Ser Glu Pro Leu Asn Val Gln
675 680 685
Thr Gly Gln Glu Gly Lys Val Ala Asp Thr Asp Val Ala Glu Asn Ser
690 695 700
Ser Thr Ala Thr Asn Pro Lys Asp Ala Ser Asp Lys Ala Asp Val Ile
705 710 715 720
Glu Pro Glu Ser Asp Val Val Lys Asp Ala Asp Asn Asn Ile Asp Lys
725 730 735
Asp Val Gln His Asp Val Asp His Leu Ser Asp Met Ser Asp Asn Asn
740 745 750
His Phe Asp Lys Tyr Asp Leu Lys Glu Met Asp Thr Gln Ile Ala Lys
755 760 765
Asp Thr Asp Arg Asn Val Asp Lys Asp Ala Asp Asn Ser Val Gly Met
770 775 780
Ser Ser Asn Val Asp Thr Asp Lys Asp Ser Asn Lys Asn Lys Asp Lys
785 790 795 800
Val Ile Gln Leu Asn His Ile Ala Asp Lys Asn Asn His Thr Gly Lys
805 810 815
Ala Ala Lys Leu Asp Val Val Lys Gln Asn Tyr Asn Asn Thr Asp Lys
820 825 830
Val Thr Asp Lys Lys Thr Thr Glu His Leu Pro Ser Asp Ile His Lys
835 840 845
Thr Val Asp Lys Thr Val Lys Thr Lys Glu Lys Ala Gly Thr Pro Ser
850 855 860
Lys Glu Asn Lys Leu Ser Gln Ser Lys Met Leu Pro Lys Thr Gly Glu
865 870 875 880
Thr Thr Ser Ser Gln Ser Trp Trp Gly Leu Tyr Ala Leu Leu Gly Met
885 890 895
Leu Ala Leu Phe Ile Pro Lys Phe Arg Lys Glu Ser Lys
900 905
<210>7
<211>1065
<212>DNA
<213>Staphylococcus epidermidis
<400>7
gaggaaaaca acatgacaaa acattattta aacagtaagt atcaatcaga acaacgttca 60
tcagctatga aaaagattac aatgggtaca gcatctatca ttttaggttc ccttgtatac 120
ataggcgcag acagccaaca agtcaatgcg gcaacagaag ctacgaacgc aactaataat 180
caaagcacac aagtttctca agcaacatca caaccaatta atttccaagt gcaaaaagat 240
ggctcttcag agaagtcaca catggatgac tatatgcaac accctggtaa agtaattaaa 300
caaaataata aatattattt ccaaaccgtg ttaaacaatg catcattctg gaaagaatac 360
aaattttaca atgcaaacaa tcaagaatta gcaacaactg ttgttaacga taataaaaaa 420
gcggatacta gaacaatcaa tgttgcagtt gaacctggat ataagagctt aactactaaa 480
gtacatattg tcgtgccaca aattaattac aatcatagat atactacgca tttggaattt 540
gaaaaagcaa ttcctacatt agctgacgca gcaaaaccaa acaatgttaa accggttcaa 600
ccaaaaccag ctcaacctaa aacacctact gagcaaacta aaccagttca acctaaagtt 660
gaaaaagtta aacctactgt aactacaaca agcaaagttg aagacaatca ctctactaaa 720
gttgtaagta ctgacacaac aaaagatcaa actaaaacac aaactgctca tacagttaaa 780
acagcacaaa ctgctcaaga acaaaataaa gttcaaacac ctgttaaaga tgttgcaaca 840
gcgaaatctg aaagcaacaa tcaagctgta agtgataata aatcacaaca aactaacaaa 900
gttacaaaac ataacgaaac gcctaaacaa gcatctaaag ctaaagaatt accaaaaact 960
ggtttaactt cagttgataa ctttattagc acagttgcct tcgcaacact tgccctttta 1020
ggttcattat ctttattact tttcaaaaga aaagaatcta aataa 1065
<210>8
<211>354
<212>PRT
<213>Staphylococcus epidermidis
<400>8
Glu Glu Asn Asn Met Thr Lys His Tyr Leu Asn Ser Lys Tyr Gln Ser
1 5 10 15
Glu Gln Arg Ser Ser Ala Met Lys Lys Ile Thr Met Gly Thr Ala Ser
20 25 30
Ile Ile Leu Gly Ser Leu Val Tyr Ile Gly Ala Asp Ser Gln Gln Val
35 40 45
Asn Ala Ala Thr Glu Ala Thr Asn Ala Thr Asn Asn Gln Ser Thr Gln
50 55 60
Val Ser Gln Ala Thr Ser Gln Pro Ile Asn Phe Gln Val Gln Lys Asp
65 70 75 80
Gly Ser Ser Glu Lys Ser His Met Asp Asp Tyr Met Gln His Pro Gly
85 90 95
Lys Val Ile Lys Gln Asn Asn Lys Tyr Tyr Phe Gln Thr Val Leu Asn
100 105 110
Asn Ala Ser Phe Trp Lys Glu Tyr Lys Phe Tyr Asn Ala Asn Asn Gln
115 120 125
Glu Leu Ala Thr Thr Val Val Asn Asp Asn Lys Lys Ala Asp Thr Arg
130 135 140
Thr Ile Asn Val Ala Val Glu Pro Gly Tyr Lys Ser Leu Thr Thr Lys
145 150 155 160
Val His Ile Val Val Pro Gln Ile Asn Tyr Asn His Arg Tyr Thr Thr
165 170 175
His Leu Glu Phe Glu Lys Ala Ile Pro Thr Leu Ala Asp Ala Ala Lys
180 185 190
Pro Asn Asn Val Lys Pro Val Gln Pro Lys Pro Ala Gln Pro Lys Thr
195 200 205
Pro Thr Glu Gln Thr Lys Pro Val Gln Pro Lys Val Glu Lys Val Lys
210 215 220
Pro Thr Val Thr Thr Thr Ser Lys Val Glu Asp Asn His Ser Thr Lys
225 230 235 240
Val Val Ser Thr Asp Thr Thr Lys Asp Gln Thr Lys Thr Gln Thr Ala
245 250 255
His Thr Val Lys Thr Ala Gln Thr Ala Gln Glu Gln Asn Lys Val Gln
260 265 270
Thr Pro Val Lys Asp Val Ala Thr Ala Lys Ser Glu Ser Asn Asn Gln
275 280 285
Ala Val Ser Asp Asn Lys Ser Gln Gln Thr Asn Lys Val Thr Lys His
290 295 300
Asn Glu Thr Pro Lys Gln Ala Ser Lys Ala Lys Glu Leu Pro Lys Thr
305 310 315 320
Gly Leu Thr Ser Val Asp Asn Phe Ile Ser Thr Val Ala Phe Ala Thr
325 330 335
Leu Ala Leu Leu Gly Ser Leu Ser Leu Leu Leu Phe Lys Arg Lys Glu
340 345 350
Ser Lys
<210>9
<211>1965
<212>DNA
<213>Staphylococcus epidermidis
<400>9
tatacaatta ggagttgttt ctacaacatg aacaaacagc aaaaagaatt taaatcattt 60
tattcaatta gaaagtcatc actaggcgtt gcatctgtag caattagtac acttttatta 120
ttaatgtcaa atggcgaagc acaagcagca gctgaagaaa caggtggtac aaatacagaa 180
gcacaaccaa aaactgaagc agttgcaagt ccaacaacaa catctgaaaa agctccagaa 240
actaaaccag tagctaatgc tgtctcagta tctaataaag aagttgaggc ccctacttct 300
gaaacaaaag aagctaaaga agttaaagaa gttaaagccc ctaaggaaac aaaagaagtt 360
aaaccagcag caaaagccac taacaataca tatcctattt tgaatcagga acttagagaa 420
gcgattaaaa accctgcaat aaaagacaaa gatcatagcg caccaaactc tcgtccaatt 480
gattttgaaa tgaaaaagaa agatggaact caacagtttt atcattatgc aagttctgtt 540
aaacctgcta gagttatttt cactgattca aaaccagaaa ttgaattagg attacaatca 600
ggtcaatttt ggagaaaatt tgaagtttat gaaggtgaca aaaagttgcc aattaaatta 660
gtatcatacg atactgttaa agattatgct tacattcgct tctctgtatc aaacggaaca 720
aaagctgtta aaattgttag ttcaacacac ttcaataaca aagaagaaaa atacgattac 780
acattaatgg aattcgcaca accaatttat aacagtgcag ataaattcaa aactgaagaa 840
gattataaag ctgaaaaatt attagcgcca tataaaaaag cgaaaacact agaaagacaa 900
gtttatgaat taaataaaat tcaagataaa cttcctgaaa aattaaaggc tgagtacaag 960
aagaaattag aggatacaaa gaaagcttta gatgagcaag tgaaatcagc tattactgaa 1020
ttcc aaatg tacaaccaac aaatgaaaaa atgactgatt tacaagatac aaaatatgtt 1080
gtttatgaaa gtgttgagaa taacgaatct atgatggata cttttgttaa acaccctatt 1140
aaaacaggta tgcttaacgg caaaaaatat atggtcatgg aaactactaa tgacgattac 1200
tggaaagatt tcatggttga aggtcaacgt gttagaacta taagcaaaga tgctaaaaat 1260
aatactagaa caattatttt cccatatgtt gaaggtaaaa ctctatatga tgctatcgtt 1320
aaagttcacg taaaaacgat tgattatgat ggacaatacc atgtcagaat cgttgataaa 1380
gaagcattta caaaagccaa taccgataaa tctaacaaaa aagaacaaca agataactca 1440
gctaagaagg aagctactcc agctacgcct agcaaaccaa caccatcacc tgttgaaaaa 1500
gaatcacaaa aacaagacag ccaaaaagat gacaataaac aattaccaag tgttgaaaaa 1560
gaaaatgacg catctagtga gtcaggtaaa gacaaaacgc ctgctacaaa accaactaaa 1620
ggtgaagtag aatcaagtag tacaactcca actaaggtag tatctacgac tcaaaatgtt 1680
gcaaaaccaa caactgcttc atcaaaaaca acaaaagatg ttgttcaaac ttcagcaggt 1740
tctagcgaag caaaagatag tgctccatta caaaaagcaa acattaaaaa cacaaatgat 1800
ggacacactc aaagccaaaa caataaaaat acacaagaaa ataaagcaaa atcattacca 1860
caaactggtg aagaatcaaa taaagatatg acattaccat taatggcatt attagcttta 1920
agtagcatcg ttgcattcgt attacctaga aaacgtaaaa actaa 1965
<210>10
<211>654
<212>PRT
<213>Staphylococcus epidermidis
<400>10
Tyr Thr Ile Arg Ser Cys Phe Tyr Asn Met Asn Lys Gln Gln Lys Glu
1 5 10 15
Phe Lys Ser Phe Tyr Ser Ile Arg Lys Ser Ser Leu Gly Val Ala Ser
20 25 30
Val Ala Ile Ser Thr Leu Leu Leu Leu Met Ser Asn Gly Glu Ala Gln
35 40 45
Ala Ala Ala Glu Glu Thr Gly Gly Thr Asn Thr Glu Ala Gln Pro Lys
50 55 60
Thr Glu Ala Val Ala Ser Pro Thr Thr Thr Ser Glu Lys Ala Pro Glu
65 70 75 80
Thr Lys Pro Val Ala Asn Ala Val Ser Val Ser Asn Lys Glu Val Glu
85 90 95
Ala Pro Thr Ser Glu Thr Lys Glu Ala Lys Glu Val Lys Glu Val Lys
100 105 110
Ala Pro Lys Glu Thr Lys Glu Val Lys Pro Ala Ala Lys Ala Thr Asn
115 120 125
Asn Thr Tyr Pro Ile Leu Asn Gln Glu Leu Arg Glu Ala Ile Lys Asn
130 135 140
Pro Ala Ile Lys Asp Lys Asp His Ser Ala Pro Asn Ser Arg Pro Ile
145 150 155 160
Asp Phe Glu Met Lys Lys Lys Asp Gly Thr Gln Gln Phe Tyr His Tyr
165 170 175
Ala Ser Ser Val Lys Pro Ala Arg Val Ile Phe Thr Asp Ser Lys Pro
180 185 190
Glu Ile Glu Leu Gly Leu Gln Ser Gly Gln Phe Trp Arg Lys Phe Glu
195 200 205
Val Tyr Glu Gly Asp Lys Lys Leu Pro Ile Lys Leu Val Ser Tyr Asp
210 215 220
Thr Val Lys Asp Tyr Ala Tyr Ile Arg Phe Ser Val Ser Asn Gly Thr
225 230 235 240
Lys Ala Val Lys Ile Val Ser Ser Thr His Phe Asn Asn Lys Glu Glu
245 250 255
Lys Tyr Asp Tyr Thr Leu Met Glu Phe Ala Gln Pro Ile Tyr Asn Ser
260 265 270
Ala Asp Lys Phe Lys Thr Glu Glu Asp Tyr Lys Ala Glu Lys Leu Leu
275 280 285
Ala Pro Tyr Lys Lys Ala Lys Thr Leu Glu Arg Gln Val Tyr Glu Leu
290 295 300
Asn Lys Ile Gln Asp Lys Leu Pro Glu Lys Leu Lys Ala Glu Tyr Lys
305 310 315 320
Lys Lys Leu Glu Asp Thr Lys Lys Ala Leu Asp Glu Gln Val Lys Ser
325 330 335
Ala Ile Thr Glu Phe Gln Asn Val Gln Pro Thr Asn Glu Lys Met Thr
340 345 350
Asp Leu Gln Asp Thr Lys Tyr Val Val Tyr Glu Ser Val Glu Asn Asn
355 360 365
Glu Ser Met Met Asp Thr Phe Val Lys His Pro Ile Lys Thr Gly Met
370 375 380
Leu Asn Gly Lys Lys Tyr Met Val Met Glu Thr Thr Asn Asp Asp Tyr
385 390 395 400
Trp Lys Asp Phe Met Val Glu Gly Gln Arg Val Arg Thr Ile Ser Lys
405 410 415
Asp Ala Lys Asn Asn Thr Arg Thr Ile Ile Phe Pro Tyr Val Glu Gly
420 425 430
Lys Thr Leu Tyr Asp Ala Ile Val Lys Val His Val Lys Thr Ile Asp
435 440 445
Tyr Asp Gly Gln Tyr His Val Arg Ile Val Asp Lys Glu Ala Phe Thr
450 455 460
Lys Ala Asn Thr Asp Lys Ser Asn Lys Lys Glu Gln Gln Asp Asn Ser
465 470 475 480
Ala Lys Lys Glu Ala Thr Pro Ala Thr Pro Ser Lys Pro Thr Pro Ser
485 490 495
Pro Val Glu Lys Glu Ser Gln Lys Gln Asp Ser Gln Lys Asp Asp Asn
500 505 510
Lys Gln Leu Pro Ser Val Glu Lys Glu Asn Asp Ala Ser Ser Glu Ser
515 520 525
Gly Lys Asp Lys Thr Pro Ala Thr Lys Pro Thr Lys Gly Glu Val Glu
530 535 540
Ser Ser Ser Thr Thr Pro Thr Lys Val Val Ser Thr Thr Gln Asn Val
545 550 555 560
Ala Lys Pro Thr Thr Ala Ser Ser Lys Thr Thr Lys Asp Val Val Gln
565 570 575
Thr Ser Ala Gly Ser Ser Glu Ala Lys Asp Ser Ala Pro Leu Gln Lys
580 585 590
Ala Asn Ile Lys Asn Thr Asn Asp Gly His Thr Gln Ser Gln Asn Asn
595 600 605
Lys Asn Thr Gln Glu Asn Lys Ala Lys Ser Leu Pro Gln Thr Gly Glu
610 615 620
Glu Ser Asn Lys Asp Met Thr Leu Pro Leu Met Ala Leu Leu Ala Leu
625 630 635 640
Ser Ser Ile Val Ala Phe Val Leu Pro Arg Lys Arg Lys Asn
645 650
<210>11
<211>2406
<212>DNA
<213>Staphylococcus epidermidis
<400>11
tttataaata atttacataa aatcaatcat tttaatataa ggattatgat aatatattgg 60
tgtatgacag ttaatggagg gaacgaaatg aaagctttat tacttaaaac aagtgtatgg 120
ctcgttttgc tttttagtgt aatgggatta tggcaagtct cgaacgcggc tgagcagcat 180
acaccaatga aagcacatgc agtaacaacg atagacaaag caacaacaga taagcaacaa 240
gtaccgccaa caaaggaagc ggctcatcat tctggcaaag aagcggcaac caacgtatca 300
gcatcagcgc agggaacagc tgatgataca aacagcaaag taacatccaa cgcaccatct 360
aacaaaccat ctacagtagt ttcaacaaaa gtaaacgaaa cacgcgacgt agatacacaa 420
caagcctcaa cacaaaaacc aactcacaca gcaacgttca aattatcaaa tgctaaaaca 480
gcatcacttt caccacgaat gtttgctgct aatgcaccac aaacaacaac acataaaata 540
ttacatacaa atgatatcca tggccgacta gccgaagaaa aagggcgtgt catcggtatg 600
gctaaattaa aaacagtaaa agaacaagaa aagcctgatt taatgttaga cgcaggagac 660
gccttccaag gtttaccact ttcaaaccag tctaaaggtg aagaaatggc taaagcaatg 720
aatgcagtag gttatgatgc tatggcagtc ggtaaccatg aatttgactt tggatacgat 780
cagttgaaaa agttagaggg tatgttagac ttcccgatgc taagtactaa cgtttataaa 840
gatggaaaac gcgcgtttaa gccttcaacg attgtaacaa aaaatggtat tcgttatgga 900
attattggtg taacgacacc agaaacaaag acgaaaacaa gacctgaagg cattaaaggc 960
gttgaattta gagatccatt acaaagtgtg acagcggaaa tgatgcgtat ttataaagac 1020
gtagatacat ttgttgttat atcacattta ggaattgatc cttcaacaca agaaacatgg 1080
cgtggtgatt acttagtgaa acaattaagt caaaatccac aattgaagaa acgtattaca 1140
gttattgatg gtcattcaca tacagtactt caaaatggtc aaatttataa caatgatgca 1200
ttggcacaaa caggtacagc acttgcgaat atcggtaaga ttacatttaa ttatcgcaat 1260
ggagaggtat cgaatattaa accgtcattg attaatgtta aagacgttga aaatgtaaca 1320
ccgaacaaag cattagctga acaaattaat caagctgatc aaacatttag agcacaaact 1380
gcagaggtaa ttattccaaa caataccatt gatttcaaag gagaaagaga tgacgttaga 1440
acgcgtgaaa caaatttagg aaacgcgatt gcagatgcta tggaagcgta tggcgttaag 1500
aatttctcta aaaagactga ctttgccgtg acaaatggtg gaggtattcg tgcctctatc 1560
gcaaaaggta aggtgacacg ctatgattta atctcagtat taccatttgg aaatacgatt 1620
gcgcaaattg atgtaaaagg ttcagacgtc tggacggctt tcgaacatag tttaggcgca 1680
ccaacaacac aaaaggacgg taagacagtg ttaacagcga atggcggttt actacatatc 1740
tctgattcaa tccgtgttta ctatgatata aataaaccgt ctggcaaacg aattaatgct 1800
attcaaattt taaataaaga gacaggtaag tttgaaaata ttgatttaaa acgtgtatat 1860
cacgtaacga tgaatgactt cacagcatca ggtggcgacg gatatagtat gttcggtggt 1920
cctagagaag aaggtatttc attagatcaa gtactagcaa gttatttaaa aacagctaac 1980
ttagctaagt atgatacgac agaaccacaa cgtatgttat taggtaaacc agcagtaagt 2040
gaacaaccag ctaaaggaca acaaggtagc aaaggtagta agtctggtaa agatacacaa 2100
ccaattggtg acgacaaagt gatggatcca gcgaaaaaac cagctccagg taaagttgta 2160
ttgttgctag cgcatagagg aactgttagt agcggtacag aaggttctgg tcgcacaata 2220
gaaggagcta ctgtatcaag caagagtggg aaacaattgg ctagaatgtc agtgcctaaa 2280
ggtagcgcgc atgagaaaca gttaccaaaa actggaacta atcaaagttc aagcccagaa 2340
gcgatgtttg tattattagc aggtataggt ttaatcgcga ctgtacgacg tagaaaagct 2400
agctaa 2406
<210>12
<211>801
<212>PRT
<213>Staphylococcus epidermidis
<400>12
Phe Ile Asn Asn Leu His Lys Ile Asn His Phe Asn Ile Arg Ile Met
1 5 10 15
Ile Ile Tyr Trp Cys Met Thr Val Asn Gly Gly Asn Glu Met Lys Ala
20 25 30
Leu Leu Leu Lys Thr Ser Val Trp Leu Val Leu Leu Phe Ser Val Met
35 40 45
Gly Leu Trp Gln Val Ser Asn Ala Ala Glu Gln His Thr Pro Met Lys
50 55 60
Ala His Ala Val Thr Thr Ile Asp Lys Ala Thr Thr Asp Lys Gln Gln
65 70 75 80
Val Pro Pro Thr Lys Glu Ala Ala His His Ser Gly Lys Glu Ala Ala
85 90 95
Thr Asn Val Ser Ala Ser Ala Gln Gly Thr Ala Asp Asp Thr Asn Ser
100 105 110
Lys Val Thr Ser Asn Ala Pro Ser Asn Lys Pro Ser Thr Val Val Ser
115 120 125
Thr Lys Val Asn Glu Thr Arg Asp Val Asp Thr Gln Gln Ala Ser Thr
130 135 140
Gln Lys Pro Thr His Thr Ala Thr Phe Lys Leu Ser Asn Ala Lys Thr
145 150 155 160
Ala Ser Leu Ser Pro Arg Met Phe Ala Ala Asn Ala Pro Gln Thr Thr
165 170 175
Thr His Lys Ile Leu His Thr Asn Asp Ile His Gly Arg Leu Ala Glu
180 185 190
Glu Lys Gly Arg Val Ile Gly Met Ala Lys Leu Lys Thr Val Lys Glu
195 200 205
Gln Glu Lys Pro Asp Leu Met Leu Asp Ala Gly Asp Ala Phe Gln Gly
210 215 220
Leu Pro Leu Ser Asn Gln Ser Lys Gly Glu Glu Met Ala Lys Ala Met
225 230 235 240
Asn Ala Val Gly Tyr Asp Ala Met Ala Val Gly Asn His Glu Phe Asp
245 250 255
Phe Gly Tyr Asp Gln Leu Lys Lys Leu Glu Gly Met Leu Asp Phe Pro
260 265 270
Met Leu Ser Thr Asn Val Tyr Lys Asp Gly Lys Arg Ala Phe Lys Pro
275 280 285
Ser Thr Ile Val Thr Lys Asn Gly Ile Arg Tyr Gly Ile Ile Gly Val
290 295 300
Thr Thr Pro Glu Thr Lys Thr Lys Thr Arg Pro Glu Gly Ile Lys Gly
305 310 315 320
Val Glu Phe Arg Asp Pro Leu Gln Ser Val Thr Ala Glu Met Met Arg
325 330 335
Ile Tyr Lys Asp Val Asp Thr Phe Val Val Ile Ser His Leu Gly Ile
340 345 350
Asp Pro Ser Thr Gln Glu Thr Trp Arg Gly Asp Tyr Leu Val Lys Gln
355 360 365
Leu Ser Gln Asn Pro Gln Leu Lys Lys Arg Ile Thr Val Ile Asp Gly
370 375 380
His Ser His Thr Val Leu Gln Asn Gly Gln Ile Tyr Asn Asn Asp Ala
385 390 395 400
Leu Ala Gln Thr Gly Thr Ala Leu Ala Asn Ile Gly Lys Ile Thr Phe
405 410 415
Asn Tyr Arg Asn Gly Glu Val Ser Asn Ile Lys Pro Ser Leu Ile Asn
420 425 430
Val Lys Asp Val Glu Asn Val Thr Pro Asn Lys Ala Leu Ala Glu Gln
435 440 445
Ile Asn Gln Ala Asp Gln Thr Phe Arg Ala Gln Thr Ala Glu Val Ile
450 455 460
Ile Pro Asn Asn Thr Ile Asp Phe Lys Gly Glu Arg Asp Asp Val Arg
465 470 475 480
Thr Arg Glu Thr Asn Leu Gly Asn Ala Ile Ala Asp Ala Met Glu Ala
485 490 495
Tyr Gly Val Lys Asn Phe Ser Lys Lys Thr Asp Phe Ala Val Thr Asn
500 505 510
Gly Gly Gly Ile Arg Ala Ser Ile Ala Lys Gly Lys Val Thr Arg Tyr
515 520 525
Asp Leu Ile Ser Val Leu Pro Phe Gly Asn Thr Ile Ala Gln Ile Asp
530 535 540
Val Lys Gly Ser Asp Val Trp Thr Ala Phe Glu His Ser Leu Gly Ala
545 550 555 560
Pro Thr Thr Gln Lys Asp Gly Lys Thr Val Leu Thr Ala Asn Gly Gly
565 570 575
Leu Leu His Ile Ser Asp Ser Ile Arg Val Tyr Tyr Asp Ile Asn Lys
580 585 590
Pro Ser Gly Lys Arg Ile Asn Ala Ile Gln Ile Leu Asn Lys Glu Thr
595 600 605
Gly Lys Phe Glu Asn Ile Asp Leu Lys Arg Val Tyr His Val Thr Met
610 615 620
Asn Asp Phe Thr Ala Ser Gly Gly Asp Gly Tyr Ser Met Phe Gly Gly
625 630 635 640
Pro Arg Glu Glu Gly Ile Ser Leu Asp Gln Val Leu Ala Ser Tyr Leu
645 650 655
Lys Thr Ala Asn Leu Ala Lys Tyr Asp Thr Thr Glu Pro Gln Arg Met
660 665 670
Leu Leu Gly Lys Pro Ala Val Ser Glu Gln Pro Ala Lys Gly Gln Gln
675 680 685
Gly Ser Lys Gly Ser Lys Ser Gly Lys Asp Thr Gln Pro Ile Gly Asp
690 695 700
Asp Lys Val Met Asp Pro Ala Lys Lys Pro Ala Pro Gly Lys Val Val
705 710 715 720
Leu Leu Leu Ala His Arg Gly Thr Val Ser Ser Gly Thr Glu Gly Ser
725 730 735
Gly Arg Thr Ile Glu Gly Ala Thr Val Ser Ser Lys Ser Gly Lys Gln
740 745 750
Leu Ala Arg Met Ser Val Pro Lys Gly Ser Ala His Glu Lys Gln Leu
755 760 765
Pro Lys Thr Gly Thr Asn Gln Ser Ser Ser Pro Glu Ala Met Phe Val
770 775 780
Leu Leu Ala Gly Ile Gly Leu Ile Ala Thr Val Arg Arg Arg Lys Ala
785 790 795 800
Ser
<210>13
<211>4914
<212>DNA
<213>Staphylococcus epidermidis
<400>13
agtggaaaat atggaaaaag gagtatgcaa atgagagata agaaaggacc ggtaaataaa 60
agagtagatt ttctatcaaa taaattgaat aaatattcaa taagaaaatt tacagttgga 120
acagcatcta ttttaattgg ctcactaatg tatttgggaa ctcaacaaga ggcagaagca 180
gctgaaaaca atattgagaa tccaactaca ttaaaagata atgtccaatc aaaagaagtg 240
aagattgaag aagtaacaaa caaagacact gcaccacagg gtgtagaagc taaatctgaa 300
gtaacttcaa acaaagacac aatcgaacat gaaccatcag taaaagctga agatatatca 360
aaaaaggagg atacaccaaa agaagtagct gatgttgctg aagttcagcc gaaatcgtca 420
gtcactcata acgcagagac acctaaggtt agaaaagctc gttctgttga tgaaggctct 480
tttgatatta caagagattc taaaaatgta gttgaatcta ccccaattac aattcaaggt 540
aaagaacatt ttgaaggtta cggaagtgtt gatatacaaa aaaaaccaac agatttaggg 600
gtatcagagg taaccaggtt taatgttggt aatgaaagta atggtttgat aggagcttta 660
caattaaaaa ataaaataga ttttagtaag gatttcaatt ttaaagttag agtggcaaat 720
aaccatcaat caaataccac aggtgctgat ggttgggggt tcttatttag taaaggaaat 780
gcagaagaat atttaactaa tggtggaatc cttggggata aaggtctggt aaattcaggc 840
ggatttaaaa ttgatactgg atacatttat acaagttcca tggacaaaac tgaaaagcaa 900
gctggacaag gttatagagg atacggagct tttgtgtaaa atgacagttc tggtaattca 960
caaatggttg gagaaaatat tgataaatca aaaactaatt ttttaaacta tgcggacaat 1020
tcaactaata catcagatgg aaagtttcat gggcaacgtt taaatgatgt catcttaact 1080
tatgttgctt caactggtaa aatgagagca gaatatgctg gtaaaacttg ggagacttca 1140
ataacagatt taggtttatc taaaaatcag gcatataatt tcttaattac atctagtcaa 1200
agatggggcc ttaatcaagg gataaatgca aatggctgga tgagaactga cttgaaaggt 1260
tcagagttta cttttacacc agaagcgcca aaaacaataa cagaattaga aaaaaaagtt 1320
gaagagattc cattcaagaa agaacgtaaa tttaatccgg atttagcacc agggacagaa 1380
aaagtaacaa gagaaggaca aaaaggtgag aagacaataa cgacaccaac actaaaaaat 1440
ccattaactg gagtaattat tagtaaaggt gaaccaaaag aagagattac aaaagatccg 1500
attaatgaat taacagaata cggacctgaa acaatagcgc caggtcatcg agacgaattt 1560
gatccgaagt taccaacagg agagaaagag gaagttccag gtaaaccagg aattaagaat 1620
ccagaaacag gagacgtagt tagaccgccg gtcgatagcg taacaaaata tggacctgta 1680
aaaggagact cgattgtaga aaaagaagag attccattcg agaaagaacg taaatttaat 1740
cctgatttag caccagggac agaaaaagta acaagagaag gacaaaaagg tgagaagaca 1800
ataacgacgc caacactaaa aaatccatta actggagaaa ttattagtaa aggtgaatcg 1860
aaagaagaaa tcacaaaaga tccgattaat gaattaacag aatacggacc agaaacgata 1920
acaccaggtc atcgagacga atttgatccg aagttaccaa caggagagaa agaggaagtt 1980
ccaggtaaac caggaattaa gaatccagaa acaggagatg tagttagacc accggtcgat 2040
agcgtaacaa aatatggacc tgtaaaagga gactcgattg tagaaaaaga agagattcca 2100
ttcgagaaag aacgtaaatt taatcctgat ttagcaccag ggacagaaaa agtaacaaga 2160
gaaggacaaa aaggtgagaa gacaataacg acaccaacac taaaaaatcc attaactgga 2220
gtaattatta gtaaaggtga accaaaagaa gaaatcacaa aagatccgat taatgaatta 2280
acagaatacg gaccagaaac gataacacca ggtcatcgag acgaatttga tccgaagtta 2340
ccaacaggag agaaagaaga agttccaggt aaaccaggaa ttaagaatcc agaaacagga 2400
gacgtagtta gaccaccggt cgatagcgta acaaaatatg gacctgtaaa aggagactcg 2460
attgtagaaa aagaagagat tccattcaag aaagaacgta aatttaatcc ggatttagca 2520
ccagggacag aaaaagtaac aagagaagga caaaaaggtg agaagacaat aacgacgcca 2580
acactaaaaa atccattaac tggagaaatt attagtaaag gtgaatcgaa agaagaaatc 2640
acaaaagatc cgattaatga attaacagaa tacggaccag aaacgataac accaggtcat 2700
cgagacgaat ttgatccgaa gttaccaaca ggagagaaag aggaagttcc aggtaaacca 2760
ggaattaaga atccagaaac aggagatgta gttagaccac cggtcgatag cgtaacaaaa 2820
tatggacctg taaaaggaga ctcgattgta gaaaaagaag agattccatt cgagaaagaa 2880
cgtaaattta atcctgattt agcaccaggg acagaaaaag taacaagaga aggacaaaaa 2940
ggtgagaaga caataacgac gccaacacta aaaaatccat taactggaga aattattagt 3000
aaaggtgaat cgaaagaaga aatcacaaaa gatccgatta atgaattaac agaatacgga 3060
ccagaaacga taacaccagg tcatcgagac gaatttgatc cgaagttacc aacaggagag 3120
aaagaggaag ttccaggtaa accaggaatt aagaatccag aaacaggaga cgtagttaga 3180
ccaccggtcg atagcgtaac aaaatatgga cctgtaaaag gagactcgat tgtagaaaaa 3240
gaagaaattc cattcaagaa agaacgtaaa tttaatcctg atttagcacc agggacagaa 3300
aaagtaacaa gagaaggaca aaaaggtgag aagacaataa cgacgccaac actaaaaaat 3360
ccattaactg gagaaattat tagtaaaggt gaatcgaaag aagaaatcac aaaagatccg 3420
attaatgaat taacagaata cggaccagaa acgataacac caggtcatcg agacgaattt 3480
gatccgaagt taccaacagg agagaaagag gaagttccag gtaaaccagg aattaagaat 3540
ccagaaacag gagatgtagt tagaccaccg gtcgatagcg taacaaaata tggacctgta 3600
aaaggagact cgattgtaga aaaagaagaa attccattcg agaaagaacg taaatttaat 3660
cctgatttag caccagggac agaaaaagta acaagagaag gacaaaaagg tgagaagaca 3720
ataacgacgc caacactaaa aaatccatta actggagaaa ttattagtaa aggtgaatcg 3780
aaagaagaaa tcacaaaaga tccgattaat gaattaacag aatacggacc agaaacgata 3840
acaccaggtc atcgagacga atttgatccg aagttaccaa caggagagaa agaggaagtt 3900
ccaggtaaac caggaattaa gaatccagaa acaggagatg tagttagacc accggtcgat 3960
agcgtaacaa aatatggacc tgtaaaagga gactcgattg tagaaaaaga agaaattcca 4020
ttcgagaaag aacgtaaatt taatcctgat ttagcaccag ggacagaaaa agtaacaaga 4080
gaaggacaaa aaggtgagaa gacaataacg acgccaacac taaaaaatcc attaactgga 4140
gaaattatta gtaaaggtga atcgaaagaa gaaatcacaa aagatccagt taatgaatta 4200
acagaattcg gtggcgagaa aataccgcaa ggtcataaag atatctttga tccaaactta 4260
ccaacagatc aaacggaaaa agtaccaggt aaaccaggaa tcaagaatcc agacacagga 4320
aaagtgatcg aagagccagt ggatgatgtg attaaacacg gaccaaaaac gggtacacca 4380
gaaacaaaaa cagtagagat accgtttgaa acaaaacgtg agtttaatcc aaaattacaa 4440
cctggtgaag agcgagtgaa acaagaagga caaccaggaa gtaagacaat cacaacacca 4500
atcacagtga acccattaac aggtgaaaaa gttggcgagg gtcaaccaac agaagagatc 4560
acaaaacaac cagtagataa gattgtagag ttcggtggag agaaaccaaa agatccaaaa 4620
ggacctgaaa acccagagaa gccgagcaga ccaactcatc caagtggccc agtaaatcct 4680
aacaatccag gattatcgaa agacagagca aaaccaaatg gcccagttca ttcaatggat 4740
aaaaatgata aagttaaaaa atctaaaatt gctaaagaat cagtagctaa tcaagagaaa 4800
aaacgagcag aattaccaaa aacaggttta gaaagcacgc aaaaaggttt gatctttagt 4860
agtataattg gaattgctgg attaatgtta ttggctcgta gaagaaagaa ttaa 4914
<210>14
<211>1637
<212>PRT
<213>Staphylococcus epidermidis
<400>14
Ser Gly Lys Tyr Gly Lys Arg Ser Met Gln Met Arg Asp Lys Lys Gly
1 5 10 15
Pro Val Asn Lys Arg Val Asp Phe Leu Ser Asn Lys Leu Asn Lys Tyr
20 25 30
Ser Ile Arg Lys Phe Thr Val Gly Thr Ala Ser Ile Leu Ile Gly Ser
35 40 45
Leu Met Tyr Leu Gly Thr Gln Gln Glu Ala Glu Ala Ala Glu Asn Asn
50 55 60
Ile Glu Asn Pro Thr Thr Leu Lys Asp Asn Val Gln Ser Lys Glu Val
65 70 75 80
Lys Ile Glu Glu Val Thr Asn Lys Asp Thr Ala Pro Gln Gly Val Glu
85 90 95
Ala Lys Ser Glu Val Thr Ser Asn Lys Asp Thr Ile Glu His Glu Pro
100 105 110
Ser Val Lys Ala Glu Asp Ile Ser Lys Lys Glu Asp Thr Pro Lys Glu
115 120 125
Val Ala Asp Val Ala Glu Val Gln Pro Lys Ser Ser Val Thr His Asn
130 135 140
Ala Glu Thr Pro Lys Val Arg Lys Ala Arg Ser Val Asp Glu Gly Ser
145 150 155 160
Phe Asp Ile Thr Arg Asp Ser Lys Asn Val Val Glu Ser Thr Pro Ile
165 170 175
Thr Ile Gln Gly Lys Glu His Phe Glu Gly Tyr Gly Ser Val Asp Ile
180 185 190
Gln Lys Lys Pro Thr Asp Leu Gly Val Ser Glu Val Thr Arg Phe Asn
195 200 205
Val Gly Asn Glu Ser Asn Gly Leu Ile Gly Ala Leu Gln Leu Lys Asn
210 215 220
Lys Ile Asp Phe Ser Lys Asp Phe Asn Phe Lys Val Arg Val Ala Asn
225 230 235 240
Asn His Gln Ser Asn Thr Thr Gly Ala Asp Gly Trp Gly Phe Leu Phe
245 250 255
Ser Lys Gly Asn Ala Glu Glu Tyr Leu Thr Asn Gly Gly Ile Leu Gly
260 265 270
Asp Lys Gly Leu Val Asn Ser Gly Gly Phe Lys Ile Asp Thr Gly Tyr
275 280 285
Ile Tyr Thr Ser Ser Met Asp Lys Thr Glu Lys Gln Ala Gly Gln Gly
290 295 300
Tyr Arg Gly Tyr Gly Ala Phe Val Lys Asn Asp Ser Ser Gly Asn Ser
305 310 315 320
Gln Met Val Gly Glu Asn Ile Asp Lys Ser Lys Thr Asn Phe Leu Asn
325 330 335
Tyr Ala Asp Asn Ser Thr Asn Thr Ser Asp Gly Lys Phe His Gly Gln
340 345 350
Arg Leu Asn Asp Val Ile Leu Thr Tyr Val Ala Ser Thr Gly Lys Met
355 360 365
Arg Ala Glu Tyr Ala Gly Lys Thr Trp Glu Thr Ser Ile Thr Asp Leu
370 375 380
Gly Leu Ser Lys Asn Gln Ala Tyr Asn Phe Leu Ile Thr Ser Ser Gln
385 390 395 400
Arg Trp Gly Leu Asn Gln Gly Ile Asn Ala Asn Gly Trp Met Arg Thr
405 410 415
Asp Leu Lys Gly Ser Glu Phe Thr Phe Thr Pro Glu Ala Pro Lys Thr
420 425 430
Ile Thr Glu Leu Glu Lys Lys Val Glu Glu Ile Pro Phe Lys Lys Glu
435 440 445
Arg Lys Phe Asn Pro Asp Leu Ala Pro Gly Thr Glu Lys Val Thr Arg
450 455 460
Glu Gly Gln Lys Gly Glu Lys Thr Ile Thr Thr Pro Thr Leu Lys Asn
465 470 475 480
Pro Leu Thr Gly Val Ile Ile Ser Lys Gly Glu Pro Lys Glu Glu Ile
485 490 495
Thr Lys Asp Pro Ile Asn Glu Leu Thr Glu Tyr Gly Pro Glu Thr Ile
500 505 510
Ala Pro Gly His Arg Asp Glu Phe Asp Pro Lys Leu Pro Thr Gly Glu
515 520 525
Lys Glu Glu Val Pro Gly Lys Pro Gly Ile Lys Asn Pro Glu Thr Gly
530 535 540
Asp Val Val Arg Pro Pro Val Asp Ser Val Thr Lys Tyr Gly Pro Val
545 550 555 560
Lys Gly Asp Ser Ile Val Glu Lys Glu Glu Ile Pro Phe Glu Lys Glu
565 570 575
Arg Lys Phe Asn Pro Asp Leu Ala Pro Gly Thr Glu Lys Val Thr Arg
580 585 590
Glu Gly Gln Lys Gly Glu Lys Thr Ile Thr Thr Pro Thr Leu Lys Asn
595 600 605
Pro Leu Thr Gly Glu Ile Ile Ser Lys Gly Glu Ser Lys Glu Glu Ile
610 615 620
Thr Lys Asp Pro Ile Asn Glu Leu Thr Glu Tyr Gly Pro Glu Thr Ile
625 630 635 640
Thr Pro Gly His Arg Asp Glu Phe Asp Pro Lys Leu Pro Thr Gly Glu
645 650 655
Lys Glu Glu Val Pro Gly Lys Pro Gly Ile Lys Asn Pro Glu Thr Gly
660 665 670
Asp Val Val Arg Pro Pro Val Asp Ser Val Thr Lys Tyr Gly Pro Val
675 680 685
Lys Gly Asp Ser Ile Val Glu Lys Glu Glu Ile Pro Phe Glu Lys Glu
690 695 700
Arg Lys Phe Asn Pro Asp Leu Ala Pro Gly Thr Glu Lys Val Thr Arg
705 710 715 720
Glu Gly Gln Lys Gly Glu Lys Thr Ile Thr Thr Pro Thr Leu Lys Asn
725 730 735
Pro Leu Thr Gly Val Ile Ile Ser Lys Gly Glu Pro Lys Glu Glu Ile
740 745 750
Thr Lys Asp Pro Ile Asn Glu Leu Thr Glu Tyr Gly Pro Glu Thr Ile
755 760 765
Thr Pro Gly His Arg Asp Glu Phe Asp Pro Lys Leu Pro Thr Gly Glu
770 775 780
Lys Glu Glu Val Pro Gly Lys Pro Gly Ile Lys Asn Pro Glu Thr Gly
785 790 795 800
Asp Val Val Arg Pro Pro Val Asp Ser Val Thr Lys Tyr Gly Pro Val
805 810 815
Lys Gly Asp Ser Ile Val Glu Lys Glu Glu Ile Pro Phe Lys Lys Glu
820 825 830
Arg Lys Phe Asn Pro Asp Leu Ala Pro Gly Thr Glu Lys Val Thr Arg
835 840 845
Glu Gly Gln Lys Gly Glu Lys Thr Ile Thr Thr Pro Thr Leu Lys Asn
850 855 860
Pro Leu Thr Gly Glu Ile Ile Ser Lys Gly Glu Ser Lys Glu Glu Ile
865 870 875 880
Thr Lys Asp Pro Ile Asn Glu Leu Thr Glu Tyr Gly Pro Glu Thr Ile
885 890 895
Thr Pro Gly His Arg Asp Glu Phe Asp Pro Lys Leu Pro Thr Gly Glu
900 905 910
Lys Glu Glu Val Pro Gly Lys Pro Gly Ile Lys Asn Pro Glu Thr Gly
915 920 925
Asp Val Val Arg Pro Pro Val Asp Ser Val Thr Lys Tyr Gly Pro Val
930 935 940
Lys Gly Asp Ser Ile Val Glu Lys Glu Glu Ile Pro Phe Glu Lys Glu
945 950 955 960
Arg Lys Phe Asn Pro Asp Leu Ala Pro Gly Thr Glu Lys Val Thr Arg
965 970 975
Glu Gly Gln Lys Gly Glu Lys Thr Ile Thr Thr Pro Thr Leu Lys Asn
980 985 990
Pro Leu Thr Gly Glu Ile Ile Ser Lys Gly Glu Ser Lys Glu Glu Ile
995 1000 1005
Thr Lys Asp Pro Ile Asn Glu Leu Thr Glu Tyr Gly Pro Glu Thr
1010 1015 1020
Ile Thr Pro Gly His Arg Asp Glu Phe Asp Pro Lys Leu Pro Thr
1025 1030 1035
Gly Glu Lys Glu Glu Val Pro Gly Lys Pro Gly Ile Lys Asn Pro
1040 1045 1050
Glu Thr Gly Asp Val Val Arg Pro Pro Val Asp Ser Val Thr Lys
1055 1060 1065
Tyr Gly Pro Val Lys Gly Asp Ser Ile Val Glu Lys Glu Glu Ile
1070 1075 1080
Pro Phe Lys Lys Glu Arg Lys Phe Asn Pro Asp Leu Ala Pro Gly
1085 1090 1095
Thr Glu Lys Val Thr Arg Glu Gly Gln Lys Gly Glu Lys Thr Ile
1100 1105 1110
Thr Thr Pro Thr Leu Lys Asn Pro Leu Thr Gly Glu Ile Ile Ser
1115 1120 1125
Lys Gly Glu Ser Lys Glu Glu Ile Thr Lys Asp Pro Ile Asn Glu
1130 1135 1140
Leu Thr Glu Tyr Gly Pro Glu Thr Ile Thr Pro Gly His Arg Asp
1145 1150 1155
Glu Phe Asp Pro Lys Leu Pro Thr Gly Glu Lys Glu Glu Val Pro
1160 1165 1170
Gly Lys Pro Gly Ile Lys Asn Pro Glu Thr Gly Asp Val Val Arg
1175 1180 1185
Pro Pro Val Asp Ser Val Thr Lys Tyr Gly Pro Val Lys Gly Asp
1190 1195 1200
Ser Ile Val Glu Lys Glu Glu Ile Pro Phe Glu Lys Glu Arg Lys
1205 1210 1215
Phe Asn Pro Asp Leu Ala Pro Gly Thr Glu Lys Val Thr Arg Glu
1220 1225 1230
Gly Gln Lys Gly Glu Lys Thr Ile Thr Thr Pro Thr Leu Lys Asn
1235 1240 1245
Pro Leu Thr Gly Glu Ile Ile Ser Lys Gly Glu Ser Lys Glu Glu
1250 1255 1260
Ile Thr Lys Asp Pro Ile Asn Glu Leu Thr Glu Tyr Gly Pro Glu
1265 1270 1275
Thr Ile Thr Pro Gly His Arg Asp Glu Phe Asp Pro Lys Leu Pro
1280 1285 1290
Thr Gly Glu Lys Glu Glu Val Pro Gly Lys Pro Gly Ile Lys Asn
1295 1300 1305
Pro Glu Thr Gly Asp Val Val Arg Pro Pro Val Asp Ser Val Thr
1310 1315 1320
Lys Tyr Gly Pro Val Lys Gly Asp Ser Ile Val Glu Lys Glu Glu
1325 1330 1335
Ile Pro Phe Glu Lys Glu Arg Lys Phe Asn Pro Asp Leu Ala Pro
1340 1345 1350
Gly Thr Glu Lys Val Thr Arg Glu Gly Gln Lys Gly Glu Lys Thr
1355 1360 1365
Ile Thr Thr Pro Thr Leu Lys Asn Pro Leu Thr Gly Glu Ile Ile
1370 1375 1380
Ser Lys Gly Glu Ser Lys Glu Glu Ile Thr Lys Asp Pro Val Asn
1385 1390 1395
Glu Leu Thr Glu Phe Gly Gly Glu Lys Ile Pro Gln Gly His Lys
1400 1405 1410
Asp Ile Phe Asp Pro Asn Leu Pro Thr Asp Gln Thr Glu Lys Val
1415 1420 1425
Pro Gly Lys Pro Gly Ile Lys Asn Pro Asp Thr Gly Lys Val Ile
1430 1435 1440
Glu Glu Pro Val Asp Asp Val Ile Lys His Gly Pro Lys Thr Gly
1445 1450 1455
Thr Pro Glu Thr Lys Thr Val Glu Ile Pro Phe Glu Thr Lys Arg
1460 1465 1470
Glu Phe Asn Pro Lys Leu Gln Pro Gly Glu Glu Arg Val Lys Gln
1475 1480 1485
Glu Gly Gln Pro Gly Ser Lys Thr Ile Thr Thr Pro Ile Thr Val
1490 1495 1500
Asn Pro Leu Thr Gly Glu Lys Val Gly Glu Gly Gln Pro Thr Glu
1505 1510 1515
Glu Ile Thr Lys Gln Pro Val Asp Lys Ile Val Glu Phe Gly Gly
1520 1525 1530
Glu Lys Pro Lys Asp Pro Lys Gly Pro Glu Asn Pro Glu Lys Pro
1535 1540 1545
Ser Arg Pro Thr His Pro Ser Gly Pro Val Asn Pro Asn Asn Pro
1550 1555 1560
Gly Leu Ser Lys Asp Arg Ala Lys Pro Asn Gly Pro Val His Ser
1565 1570 1575
Met Asp Lys Asn Asp Lys Val Lys Lys Ser Lys Ile Ala Lys Glu
1580 1585 1590
Ser Val Ala Asn Gln Glu Lys Lys Arg Ala Glu Leu Pro Lys Thr
1595 1600 1605
Gly Leu Glu Ser Thr Gln Lys Gly Leu Ile Phe Ser Ser Ile Ile
1610 1615 1620
Gly Ile Ala Gly Leu Met Leu Leu Ala Arg Arg Arg Lys Asn
1625 1630 1635
<210>15
<211>1923
<212>DNA
<213>Staphylococcus epidermidis
<400>15
ggaaggagta tgttgatggc taaatatcga gggaaaccgt ttcaattata tgtaaagtta 60
tcgtgttcga caatgatggc gacaagtatc attttaacga atatcttgcc gtacgatgcc 120
caagctgcat ctgaaaagga tactgaaatt acaaaagaga tattatctaa gcaagattta 180
ttagacaaag ttgacaaggc aattcgtcaa attgagcaat taaaacagtt atcggcttca 240
tctaaagaac attataaagc acaactaaat gaagcgaaaa cagcatcgca aatagatgaa 300
atcataaaac gagctaatga gttggatagc aaagacaata aaagttctca cactgaaatg 360
aacggtcaaa gtgatataga cagtaaatta gatcaattgc ttaaagattt aaatgaggtt 420
tcttcaaatg ttgatagggg tcaacaaagt ggcgaggacg atcttaatgc aatgaaaaat 480
gatatgtcac aaacggctac aacaaaacat ggagaaaaag atgataaaaa tgatgaagca 540
atggtaaata aggcgttaga agacctagac catttgaatc agcaaataca caaatcgaaa 600
gatgcatcga aagatacatc ggaagatcca gcagtgtcta caacagataa taatcatgaa 660
gtagctaaaa cgccaaataa tgatggttct ggacatgttg tgttaaataa attcctttca 720
aatgaagaga atcaaagcca tagtaatcga ctcactgata aattacaagg aagcgataaa 780
attaatcatg ctatgattga aaaattagct aaaagtaatg cctcaacgca acattacaca 840
tatcataaac tgaatacgtt acaatcttta gatcaacgta ttgcaaatac gcaacttcct 900
aaaaatcaaa aatcagactt aatgagcgaa gtaaataaga cgaaagagcg tataaaaagt 960
caacgaaata ttattttgga agaacttgca cgtactgatg ataaaaagta tgctacacaa 1020
agcattttag aaagtatatt taataaagac gaggcagtta aaattctaaa agatatacgt 1080
gttgatggta aaacagatca acaaattgca gatcaaatta ctcgtcatat tgatcaatta 1140
tctctgacaa cgagtgatga tttattaacg tcattgattg atcaatcaca agataagtcg 1200
ctattgattt ctcaaatttt acaaacgaaa ttaggaaaag ctgaagcaga taaattggct 1260
aaagattgga cgaataaagg attatcaaat cgccaaatcg ttgaccaatt gaagaaacat 1320
tttgcatcaa ctggcgacac gtcttcagat gatatattaa aagcaatttt gaataatgcc 1380
aaagataaaa aacaagcaat tgaaacgatt ttagcaacac gtatagaaag acaaaaggca 1440
aaattactgg cagatttaat tactaaaata gaaacagatc aaaataaaat ttttaattta 1500
gttaaatcgg cattgaatgg taaagcggat gatttattga atttacaaaa gagactcaat 1560
caaacgaaaa aagatataga ttatatttta tcaccaatag taaatcgtcc aagtttacta 1620
gatcgattga ataaaaatgg gaaaacgaca gatttaaata agttagcaaa tttaatgaat 1680
caaggatcag atttattaga cagtattcca gatataccca caccaaagcc agaaaagacg 1740
ttaacacttg gtaaaggtaa tggattgtta agtggattat taaatgctga tggtaatgta 1800
tctttgccta aagcggggga aacgataaaa gaacattggt tgccgatatc tgtaattgtt 1860
ggtgcaatgg gtgtactaat gatttggtta tcacgacgca ataagttgaa aaataaagca 1920
taa 1923
<210>16
<211>640
<212>PRT
<213>Staphylococcus epidermidis
<400>16
Gly Arg Ser Met Leu Met Ala Lys Tyr Arg Gly Lys Pro Phe Gln Leu
1 5 10 15
Tyr Val Lys Leu Ser Cys Ser Thr Met Met Ala Thr Ser Ile Ile Leu
20 25 30
Thr Asn Ile Leu Pro Tyr Asp Ala Gln Ala Ala Ser Glu Lys Asp Thr
35 40 45
Glu Ile Thr Lys Glu Ile Leu Ser Lys Gln Asp Leu Leu Asp Lys Val
50 55 60
Asp Lys Ala Ile Arg Gln Ile Glu Gln Leu Lys Gln Leu Ser Ala Ser
65 70 75 80
Ser Lys Glu His Tyr Lys Ala Gln Leu Asn Glu Ala Lys Thr Ala Ser
85 90 95
Gln Ile Asp Glu Ile Ile Lys Arg Ala Asn Glu Leu Asp Ser Lys Asp
100 105 110
Asn Lys Ser Ser His Thr Glu Met Asn Gly Gln Ser Asp Ile Asp Ser
115 120 125
Lys Leu Asp Gln Leu Leu Lys Asp Leu Asn Glu Val Ser Ser Asn Val
130 135 140
Asp Arg Gly Gln Gln Ser Gly Glu Asp Asp Leu Asn Ala Met Lys Asn
145 150 155 160
Asp Met Ser Gln Thr Ala Thr Thr Lys His Gly Glu Lys Asp Asp Lys
165 170 175
Asn Asp Glu Ala Met Val Asn Lys Ala Leu Glu Asp Leu Asp His Leu
180 185 190
Asn Gln Gln Ile His Lys Ser Lys Asp Ala Ser Lys Asp Thr Ser Glu
195 200 205
Asp Pro Ala Val Ser Thr Thr Asp Asn Asn His Glu Val Ala Lys Thr
210 215 220
Pro Asn Asn Asp Gly Ser Gly His Val Val Leu Asn Lys Phe Leu Ser
225 230 235 240
Asn Glu Glu Asn Gln Ser His Ser Asn Arg Leu Thr Asp Lys Leu Gln
245 250 255
Gly Ser Asp Lys Ile Asn His Ala Met Ile Glu Lys Leu Ala Lys Ser
260 265 270
Asn Ala Ser Thr Gln His Tyr Thr Tyr His Lys Leu Asn Thr Leu Gln
275 280 285
Ser Leu Asp Gln Arg Ile Ala Asn Thr Gln Leu Pro Lys Asn Gln Lys
290 295 300
Ser Asp Leu Met Ser Glu Val Asn Lys Thr Lys Glu Arg Ile Lys Ser
305 310 315 320
Gln Arg Asn Ile Ile Leu Glu Glu Leu Ala Arg Thr Asp Asp Lys Lys
325 330 335
Tyr Ala Thr Gln Ser Ile Leu Glu Ser Ile Phe Asn Lys Asp Glu Ala
340 345 350
Val Lys Ile Leu Lys Asp Ile Arg Val Asp Gly Lys Thr Asp Gln Gln
355 360 365
Ile Ala Asp Gln Ile Thr Arg His Ile Asp Gln Leu Ser Leu Thr Thr
370 375 380
Ser Asp Asp Leu Leu Thr Ser Leu Ile Asp Gln Ser Gln Asp Lys Ser
385 390 395 400
Leu Leu Ile Ser Gln Ile Leu Gln Thr Lys Leu Gly Lys Ala Glu Ala
405 410 415
Asp Lys Leu Ala Lys Asp Trp Thr Asn Lys Gly Leu Ser Asn Arg Gln
420 425 430
Ile Val Asp Gln Leu Lys Lys His Phe Ala Ser Thr Gly Asp Thr Ser
435 440 445
Ser Asp Asp Ile Leu Lys Ala Ile Leu Asn Asn Ala Lys Asp Lys Lys
450 455 460
Gln Ala Ile Glu Thr Ile Leu Ala Thr Arg Ile Glu Arg Gln Lys Ala
465 470 475 480
Lys Leu Leu Ala Asp Leu Ile Thr Lys Ile Glu Thr Asp Gln Asn Lys
485 490 495
Ile Phe Asn Leu Val Lys Ser Ala Leu Asn Gly Lys Ala Asp Asp Leu
500 505 510
Leu Asn Leu Gln Lys Arg Leu Asn Gln Thr Lys Lys Asp Ile Asp Tyr
515 520 525
Ile Leu Ser Pro Ile Val Asn Arg Pro Ser Leu Leu Asp Arg Leu Asn
530 535 540
Lys Asn Gly Lys Thr Thr Asp Leu Asn Lys Leu Ala Asn Leu Met Asn
545 550 555 560
Gln Gly Ser Asp Leu Leu Asp Ser Ile Pro Asp Ile Pro Thr Pro Lys
565 570 575
Pro Glu Lys Thr Leu Thr Leu Gly Lys Gly Asn Gly Leu Leu Ser Gly
580 585 590
Leu Leu Asn Ala Asp Gly Asn Val Ser Leu Pro Lys Ala Gly Glu Thr
595 600 605
Ile Lys Glu His Trp Leu Pro Ile Ser Val Ile Val Gly Ala Met Gly
610 615 620
Val Leu Met Ile Trp Leu Ser Arg Arg Asn Lys Leu Lys Asn Lys Ala
625 630 635 640
<210>17
<211>522
<212>PRT
<213>Staphylococcus epidermidis
<400>17
Ala Ser Glu Thr Pro Ile Thr Ser Glu Ile Ser Ser Asn Ser Glu Thr
1 5 10 15
Val Ala Asn Gln Asn Ser Thr Thr Ile Lys Asn Ser Gln Lys Glu Thr
20 25 30
Val Asn Ser Thr Ser Leu Glu Ser Asn His Ser Asn Ser Thr Asn Lys
35 40 45
Gln Met Ser Ser Glu Val Thr Asn Thr Ala Gln Ser Ser Glu Lys Ala
50 55 60
Gly Ile Ser Gln Gln Ser Ser Glu Thr Ser Asn Gln Ser Ser Lys Leu
65 70 75 80
Asn Thr Tyr Ala Ser Thr Asp His Val Glu Ser Thr Thr Ile Asn Asn
85 90 95
Asp Asn Thr Ala Gln Gln Asp Gln Asn Lys Ser Ser Asn Val Thr Ser
100 105 110
Lys Ser Thr Gln Ser Asn Thr Ser Ser Ser Glu Lys Asn Ile Ser Ser
115 120 125
Asn Leu Thr Gln Ser Ile Glu Thr Lys Ala Thr Asp Ser Leu Ala Thr
130 135 140
Ser Glu Ala Arg Thr Ser Thr Asn Gln Ile Ser Asn Leu Thr Ser Thr
145 150 155 160
Ser Thr Ser Asn Gln Ser Ser Pro Thr Ser Phe Ala Asn Leu Arg Thr
165 170 175
Phe Ser Arg Phe Thr Val Leu Asn Thr Met Ala Ala Pro Thr Thr Thr
180 185 190
Ser Thr Thr Thr Thr Ser Ser Leu Thr Ser Asn Ser Val Val Val Asn
195 200 205
Lys Asp Asn Phe Asn Glu His Met Asn Leu Ser Gly Ser Ala Thr Tyr
210 215 220
Asp Pro Lys Thr Gly Ile Ala Thr Leu Thr Pro Asp Ala Tyr Ser Gln
225 230 235 240
Lys Gly Ala Ile Ser Leu Asn Thr Arg Leu Asp Ser Asn Arg Ser Phe
245 250 255
Arg Phe Ile Gly Lys Val Asn Leu Gly Asn Arg Tyr Glu Gly Tyr Ser
260 265 270
Pro Asp Gly Val Ala Gly Gly Asp Gly Ile Gly Phe Ala Phe Ser Pro
275 280 285
Gly Pro Leu Gly Gln Ile Gly Lys Glu Gly Ala Ala Val Gly Ile Gly
290 295 300
Gly Leu Asn Asn Ala Phe Gly Phe Lys Leu Asp Thr Tyr His Asn Thr
305 310 315 320
Ser Thr Pro Arg Ser Asp Ala Lys Ala Lys Ala Asp Pro Arg Asn Val
325 330 335
Gly Gly Gly Gly Ala Phe Gly Ala Phe Val Ser Thr Asp Arg Asn Gly
340 345 350
Met Ala Thr Thr Glu Glu Ser Thr Ala Ala Lys Leu Asn Val Gln Pro
355 360 365
Thr Asp Asn Ser Phe Gln Asp Phe Val Ile Asp Tyr Asn Gly Asp Thr
370 375 380
Lys Val Met Thr Val Thr Tyr Ala Gly Gln Thr Phe Thr Arg Asn Leu
385 390 395 400
Thr Asp Trp Ile Lys Asn Ser Gly Gly Thr Thr Phe Ser Leu Ser Met
405 410 415
Thr Ala Ser Thr Gly Gly Ala Lys Asn Leu Gln Gln Val Gln Phe Gly
420 425 430
Thr Phe Glu Tyr Thr Glu Ser Ala Val Ala Lys Val Arg Tyr Val Asp
435 440 445
Ala Asn Thr Gly Lys Asp Ile Ile Pro Pro Lys Thr Ile Ala Gly Glu
450 455 460
Val Asp Gly Thr Val Asn Ile Asp Lys Gln Leu Asn Asn Phe Lys Asn
465 470 475 480
Leu Gly Tyr Ser Tyr Val Gly Thr Asp Ala Leu Lys Ala Pro Asn Tyr
485 490 495
Thr Glu Thr Ser Gly Thr Pro Thr Leu Lys Leu Thr Asn Ser Ser Gln
500 505 510
Thr Val Ile Tyr Lys Phe Lys Asp Val Gln
515 520
<210>18
<211>485
<212>PRT
<213>Staphylococcus epidermidis
<400>18
Ala Ser Asp Ala Pro Leu Thr Ser Glu Leu Asn Thr Gln Ser Glu Thr
1 5 10 15
Val Gly Asn Gln Asn Ser Thr Thr Ile Glu Ala Ser Thr Ser Thr Ala
20 25 30
Asp Ser Thr Ser Val Thr Lys Asn Ser Ser Ser Val Gln Thr Ser Asn
35 40 45
Ser Asp Thr Val Ser Ser Glu Lys Ser Glu Lys Val Thr Ser Thr Thr
50 55 60
Asn Ser Thr Ser Asn Gln Gln Glu Lys Leu Thr Ser Thr Ser Glu Ser
65 70 75 80
Thr Ser Ser Lys Asn Thr Thr Ser Ser Ser Asp Thr Lys Ser Val Ala
85 90 95
Ser Thr Ser Ser Thr Glu Gln Pro Ile Asn Thr Ser Thr Asn Gln Ser
100 105 110
Thr Ala Ser Asn Asn Thr Ser Gln Ser Thr Thr Pro Ser Ser Val Asn
115 120 125
Leu Asn Lys Thr Ser Thr Thr Ser Thr Ser Thr Ala Pro Val Lys Leu
130 135 140
Arg Thr Phe Ser Arg Leu Ala Met Ser Thr Phe Ala Ser Ala Ala Thr
145 150 155 160
Thr Thr Ala Val Thr Ala Asn Thr Ile Thr Val Asn Lys Asp Asn Leu
165 170 175
Lys Gln Tyr Met Thr Thr Ser Gly Asn Ala Thr Tyr Asp Gln Ser Thr
180 185 190
Gly Ile Val Thr Leu Thr Gln Asp Ala Tyr Ser Gln Lys Gly Ala Ile
195 200 205
Thr Leu Gly Thr Arg Ile Asp Ser Asn Lys Ser Phe His Phe Ser Gly
210 215 220
Lys Val Asn Leu Gly Asn Lys Tyr Glu Gly His Gly Asn Gly Gly Asp
225 230 235 240
Gly Ile Gly Phe Ala Phe Ser Pro Gly Val Leu Gly Glu Thr Gly Leu
245 250 255
Asn Gly Ala Ala Val Gly Ile Gly Gly Leu Ser Asn Ala Phe Gly Phe
260 265 270
Lys Leu Asp Thr Tyr His Asn Thr Ser Lys Pro Asn Ser Ala Ala Lys
275 280 285
Ala Asn Ala Asp Pro Ser Asn Val Ala Gly Gly Gly Ala Phe Gly Ala
290 295 300
Phe Val Thr Thr Asp Ser Tyr Gly Val Ala Thr Thr Tyr Thr Ser Ser
305 310 315 320
Ser Thr Ala Asp Asn Ala Ala Lys Leu Asn Val Gln Pro Thr Asn Asn
325 330 335
Thr Phe Gln Asp Phe Asp Ile Asn Tyr Asn Gly Asp Thr Lys Val Met
340 345 350
Thr Val Lys Tyr Ala Gly Gln Thr Trp Thr Arg Asn Ile Ser Asp Trp
355 360 365
Ile Ala Lys Ser Gly Thr Thr Asn Phe Ser Leu Ser Met Thr Ala Ser
370 375 380
Thr Gly Gly Ala Thr Asn Leu Gln Gln Val Gln Phe Gly Thr Phe Glu
385 390 395 400
Tyr Thr Glu Ser Ala Val Thr Gln Val Arg Tyr Val Asp Val Thr Thr
405 410 415
Gly Lys Asp Ile Ile Pro Pro Lys Thr Tyr Ser Gly Asn Val Asp Gln
420 425 430
Val Val Thr Ile Asp Asn Gln Gln Ser Ala Leu Thr Ala Lys Gly Tyr
435 440 445
Asn Tyr Thr Ser Val Asp Ser Ser Tyr Ala Ser Thr Tyr Asn Asp Thr
450 455 460
Asn Lys Thr Val Lys Met Thr Asn Ala Gly Gln Ser Val Thr Tyr Tyr
465 470 475 480
Phe Thr Asp Val Val
485
<210>19
<211>1245
<212>PRT
<213>Staphylococcus epidermidis
<400>19
Met Gly Lys Arg Arg Gln Gly Pro Ile Asn Lys Lys Val Asp Phe Leu
1 5 10 15
Pro Asn Lys Leu Asn Lys Tyr Ser Ile Arg Lys Phe Thr Val Gly Thr
20 25 30
Ala Ser Ile Leu Leu Gly Ser Thr Leu Ile Phe Gly Ser Ser Ser His
35 40 45
Glu Ala Lys Ala Ala Glu Glu Lys Gln Val Asp Pro Ile Thr Gln Ala
50 55 60
Asn Gln Asn Asp Ser Ser Glu Arg Ser Leu Glu Asn Thr Asn Gln Pro
65 70 75 80
Thr Val Asn Asn Glu Ala Pro Gln Met Ser Ser Thr Leu Gln Ala Glu
85 90 95
Glu Gly Ser Asn Ala Glu Ala Pro Gln Ser Glu Pro Thr Lys Ala Glu
100 105 110
Glu Gly Gly Asn Ala Glu Ala Ala Gln Ser Glu Pro Thr Lys Ala Glu
115 120 125
Glu Gly Gly Asn Ala Glu Ala Pro Gln Ser Glu Pro Thr Lys Ala Glu
130 135 140
Glu Gly Gly Asn Ala Glu Ala Ala Gln Ser Glu Pro Thr Lys Thr Glu
145 150 155 160
Glu Gly Ser Asn Val Lys Ala Ala Gln Ser Glu Pro Thr Lys Ala Glu
165 170 175
Glu Gly Ser Asn Ala Glu Ala Pro Gln Ser Glu Pro Thr Lys Thr Glu
180 185 190
Glu Gly Ser Asn Ala Lys Ala Ala Gln Ser Glu Pro Thr Lys Ala Glu
195 200 205
Glu Gly Gly Asn Ala Glu Ala Ala Gln Ser Glu Pro Thr Lys Thr Glu
210 215 220
Glu Gly Ser Asn Ala Glu Ala Pro Gln Ser Glu Pro Thr Lys Ala Glu
225 230 235 240
Glu Gly Gly Asn Ala Glu Ala Pro Gln Ser Glu Pro Thr Lys Thr Glu
245 250 255
Glu Gly Gly Asn Ala Glu Ala Pro Asn Val Pro Thr Ile Lys Ala Asn
260 265 270
Ser Asp Asn Asp Thr Gln Thr Gln Phe Ser Glu Ala Pro Thr Arg Asn
275 280 285
Asp Leu Ala Arg Lys Glu Asp Ile Pro Ala Val Ser Lys Asn Glu Glu
290 295 300
Leu Gln Ser Ser Gln Pro Asn Thr Asp Ser Lys Ile Glu Pro Thr Thr
305 310 315 320
Ser Glu Pro Val Asn Leu Asn Tyr Ser Ser Pro Phe Met Ser Leu Leu
325 330 335
Ser Met Pro Ala Asp Ser Ser Ser Asn Asn Thr Lys Asn Thr Ile Asp
340 345 350
Ile Pro Pro Thr Thr Val Lys Gly Arg Asp Asn Tyr Asp Phe Tyr Gly
355 360 365
Arg Val Asp Ile Glu Ser Asn Pro Thr Asp Leu Asn Ala Thr Asn Leu
370 375 380
Thr Arg Tyr Asn Tyr Gly Gln Pro Pro Gly Thr Thr Thr Ala Gly Ala
385 390 395 400
Val Gln Phe Lys Asn Gln Val Ser Phe Asp Lys Asp Phe Asp Phe Asn
405 410 415
Ile Arg Val Ala Asn Asn Arg Gln Ser Asn Thr Thr Gly Ala Asp Gly
420 425 430
Trp Gly Phe Met Phe Ser Lys Lys Asp Gly Asp Asp Phe Leu Lys Asn
435 440 445
Gly Gly Ile Leu Arg Glu Lys Gly Thr Pro Ser Ala Ala Gly Phe Arg
450 455 460
Ile Asp Thr Gly Tyr Tyr Asn Asn Asp Pro Leu Asp Lys Ile Gln Lys
465 470 475 480
Gln Ala Gly Gln Gly Tyr Arg Gly Tyr Gly Thr Phe Val Lys Asn Asp
485 490 495
Ser Gln Gly Asn Thr Ser Lys Val Gly Ser Gly Thr Pro Ser Thr Asp
500 505 510
Phe Leu Asn Tyr Ala Asp Asn Thr Thr Asn Asp Leu Asp Gly Lys Phe
515 520 525
His Gly Gln Lys Leu Asn Asn Val Asn Leu Lys Tyr Asn Ala Ser Asn
530 535 540
Gln Thr Phe Thr Ala Thr Tyr Ala Gly Lys Thr Trp Thr Ala Thr Leu
545 550 555 560
Ser Glu Leu Gly Leu Ser Pro Thr Asp Ser Tyr Asn Phe Leu Val Thr
565 570 575
Ser Ser Gln Tyr Gly Asn Gly Asn Ser Gly Thr Tyr Ala Ser Gly Val
580 585 590
Met Arg Ala Asp Leu Asp Gly Ala Thr Leu Thr Tyr Thr Pro Lys Ala
595 600 605
Val Asp Gly Asp Pro Ile Ile Ser Thr Lys Glu Ile Pro Phe Asn Lys
610 615 620
Lys Arg Glu Phe Asp Pro Asn Leu Ala Pro Gly Thr Glu Lys Val Val
625 630 635 640
Gln Lys Gly Glu Pro Gly Ile Glu Thr Thr Thr Thr Pro Thr Tyr Val
645 650 655
Asn Pro Asn Thr Gly Glu Lys Val Gly Glu Gly Glu Pro Thr Glu Lys
660 665 670
Ile Thr Lys Gln Pro Val Asp Glu Ile Val His Tyr Gly Gly Glu Glu
675 680 685
Ile Lys Pro Gly His Lys Asp Glu Phe Asp Pro Asn Ala Pro Lys Gly
690 695 700
Ser Gln Thr Thr Gln Pro Gly Lys Pro Gly Val Lys Asn Pro Asp Thr
705 710 715 720
Gly Glu Val Val Thr Pro Pro Val Asp Asp Val Thr Lys Tyr Gly Pro
725 730 735
Val Asp Gly Asp Pro Ile Thr Ser Thr Glu Glu Ile Pro Phe Asp Lys
740 745 750
Lys Arg Glu Phe Asn Pro Asp Leu Lys Pro Gly Glu Glu Arg Val Lys
755 760 765
Gln Lys Gly Glu Pro Gly Thr Lys Thr Ile Thr Thr Pro Thr Thr Lys
770 775 780
Asn Pro Leu Thr Gly Glu Lys Val Gly Glu Gly Glu Pro Thr Glu Lys
785 790 795 800
Ile Thr Lys Gln Pro Val Asp Glu Ile Thr Glu Tyr Gly Gly Glu Glu
805 810 815
Ile Lys Pro Gly His Lys Asp Glu Phe Asp Pro Asn Ala Pro Lys Gly
820 825 830
Ser Gln Glu Asp Val Pro Gly Lys Pro Gly Val Lys Asn Pro Gly Thr
835 840 845
Gly Glu Val Val Thr Pro Pro Val Asp Asp Val Thr Lys Tyr Gly Pro
850 855 860
Val Asp Gly Asp Pro Ile Thr Ser Thr Glu Glu Ile Pro Phe Asp Lys
865 870 875 880
Lys Arg Glu Phe Asn Pro Asp Leu Lys Pro Gly Glu Glu Arg Val Lys
885 890 895
Gln Lys Gly Glu Pro Gly Thr Lys Thr Ile Thr Thr Pro Thr Thr Lys
900 905 910
Asn Pro Leu Thr Gly Glu Lys Val Gly Glu Gly Glu Pro Thr Glu Lys
915 920 925
Ile Thr Lys Gln Pro Val Asp Glu Ile Val His Tyr Gly Gly Glu Gln
930 935 940
Ile Pro Gln Gly His Lys Asp Glu Phe Asp Pro Asn Ala Pro Val Asp
945 950 955 960
Ser Lys Thr Glu Val Pro Gly Lys Pro Gly Val Lys Asn Pro Asp Thr
965 970 975
Gly Glu Val Val Thr Pro Pro Val Asp Asp Val Thr Lys Tyr Gly Pro
980 985 990
Val Asp Gly Asp Ser Ile Thr Ser Thr Glu Glu Ile Pro Phe Asp Lys
995 1000 1005
Lys Arg Glu Phe Asp Pro Asn Leu Ala Pro Gly Thr Glu Lys Val
1010 1015 1020
Val Gln Lys Gly Glu Pro Gly Thr Lys Thr Ile Thr Thr Pro Thr
1025 1030 1035
Thr Lys Asn Pro Leu Thr Gly Glu Lys Val Gly Glu Gly Lys Ser
1040 1045 1050
Thr Glu Lys Val Thr Lys Gln Pro Val Asp Glu Ile Val Glu Tyr
1055 1060 1065
Gly Pro Thr Lys Ala Glu Pro Gly Lys Pro Ala Glu Pro Gly Lys
1070 1075 1080
Pro Ala Glu Pro Gly Lys Pro Ala Glu Pro Gly Thr Pro Ala Glu
1085 1090 1095
Pro Gly Lys Pro Ala Glu Pro Gly Thr Pro Ala Glu Pro Gly Lys
1100 1105 1110
Pro Ala Glu Pro Gly Lys Pro Ala Glu Pro Gly Lys Pro Ala Glu
1115 1120 1125
Pro Gly Lys Pro Ala Glu Pro Gly Thr Pro Ala Glu Pro Gly Thr
1130 1135 1140
Pro Ala Glu Pro Gly Lys Pro Ala Glu Pro Gly Thr Pro Ala Glu
1145 1150 1155
Pro Gly Lys Pro Ala Glu Pro Gly Thr Pro Ala Glu Pro Gly Lys
1160 1165 1170
Pro Ala Glu Ser Gly Lys Pro Val Glu Pro Gly Thr Pro Ala Gln
1175 1180 1185
Ser Gly Ala Pro Glu Gln Pro Asn Arg Ser Met His Ser Thr Asp
1190 1195 1200
Asn Lys Asn Gln Leu Pro Asp Thr Gly Glu Asn Arg Gln Ala Asn
1205 1210 1215
Glu Gly Thr Leu Val Gly Ser Leu Leu Ala Ile Val Gly Ser Leu
1220 1225 1230
Phe Ile Phe Gly Arg Arg Lys Lys Gly Asn Glu Lys
1235 1240 1245
<210>20
<211>3765
<212>DNA
<213>Staphylococcus epidermidis
<400>20
atgggcaaac gtagacaagg tcctattaat aaaaaagtgg attttttacc taacaaatta 60
aacaagtatt ctataagaaa attcactgtt ggtacggcct caatattact tggttcgaca 120
cttatttttg gaagtagtag ccatgaagcg aaagctgcag aagaaaaaca agttgatcca 180
attacacaag ctaatcaaaa tgatagtagt gaaagatcac ttgaaaacac aaatcaacct 240
actgtaaaca atgaagcacc acagatgtct tctacattgc aagcagaaga aggaagcaat 300
gcagaagcac ctcaatctga gccaacgaag gcagaagaag gaggcaatgc agaagcagct 360
caatctgagc caacgaaggc agaagaagga ggcaatgcag aagcacctca atctgagcca 420
acgaaggcag aagaaggagg caatgcagaa gcagctcaat ctgagccaac gaagacagaa 480
gaaggaagca acgtaaaagc agctcaatct gagccaacga aggcagaaga aggaagcaat 540
gcagaagcac ctcaatctga gccaacgaag acagaagaag gaagcaacgc aaaagcagct 600
caatctgagc caacgaaggc agaagaagga ggcaatgcag aagcagctca atctgagcca 660
acgaagacag aagaaggaag caatgcagaa gcacctcaat ctgagccaac gaaggcagaa 720
gaaggaggca atgcagaagc acctcaatct gagccaacga agacagaaga aggaggcaat 780
gcagaagcac cgaatgttcc aactatcaaa gctaattcag ataatgatac acaaacacaa 840
ttttcagaag cccctacaag aaatgaccta gctagaaaag aagatatccc tgctgtttct 900
aaaaacgagg aattacaatc atcacaacca aacactgaca gtaaaataga acctacaact 960
tcagaacctg tgaatttaaa ttatagttct ccgtttatgt ccttattaag catgcctgct 1020
gatagttcat ccaataacac taaaaataca atagatatac cgccaactac ggttaaaggt 1080
agagataatt acgattttta cggtagagta gatatcgaaa gtaatcctac agatttaaat 1140
gcgacaaatt taacgagata taattatgga cagccacctg gtacaacaac agctggtgca 1200
gttcaattta aaaatcaagt tagttttgat aaagatttcg actttaacat tagagtagca 1260
aacaatcgtc aaagtaatac aactggtgca gatggttggg gctttatgtt cagcaagaaa 1320
gatggggatg atttcctaaa aaacggtggt atcttacgtg aaaaaggtac acctagtgca 1380
gctggtttca gaattgatac aggatattat aataacgatc cattagataa aatacagaaa 1440
caagctggtc aaggctatag agggtatggg acatttgtta aaaatgactc ccaaggtaat 1500
acttctaaag taggatcagg tactccatca acagattttc ttaactacgc agataatact 1560
actaatgatt tagatggtaa attccatggt caaaaattaa ataatgttaa tttgaaatat 1620
aatgcttcaa atcaaacttt tacagctact tatgctggta aaacttggac ggctacgtta 1680
tctgaattag gattgagtcc aactgatagt tacaattttt tagttacatc aagtcaatat 1740
ggaaatggta atagtggtac atacgcaagt ggcgttatga gagctgattt agatggtgca 1800
acattgacat acactcctaa agcagtcgat ggagatccaa ttatatcaac taaggaaata 1860
ccatttaata agaaacgtga atttgatcca aacttagccc caggtacaga aaaagtagtc 1920
caaaaaggtg aaccaggaat tgaaacaaca acaacaccaa cttatgtcaa tcctaataca 1980
ggagaaaaag ttggcgaagg tgaaccaaca gaaaaaataa caaaacaacc agtggatgaa 2040
atcgttcatt atggtggcga agaaatcaag ccaggccata aggatgaatt tgatccaaat 2100
gcaccgaaag gtagtcaaac aacgcaacca ggtaagccgg gggttaaaaa tcctgataca 2160
ggcgaagtag ttactccacc tgtggatgat gtgacaaaat atggtccagt tgatggagat 2220
ccgatcacgt caacggaaga aattccattc gacaagaaac gtgaattcaa tcctgattta 2280
aaaccaggtg aagagcgtgt taaacaaaaa ggtgaaccag gaacaaaaac aattacaaca 2340
ccaacaacta agaacccatt aacaggggaa aaagttggcg aaggtgaacc aacagaaaaa 2400
ataacaaaac aaccagtaga tgaaatcaca gaatatggtg gcgaagaaat caagccaggc 2460
cataaggatg aatttgatcc aaatgcaccg aaaggtagcc aagaggacgt tccaggtaaa 2520
ccaggagtta aaaaccctgg aacaggcgaa gtagtcacac caccagtgga tgatgtgaca 2580
aaatatggtc cagttgatgg agatccgatc acgtcaacgg aagaaattcc attcgacaag 2640
aaacgtgaat tcaatcctga tttaaaacca ggtgaagagc gcgttaaaca gaaaggtgaa 2700
ccaggaacaa aaacaattac aacgccaaca actaagaacc cattaacagg agaaaaagtt 2760
ggcgaaggtg aaccaacaga aaaaataaca aaacaaccag tggatgagat tgttcattat 2820
ggtggtgaac aaataccaca aggtcataaa gatgaatttg atccaaatgc acctgtagat 2880
agtaaaactg aagttccagg taaaccagga gttaaaaatc ctgatacagg tgaagttgtt 2940
accccaccag tggatgatgt gacaaaatat ggtccagttg atggagattc gattacgtca 3000
acggaagaaa ttccgtttga taaaaaacgc gaatttgatc caaacttagc gccaggtaca 3060
gagaaagtcg ttcaaaaagg tgaaccagga acaaaaacaa ttacaacgcc aacaactaag 3120
aacccattaa caggagaaaa agttggcgaa ggtaaatcaa cagaaaaagt cactaaacaa 3180
cctgttgacg aaattgttga gtatggtcca acaaaagcag aaccaggtaa accagcggaa 3240
ccaggtaaac cagcggaacc aggtaaacca gcggaaccag gtacgccagc agaaccaggt 3300
aaaccagcgg aaccaggtac gccagcagaa ccaggtaaac cagcggaacc aggtaaacca 3360
gcggaaccag gtaaaccagc ggaaccaggt aaaccagcgg aaccaggtac gccagcagaa 3420
ccaggtacgc cagcagaacc aggtaaacca gcggaaccag gtacgccagc agaaccaggt 3480
aaaccagcgg aaccaggtac gccagcagaa ccaggtaaac cagcggaatc aggtaaacca 3540
gtggaaccag gtacgccagc acaatcaggt gcaccagaac aaccaaatag atcaatgcat 3600
tcaacagata ataaaaatca attacctgat acaggtgaaa atcgtcaagc taatgaggga 3660
actttagtcg gatctctatt agcaattgtc ggatcattgt tcatatttgg tcgtcgtaaa 3720
aaaggtaatg aaaaataatt tcatataaaa actttctgcc attaa 3765
<210>21
<211>546
<212>PRT
<213>Staphylococcus epidermidis
<400>21
Glu Lys Gln Val Asp Pro Ile Thr Gln Ala Asn Gln Asn Asp Ser Ser
1 5 10 15
Glu Arg Ser Leu Glu Asn Thr Asn Gln Pro Thr Val Asn Asn Glu Ala
20 25 30
Pro Gln Met Ser Ser Thr Leu Gln Ala Glu Glu Gly Ser Asn Ala Glu
35 40 45
Ala Pro Gln Ser Glu Pro Thr Lys Ala Glu Glu Gly Gly Asn Ala Glu
50 55 60
Ala Ala Gln Ser Glu Pro Thr Lys Ala Glu Glu Gly Gly Asn Ala Glu
65 70 75 80
Ala Pro Gln Ser Glu Pro Thr Lys Ala Glu Glu Gly Gly Asn Ala Glu
85 90 95
Ala Ala Gln Ser Glu Pro Thr Lys Thr Glu Glu Gly Ser Asn Val Lys
100 105 110
Ala Ala Gln Ser Glu Pro Thr Lys Ala Glu Glu Gly Ser Asn Ala Glu
115 120 125
Ala Pro Gln Ser Glu Pro Thr Lys Thr Glu Glu Gly Ser Asn Ala Lys
130 135 140
Ala Ala Gln Ser Glu Pro Thr Lys Ala Glu Glu Gly Gly Asn Ala Glu
145 150 155 160
Ala Ala Gln Ser Glu Pro Thr Lys Thr Glu Glu Gly Ser Asn Ala Glu
165 170 175
Ala Pro Gln Ser Glu Pro Thr Lys Ala Glu Glu Gly Gly Asn Ala Glu
180 185 190
Ala Pro Gln Ser Glu Pro Thr Lys Thr Glu Glu Gly Gly Asn Ala Glu
195 200 205
Ala Pro Asn Val Pro Thr Ile Lys Ala Asn Ser Asp Asn Asp Thr Gln
210 215 220
Thr Gln Phe Ser Glu Ala Pro Thr Arg Asn Asp Leu Ala Arg Lys Glu
225 230 235 240
Asp Ile Pro Ala Val Ser Lys Asn Glu Glu Leu Gln Ser Ser Gln Pro
245 250 255
Asn Thr Asp Ser Lys Ile Glu Pro Thr Thr Ser Glu Pro Val Asn Leu
260 265 270
Asn Tyr Ser Ser Pro Phe Met Ser Leu Leu Ser Met Pro Ala Asp Ser
275 280 285
Ser Ser Asn Asn Thr Lys Asn Thr Ile Asp Ile Pro Pro Thr Thr Val
290 295 300
Lys Gly Arg Asp Asn Tyr Asp Phe Tyr Gly Arg Val Asp Ile Glu Ser
305 310 315 320
Asn Pro Thr Asp Leu Asn Ala Thr Asn Leu Thr Arg Tyr Asn Tyr Gly
325 330 335
Gln Pro Pro Gly Thr Thr Thr Ala Gly Ala Val Gln Phe Lys Asn Gln
340 345 350
Val Ser Phe Asp Lys Asp Phe Asp Phe Asn Ile Arg Val Ala Asn Asn
355 360 365
Arg Gln Ser Asn Thr Thr Gly Ala Asp Gly Trp Gly Phe Met Phe Ser
370 375 380
Lys Lys Asp Gly Asp Asp Phe Leu Lys Asn Gly Gly Ile Leu Arg Glu
385 390 395 400
Lys Gly Thr Pro Ser Ala Ala Gly Phe Arg Ile Asp Thr Gly Tyr Tyr
405 410 415
Asn Asn Asp Pro Leu Asp Lys Ile Gln Lys Gln Ala Gly Gln Gly Tyr
420 425 430
Arg Gly Tyr Gly Thr Phe Val Lys Asn Asp Ser Gln Gly Asn Thr Ser
435 440 445
Lys Val Gly Ser Gly Thr Pro Ser Thr Asp Phe Leu Asn Tyr Ala Asp
450 455 460
Asn Thr Thr Asn Asp Leu Asp Gly Lys Phe His Gly Gln Lys Leu Asn
465 470 475 480
Asn Val Asn Leu Lys Tyr Asn Ala Ser Asn Gln Thr Phe Thr Ala Thr
485 490 495
Tyr Ala Gly Lys Thr Trp Thr Ala Thr Leu Ser Glu Leu Gly Leu Ser
500 505 510
Pro Thr Asp Ser Tyr Asn Phe Leu Val Thr Ser Ser Gln Tyr Gly Asn
515 520 525
Gly Asn Ser Gly Thr Tyr Ala Ser Gly Val Met Arg Ala Asp Leu Asp
530 535 540
Gly Ala
545
<210>22
<211>36
<212>PRT
<213>Staphylococcus aureus
<400>22
Leu Pro Asn Thr Gly Ser Glu Glu Met Asp Leu Pro Leu Lys Glu Leu
1 5 10 15
Ala Leu IIe Thr Gly Ala Ala Leu Leu Ala Arg Arg Arg Ser Lys Lys
20 25 30
Glu Lys Glu Ser
35
<210>23
<211>43
<212>PRT
<213>Staphylococcus aureus
<400>23
Leu Pro Asp Thr Gly Asp Ser Ile Lys Gln Asn Gly Leu Leu Gly Gly
1 5 10 15
Val Met Thr Leu Leu Val Gly Leu Gly Leu Met Lys Arg Lys Lys Lys
20 25 30
Lys Asp Glu Asn Asp Gln Asp Asp Ser Gln Ala
35 40
<210>24
<211>35
<212>PRT
<213>Staphylococcus aureus
<400>24
Leu Pro Lys Thr Gly Glu Thr Thr Ser Ser Gln Ser Trp Trp Gly Leu
1 5 10 15
Tyr Ala Leu Leu Gly Met Leu Ala Leu Phe Ile Pro Lys Phe Arg Lys
20 25 30
Glu Ser Lys
35
<210>25
<211>38
<212>PRT
<213>Staphylococcus aureus
<400>25
Leu Pro Lys Thr Gly Leu Thr Ser Val Asp Asn Phe Ile Ser Thr Val
1 5 10 15
Ala Phe Ala Thr Leu Ala Leu Leu Gly Ser Leu Ser Leu Leu Leu Phe
20 25 30
Lys Arg Lys Glu Ser Lys
35
<210>26
<211>36
<212>PRT
<213>Staphylococcus aureus
<400>26
Leu Pro Gln Thr Gly Glu Glu Ser Asn Lys Asp Met Thr Leu Pro Leu
1 5 10 15
Met Ala Leu Ile Ala Leu Ser Ser Ile Val Ala Phe Val Leu Pro Arg
20 25 30
Lys Arg Lys Asn
35
<210>27
<211>34
<212>PRT
<213>Staphylococcus aureus
<400>27
Leu Pro Lys Thr Gly Thr Asn Gln Ser Ser Ser Pro Glu Ala Met Phe
1 5 10 15
Val Leu Leu Ala Gly Ile Gly Leu Ile Ala Thr Val Arg Arg Arg Lys
20 25 30
Ala Ser
<210>28
<211>33
<212>PRT
<213>Staphylococcus aureus
<400>28
Leu Pro Lys Thr Gly Leu Glu Ser Thr Gln Lys Gly Leu Ile Phe Ser
1 5 10 15
Ser Ile Ile Gly Ile Ala Gly Leu Met Leu Leu Ala Arg Arg Arg Lys
20 25 30
Asn
<210>29
<211>39
<212>PRT
<213>Staphylococcus aureus
<400>29
Leu Pro Lys Ala Gly Glu Thr Ile Lys Glu His Trp Leu Pro Ile Ser
1 5 10 15
Val Ile Val Gly Ala Met Gly Val Leu Met Ile Trp Leu Ser Arg Arg
20 25 30
Asn Lys Leu Lys Asn Lys Ala
35
Claims (22)
1.一种分离的抗体,其与葡萄球菌的表面蛋白质结合,所述蛋白质选自于下列组:SEQ ID NOS.2、4、6、8、10、12、14、16、17、18、19和21。
2.根据权利要求1所述的抗体,其中抗体针对所述表面蛋白质的A区域。
3.根据权利要求1所述的抗体,其中抗体用于治疗或预防人类或动物的金黄色葡萄球菌感染。
4.根据权利要求1所述的抗体,其中抗体适用于人类或动物的非肠道的,口部的,鼻内的,皮下的,aerosolized或静脉内的给药。
5.根据权利要求1所述的抗体,其中所述的抗体是单克隆抗体。
6.根据权利要求1所述的抗体,其中所述的抗体是多克隆抗体。
7.根据权利要求5所述的抗体,其中单克隆抗体是一种选自于下列组的类型:鼠的,嵌合的,人性化的,和人的单克隆抗体。
8.根据权利要求5所述的抗体,其中抗体是一种单链单克隆抗体。
9.根据权利要求1所述的抗体,它包括具有类似于一种抗体的结合特异性的抗体片段,所述的抗体结合到具有选自于下列组:SEQ ID NOS.2、4、6、8、10、12、14、16、17、18、19和21的序列的葡萄球菌的表面蛋白质。
10.根据权利要求1所述的抗体,它针对具有选自于下列组:SEQID NOS.2、4、6、8、10、12、14、16、17、18、19和21的氨基酸序列的蛋白质。
11.根据权利要求1所述的抗体,其中所述的表面蛋白质具有由选自于下列组的核酸序列SEQ ID NOS.1、3、5、7、9、11、13、15、20和编码Aap蛋白质的A区域或其简并序列的核酸序列编码的一个氨基酸序列的核酸序列。
12.含有权利要求1的抗体的分离的抗血清。
13.一种诊断试剂盒,包括权利要求1的抗体和用于检测该抗体引起的结合的工具。
14.根据权利要求13所述的诊断试剂盒,其中所述的用于检测结合的工具包括连接到所述的抗体的一种可检测标记物。
15.一种用于诊断金黄色葡萄球菌感染的方法,包括将权利要求1的抗体加入到被怀疑感染了金黄色葡萄球菌的样品中,测定抗体是否已经结合到该样品。
16.一种用于治疗或预防金黄色葡萄球菌感染的药物组合物,包括有效量的权利要求1的抗体和药学的可接受的介质,载体或赋形剂。
17.一种治疗或预防金黄色葡萄球菌感染的方法,包括将有效量的权利要求1的抗体给人或动物患者给药。
18.一种诱导免疫应答的方法,包括以致免疫量的选自于下列组:SEQ ID NOS.2、4、6、8、10、12、14、16、17、18、19和21的氨基酸序列的分离的蛋白质给人类或动物给药。
19.根据权利要求1所述的分离的抗体,它具有结合到由SEQ IDNOS.1、3、5、7、9、11、13、15、20的核酸序列和编码Aap蛋白质的A区域的核酸序列或其简并序列编码的氨基酸序列的能力。
20.一种来自DsqA蛋白质的A区域的分离的活性片段。
21.根据权利要求1所述的分离的抗体,进一步包括生理学上的可接受的抗生素。
22.一种用于治疗或预防金黄色葡萄球菌感染的疫苗,包括选自于下列组SEQ ID NOS.2、4、6、8、10、12、14、16、17、18、19和21的蛋白质序列,和一种药学的可接受的介质,载体或赋形剂,所述的蛋白质的量可有效地激发免疫应答。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29809801P | 2001-06-15 | 2001-06-15 | |
US60/298,098 | 2001-06-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1543569A true CN1543569A (zh) | 2004-11-03 |
CN100359327C CN100359327C (zh) | 2008-01-02 |
Family
ID=23149018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB028160010A Expired - Fee Related CN100359327C (zh) | 2001-06-15 | 2002-06-17 | 识别凝血酶阴性的葡萄球菌和金黄色葡萄球菌的表面蛋白的交叉反应性单克隆抗体和多克隆抗体 |
Country Status (9)
Country | Link |
---|---|
US (3) | US6841154B2 (zh) |
EP (3) | EP2339344A1 (zh) |
JP (2) | JP4424984B2 (zh) |
CN (1) | CN100359327C (zh) |
AU (2) | AU2002322127B2 (zh) |
CA (1) | CA2450939C (zh) |
HK (1) | HK1068949A1 (zh) |
MX (1) | MXPA03011701A (zh) |
WO (1) | WO2002102829A2 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102649817A (zh) * | 2011-02-24 | 2012-08-29 | 复旦大学 | 一种抑制细菌生物膜形成的单克隆抗体 |
CN104098693A (zh) * | 2014-07-15 | 2014-10-15 | 中国人民解放军军事医学科学院生物工程研究所 | 抗金黄色葡萄球菌SasA抗原的单克隆抗体及其应用 |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020092987A1 (en) * | 1998-09-05 | 2002-07-18 | Taehee Cho | Photo detect device using quantum dots and materialization method thereof |
AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
CA2808598A1 (en) * | 2001-08-02 | 2003-02-13 | University Of Sheffield | Antigenic polypeptides |
CA2484335A1 (en) * | 2002-10-03 | 2004-04-15 | Intercell Ag | Use of molecules which interact with the haptoglobin receptor ligand binding |
AU2004220590B2 (en) * | 2003-03-07 | 2010-02-18 | Inhibitex, Inc. | Polysaccharide - Staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
ATE457737T1 (de) * | 2003-07-24 | 2010-03-15 | Merck & Co Inc | Polypeptide zur induktion einer schützenden immunantwort gegen staphylococcus aureus |
AU2005214061B2 (en) * | 2004-02-18 | 2010-02-04 | Merck Sharp & Dohme Corp. | Polypeptides for inducing a protective immune response against Staphylococcus aureus |
WO2005086663A2 (en) * | 2004-02-27 | 2005-09-22 | Merck & Co., Inc. | Polypeptides for inducing a protective immune response against staphlococcus aureus |
US20080095792A1 (en) * | 2004-09-17 | 2008-04-24 | Anderson Annaliesa S | Polypeptides For Inducing A Protective Immune Response Against Staphylococcus Aureus |
EP2305294B1 (en) * | 2004-09-22 | 2015-04-01 | GlaxoSmithKline Biologicals SA | Immunogenic composition for use in vaccination against staphylococcei |
JP2008517900A (ja) * | 2004-10-25 | 2008-05-29 | ザ ユニバーシティ オブ ウェスタン オンタリオ | スタフィロコッカス−アウレウスIsdたんぱく質ベースの抗感染薬 |
EP1853306B1 (en) | 2005-02-14 | 2016-06-15 | Epitopix, LLC | Polypeptides from staphylococcus aureus and methods of use |
WO2006138627A2 (en) * | 2005-06-16 | 2006-12-28 | Inhibitex, Inc. | Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein |
AU2007281934B2 (en) * | 2006-01-18 | 2012-11-15 | University Of Chicago | Compositions and methods related to Staphylococcal bacterium proteins |
AU2007221321B2 (en) * | 2006-02-22 | 2012-06-28 | The Texas A & M University System | Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use |
US7488807B2 (en) * | 2006-11-22 | 2009-02-10 | 3M Innovative Properties Company | Antibody with protein A selectivity |
EP2089533A2 (en) * | 2006-11-22 | 2009-08-19 | 3M Innovative Properties Company | Methods of capturing bacterial whole cells and methods of analyzing samples for bacteria |
US20100047252A1 (en) * | 2006-11-22 | 2010-02-25 | 3M Innovative Properties Company | Antibody with protein a selectivity |
CN105367656A (zh) | 2007-08-31 | 2016-03-02 | 芝加哥大学 | 与针对葡萄球菌性肺部疾病和病症进行免疫相关的方法和组合物 |
US9181329B2 (en) | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
PT2268618E (pt) | 2008-03-03 | 2015-10-12 | Novartis Ag | Compostos e composições moduladores da actividade tlr |
WO2010014304A1 (en) * | 2008-07-29 | 2010-02-04 | University Of Chicago | Compositions and methods related to staphylococcal bacterium proteins |
KR20120005471A (ko) | 2009-03-23 | 2012-01-16 | 이피토픽스, 엘엘씨 | 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법 |
PT3281947T (pt) | 2009-04-03 | 2020-05-07 | Univ Chicago | Composições e métodos relacionados com variantes da proteína a (spa) |
AU2010258677B2 (en) | 2009-06-10 | 2016-10-06 | Glaxosmithkline Biologicals S.A. | Benzonaphthyridine-containing vaccines |
SG10201707084SA (en) | 2009-06-22 | 2017-10-30 | Wyeth Llc | Immunogenic compositions of staphylococcus aureus antigens |
JP5988492B2 (ja) | 2009-09-02 | 2016-09-07 | ノバルティス アーゲー | Tlr活性モジュレーターを含む免疫原性組成物 |
TWI445708B (zh) | 2009-09-02 | 2014-07-21 | Irm Llc | 作為tlr活性調節劑之化合物及組合物 |
WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
WO2011084549A1 (en) | 2009-12-15 | 2011-07-14 | Novartis Ag | Homogeneous suspension of immunopotentiating compounds and uses thereof |
WO2011119759A1 (en) | 2010-03-23 | 2011-09-29 | Irm Llc | Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
CN102268444B (zh) * | 2010-06-03 | 2015-05-13 | 中国人民解放军军事医学科学院生物工程研究所 | 金黄色葡萄球菌截短SasA蛋白在大肠杆菌中的表达及应用 |
SG186290A1 (en) | 2010-07-02 | 2013-01-30 | Univ Chicago | Compositions and methods related to protein a (spa) variants |
US9192661B2 (en) | 2010-07-06 | 2015-11-24 | Novartis Ag | Delivery of self-replicating RNA using biodegradable polymer particles |
RU2570730C2 (ru) | 2010-12-22 | 2015-12-10 | УАЙТ ЭлЭлСи | Стабильные иммуногенные композиции антигенов staphylococcus aureus |
US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
BR112015018014A2 (pt) | 2013-02-01 | 2017-07-11 | Glaxosmithkline Biologicals Sa | liberação intradérmica de composições imunológicas compreendendo agonistas do receptor do tipo toll |
WO2016095832A1 (en) * | 2014-12-18 | 2016-06-23 | The University Of Hong Kong | Immunotherapeutic targets against staphylococcus aureus |
US11446371B2 (en) | 2015-11-05 | 2022-09-20 | The Texas A&M University System | Targeting of ligand binding sites in ClfA |
US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
CA3090271A1 (en) | 2018-02-12 | 2019-08-15 | Inimmune Corporation | Toll-like receptor ligands |
KR20230117105A (ko) | 2020-11-04 | 2023-08-07 | 엘리고 바이오사이언스 | 큐티박테리움 아크네스 재조합 파지, 그의 제조 방법 및 용도 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US519596A (en) | 1894-05-08 | Tian voigt | ||
JPS4954801A (zh) | 1972-09-27 | 1974-05-28 | ||
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
US5981216A (en) | 1985-04-01 | 1999-11-09 | Alusuisse Holdings A.G. | Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
US5571514A (en) | 1987-06-01 | 1996-11-05 | Alfa Laval Ab | Fibronectin binding protein as well as its preparation |
US5320951A (en) | 1987-06-01 | 1994-06-14 | Hoeoek Magnus | Fibronectin binding protein as well as its preparation |
SE8801894D0 (sv) | 1988-05-20 | 1988-05-20 | Alfa Laval Agri Int | Fibronektinbindande protein |
US5789549A (en) | 1988-05-20 | 1998-08-04 | Alfa Laval Agri International Aktiebolag | Fibronectin binding protein |
SE8901687D0 (sv) | 1989-05-11 | 1989-05-11 | Alfa Laval Agri Int | Fibronectin binding protein as well as its preparation |
US5440014A (en) | 1990-08-10 | 1995-08-08 | H+E,Uml/Oo/ K; Magnus | Fibronectin binding peptide |
US5851794A (en) | 1990-10-22 | 1998-12-22 | Alfa Laval Ab | Collagen binding protein as well as its preparation |
EP0519596B1 (en) | 1991-05-17 | 2005-02-23 | Merck & Co. Inc. | A method for reducing the immunogenicity of antibody variable domains |
US5980908A (en) | 1991-12-05 | 1999-11-09 | Alfa Laval Ab | Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment |
ATE300617T1 (de) * | 1993-02-05 | 2005-08-15 | Smithkline Beecham Plc | Fibronektinbindungsprotein, monoklonaler antikoerper und ihre verwendung zur verhuetung der adhäsion von bakterien |
US6008341A (en) | 1994-08-22 | 1999-12-28 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | S. aureus fibrinogen binding protein gene |
US5707702A (en) | 1994-12-14 | 1998-01-13 | Brady, Jr.; Robert F. | Epoxy pipelining composition and method of manufacture |
US6013482A (en) * | 1996-10-15 | 2000-01-11 | Smithkline Beecham Plc | Cell surface protein compounds |
US6737248B2 (en) * | 1996-01-05 | 2004-05-18 | Human Genome Sciences, Inc. | Staphylococcus aureus polynucleotides and sequences |
AU2192497A (en) * | 1996-02-29 | 1998-09-18 | Washington University | Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
EP0950068B1 (en) | 1996-05-16 | 2005-11-09 | THE TEXAS A&M UNIVERSITY SYSTEM | Collagen binding protein compositions and methods of use |
SE9602496D0 (sv) | 1996-06-20 | 1996-06-20 | Bengt Guss | Method and means for producing a fibrinogen binding protein and its use in biotechnology |
US6294177B1 (en) * | 1996-09-11 | 2001-09-25 | Nabi | Staphylococcus aureus antigen-containing whole cell vaccine |
WO1999027109A2 (en) * | 1997-11-26 | 1999-06-03 | Inhibitex, Inc. | EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS) |
EP2330192A1 (en) | 1998-08-31 | 2011-06-08 | The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin | Polypeptides and polynucleotides from coagulase-negative staphylococci |
WO2000012132A1 (en) * | 1998-08-31 | 2000-03-09 | Inhibitex, Inc. | Staphylococcal immunotherapeutics via donor selection and donor stimulation |
EP1173485A1 (en) | 1999-05-03 | 2002-01-23 | Medarex, Inc. | Human antibodies to staphylococcus aureus |
GB0014907D0 (en) * | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
AT410798B (de) * | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
-
2002
- 2002-06-17 EP EP10182270A patent/EP2339344A1/en not_active Withdrawn
- 2002-06-17 EP EP10182027A patent/EP2320233A1/en not_active Withdrawn
- 2002-06-17 AU AU2002322127A patent/AU2002322127B2/en not_active Ceased
- 2002-06-17 CN CNB028160010A patent/CN100359327C/zh not_active Expired - Fee Related
- 2002-06-17 EP EP02756219A patent/EP1423701B1/en not_active Expired - Lifetime
- 2002-06-17 JP JP2003506301A patent/JP4424984B2/ja not_active Expired - Fee Related
- 2002-06-17 CA CA2450939A patent/CA2450939C/en not_active Expired - Fee Related
- 2002-06-17 WO PCT/US2002/019220 patent/WO2002102829A2/en active Application Filing
- 2002-06-17 US US10/172,502 patent/US6841154B2/en not_active Expired - Lifetime
- 2002-06-17 MX MXPA03011701A patent/MXPA03011701A/es active IP Right Grant
-
2004
- 2004-12-27 US US11/020,509 patent/US20050106648A1/en not_active Abandoned
-
2005
- 2005-01-31 HK HK05100802A patent/HK1068949A1/xx not_active IP Right Cessation
-
2008
- 2008-11-21 AU AU2008249159A patent/AU2008249159B2/en not_active Ceased
-
2009
- 2009-02-04 US US12/365,481 patent/US7968100B2/en not_active Expired - Fee Related
- 2009-10-06 JP JP2009232231A patent/JP2010047581A/ja active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102649817A (zh) * | 2011-02-24 | 2012-08-29 | 复旦大学 | 一种抑制细菌生物膜形成的单克隆抗体 |
CN104098693A (zh) * | 2014-07-15 | 2014-10-15 | 中国人民解放军军事医学科学院生物工程研究所 | 抗金黄色葡萄球菌SasA抗原的单克隆抗体及其应用 |
CN104098693B (zh) * | 2014-07-15 | 2017-05-17 | 中国人民解放军军事医学科学院生物工程研究所 | 抗金黄色葡萄球菌SasA抗原的单克隆抗体及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CA2450939C (en) | 2012-11-06 |
US6841154B2 (en) | 2005-01-11 |
EP1423701A2 (en) | 2004-06-02 |
JP2004534080A (ja) | 2004-11-11 |
CN100359327C (zh) | 2008-01-02 |
EP1423701A4 (en) | 2006-03-29 |
MXPA03011701A (es) | 2004-12-06 |
US7968100B2 (en) | 2011-06-28 |
WO2002102829A2 (en) | 2002-12-27 |
AU2002322127B2 (en) | 2008-08-21 |
JP4424984B2 (ja) | 2010-03-03 |
EP1423701B1 (en) | 2012-07-25 |
US20030185833A1 (en) | 2003-10-02 |
EP2320233A1 (en) | 2011-05-11 |
AU2008249159B2 (en) | 2011-04-14 |
US20050106648A1 (en) | 2005-05-19 |
WO2002102829A3 (en) | 2004-03-25 |
AU2008249159A1 (en) | 2008-12-11 |
EP2339344A1 (en) | 2011-06-29 |
US20090202578A1 (en) | 2009-08-13 |
CA2450939A1 (en) | 2002-12-27 |
JP2010047581A (ja) | 2010-03-04 |
HK1068949A1 (en) | 2005-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1543569A (zh) | 识别凝血酶阴性的葡萄球菌和金黄色葡萄球菌的表面蛋白的交叉反应性单克隆抗体和多克隆抗体 | |
US9688745B2 (en) | Gram-positive bacteria specific binding compounds | |
Pandey | Hybridoma technology for production of monoclonal antibodies | |
CN1283798C (zh) | 凝固酶阴性葡萄球菌的多肽及多核苷酸 | |
AU2002322127A1 (en) | Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus | |
CN113150129B (zh) | 抗新冠病毒SARS-CoV-2表面S2蛋白的单链抗体及其应用 | |
CN1317976A (zh) | 多组分疫苗 | |
CN1711476A (zh) | 小分析物的非竞争性免疫测定 | |
CN111153992A (zh) | 结核分枝杆菌lam的单克隆抗体及其用途 | |
WO2018165089A1 (en) | Human monoclonal antibodies to staphylococcus aureus lukab toxin | |
CN110702913B (zh) | 一种用于定量检测贝氏柯克斯体i相株的单抗组合物 | |
CN109096394B (zh) | 一种抗葡萄球菌蛋白a的b亚单位的纳米抗体及核酸分子和应用 | |
CN101074263A (zh) | 一种重组抗proteinA单克隆抗体及其制备方法和用途 | |
Lenkey | Using phage display to select peptides binding to type 8 capsular polysaccharide of Staphylococcus aureus | |
BEAUMONT et al. | Patent 2768204 Summary | |
Linnes | Staphylococcus epidermidis extracellular matrix binding protein and its role in adhesion and biofilm formation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1068949 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1068949 Country of ref document: HK |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080102 Termination date: 20130617 |